intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
NA,95,296,44,578,6,1019
placebo,125,209,14,326,67,741
standard care,19,85,3,81,14,202
questionnaire,11,63,4,65,2,145
hydroxychloroquine,19,38,6,35,30,128
convalescent plasma,13,52,2,40,8,115
no intervention,6,30,4,41,0,81
blood sample,8,16,2,45,1,72
ivermectin,2,28,1,19,2,52
remdesivir,4,17,0,29,2,52
saline,13,17,1,20,1,52
azithromycin,8,11,2,18,7,46
tocilizumab,6,14,0,21,5,46
pcr,2,20,2,13,0,37
favipiravir,7,15,0,14,0,36
serology test,4,11,3,18,0,36
vaccine,3,1,1,31,0,36
prone positioning,3,17,0,13,1,34
ritonavir,4,10,2,17,1,34
exercise,1,11,3,18,0,33
mesenchymal stem cells,7,10,0,16,0,33
vitamin d,4,9,2,12,4,31
dexamethasone,2,5,0,18,4,29
lopinavir,4,7,2,12,1,26
oxygen,6,3,0,14,3,26
colchicine,1,8,0,13,2,24
control,4,6,0,11,3,24
methylprednisolone,0,12,0,12,0,24
enoxaparin,0,8,0,12,2,22
lopinavir/ritonavir,4,6,2,9,1,22
biological samples,2,5,0,14,0,21
bnt162b2,4,4,0,13,0,21
heparin,2,8,1,10,0,21
nitazoxanide,2,8,0,9,2,21
saliva,5,7,1,8,0,21
chloroquine,0,8,1,4,7,20
observational,3,6,0,10,1,20
vitamin c,3,6,0,9,1,19
data collection,1,7,1,9,0,18
interferon,1,5,1,11,0,18
telehealth,2,8,1,7,0,18
online survey,1,9,2,5,0,17
camostat mesilate,2,3,0,8,3,16
mrna-1273,6,0,0,10,0,16
plasma,4,7,0,3,2,16
survey,2,9,0,5,0,16
anakinra,2,5,0,4,4,15
baricitinib,1,5,0,7,1,14
covid-19,0,3,0,10,1,14
ad26.cov2.s,5,2,0,6,0,13
bcg,6,2,0,5,0,13
zinc,1,3,1,8,0,13
blood test,2,2,0,8,0,12
hydroxychloroquine / azithromycin,3,5,2,1,1,12
lung ultrasound,2,5,0,4,1,12
radiotherapy,1,3,0,7,1,12
best available therapy,0,5,0,6,0,11
ct-scan,0,5,0,6,0,11
rivaroxaban,1,2,0,7,1,11
ruxolitinib,0,5,0,2,4,11
rapid test,1,5,1,3,0,10
ace inhibitor,0,5,0,4,0,9
coronavac,3,0,0,6,0,9
igm/igg rapid test,0,4,2,3,0,9
nasopharyngeal swab,1,5,0,3,0,9
observation,2,4,0,3,0,9
azd1222,2,1,0,5,0,8
exposure,1,4,0,3,0,8
famotidine,2,3,0,2,1,8
gam-covid-vac,4,2,0,2,0,8
inactivated sars-cov-2 vaccine,4,0,2,2,0,8
interview,1,3,0,4,0,8
losartan,0,5,0,3,0,8
nitric oxide,6,1,0,0,1,8
sarilumab,2,4,0,1,1,8
apixaban,0,1,0,5,1,7
biospecimen collection,1,1,0,5,0,7
casirivimab,1,0,0,6,0,7
cholecalciferol,0,3,0,4,0,7
covid-19 pandemic,1,3,0,3,0,7
imdevimab,1,0,0,6,0,7
inactivated covid-19 vaccine,0,0,0,7,0,7
mindfulness,0,2,1,4,0,7
niclosamide,0,2,0,4,1,7
quality-of-life assessment,0,0,0,7,0,7
spirometry,1,1,1,4,0,7
therapeutic plasma exchange (tpe),0,5,0,2,0,7
,0,3,1,2,0,6
adenovirus type 5 vector,2,1,0,3,0,6
azd7442,3,1,0,2,0,6
budesonide,0,2,0,3,1,6
cellectraâ® 2000,2,0,0,4,0,6
chest ct,1,3,0,2,0,6
corticosteroid,1,0,0,5,0,6
doxycycline,0,4,0,2,0,6
echocardiography,0,3,0,3,0,6
igg,0,3,1,2,0,6
igg antibody test,1,3,2,0,0,6
igm,0,2,1,3,0,6
interleukin,0,1,0,5,0,6
lenzilumab,2,2,0,2,0,6
melatonin,1,2,0,3,0,6
n-acetylcysteine,1,2,0,2,1,6
nafamostat mesilate,1,2,0,3,0,6
oseltamivir,1,0,0,5,0,6
peginterferon,0,1,0,3,2,6
povidone/iodine,0,4,0,2,0,6
pulmonary rehabilitation,0,2,1,3,0,6
pulmozyme,0,1,0,5,0,6
serum test,0,3,0,3,0,6
sofosbuvir,0,3,0,3,0,6
supportive care,1,4,0,1,0,6
ampion,1,1,0,3,0,5
arb,1,1,0,3,0,5
arbidol,1,2,0,2,0,5
aspirin,0,0,1,3,1,5
atorvastatin,0,1,0,4,0,5
bamlanivimab,1,2,0,2,0,5
best supportive care,0,2,0,2,1,5
biological,1,1,0,3,0,5
blood,2,1,0,2,0,5
ciclesonide,0,2,0,2,1,5
clazakizumab,0,3,0,2,0,5
clinical assessment,0,3,0,2,0,5
data,2,3,0,0,0,5
ecg,0,1,0,4,0,5
experimental group,0,2,0,3,0,5
fluvoxamine,0,2,0,3,0,5
high flow nasal cannula,0,4,0,1,0,5
inactivated vaccine,1,1,0,3,0,5
kg,0,2,0,2,1,5
ly3819253,1,3,0,1,0,5
mri,0,0,0,5,0,5
nk cells,2,0,0,3,0,5
pf-07321332,0,1,0,4,0,5
proxalutamide,1,3,0,1,0,5
quercetin,0,3,0,2,0,5
recombinant new coronavirus vaccine (cho cell) group,0,1,0,4,0,5
sargramostim,1,3,0,1,0,5
sars-cov-2 vaccine,0,0,0,5,0,5
telmisartan,0,1,0,4,0,5
test,0,1,0,4,0,5
tinzaparin,0,2,0,3,0,5
ultrasound,0,5,0,0,0,5
vir-7831,1,2,0,2,0,5
acalabrutinib,1,2,0,0,1,4
bacille calmette-guã©rin (bcg),2,0,0,2,0,4
bromhexine hydrochloride,1,1,1,1,0,4
chadox1,3,0,0,1,0,4
chloroquine/hydroxychloroquine,0,1,1,2,0,4
cpap,1,0,0,2,1,4
cyclosporine,1,1,0,2,0,4
daclatasvir,0,1,0,3,0,4
defibrotide,0,1,0,3,0,4
education,0,2,1,1,0,4
electronic health record review,0,0,0,4,0,4
emtricitabine,0,3,0,1,0,4
fostamatinib,0,1,0,3,0,4
igm antibodytest,0,3,0,1,0,4
immunoglobulin,0,3,0,1,0,4
infliximab,0,1,0,3,0,4
information,3,0,0,1,0,4
mask,0,3,0,0,1,4
mavrilimumab,0,2,0,2,0,4
mesenchymalÂ stem cells,0,1,0,3,0,4
methylene blue,1,1,0,2,0,4
mvc-cov1901(s protein with adjuvant),4,0,0,0,0,4
na-831,0,0,2,2,0,4
other,0,2,0,2,0,4
paracetamol,1,1,0,2,0,4
phone call,2,1,0,1,0,4
physiotherapy,0,2,0,2,0,4
pirfenidone,0,0,0,4,0,4
probiotic,0,1,0,3,0,4
quality of life,0,2,1,1,0,4
regn10933,1,3,0,0,0,4
regn10987,1,3,0,0,0,4
sars-cov-2 rs,3,0,0,1,0,4
sodium,0,0,0,4,0,4
walk test,1,0,0,3,0,4
6 minute walk test,0,1,1,1,0,3
active placebo,0,0,0,3,0,3
acupressure,0,0,2,1,0,3
adsorbed covid-19 (inactivated) vaccine,3,0,0,0,0,3
allocetra-ots,1,0,0,2,0,3
anticoagulation,0,2,0,1,0,3
appendectomy,0,3,0,0,0,3
asbrip,0,3,0,0,0,3
at-527,0,1,0,2,0,3
atazanavir,0,1,0,2,0,3
av-covid-19,0,2,0,1,0,3
ayurveda,0,3,0,0,0,3
behavior,0,0,1,2,0,3
bevacizumab,0,1,0,1,1,3
blood donation sms,0,1,2,0,0,3
bnt162b1,0,1,0,2,0,3
breath biopsy,0,3,0,0,0,3
breath test,1,2,0,0,0,3
brii-196,0,0,0,3,0,3
brii-196/brii-198,0,0,0,3,0,3
brii-198,0,0,0,3,0,3
bronchoalveolar lavage,1,0,0,2,0,3
canakinumab,0,3,0,0,0,3
cannabidiol,1,1,0,1,0,3
cardiac mri,1,1,0,1,0,3
casirivimab/imdevimab,1,0,0,2,0,3
clinical data,2,0,0,1,0,3
clopidogrel,0,1,0,2,0,3
comirnaty,1,1,0,1,0,3
coviage,0,3,0,0,0,3
covid-19 vaccination,0,0,0,3,0,3
cvncov vaccine,2,1,0,0,0,3
cytosorb,0,1,0,2,0,3
dalteparin,0,2,0,1,0,3
data record,0,0,0,3,0,3
diagnostic laboratory biomarker analysis,0,0,0,3,0,3
distilled water,0,2,0,1,0,3
eidd-2801,0,2,0,1,0,3
elisa,0,3,0,0,0,3
ensovibep,0,1,0,2,0,3
epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),2,1,0,0,0,3
fisetin,0,0,3,0,0,3
flow cytometry,0,2,0,1,0,3
had5-s-fusion,2,0,0,1,0,3
honey,0,1,0,2,0,3
hyperbaric oxygen,0,0,0,2,1,3
hzvsf-v13,0,2,0,1,0,3
inactive sars-cov-2 vaccine (vero cell),1,0,0,2,0,3
ino-4800,1,0,0,2,0,3
kb109,0,3,0,0,0,3
leflunomide,1,0,0,2,0,3
low,1,0,0,2,0,3
ly3832479,1,2,0,0,0,3
maraviroc,0,1,0,2,0,3
meditation,1,1,1,0,0,3
moderna covid-19 vaccine,1,0,0,2,0,3
molnupiravir,1,0,0,1,1,3
naltrexone,0,0,1,1,1,3
nasal,0,1,0,2,0,3
non-interventional,1,1,0,1,0,3
nutrition,1,0,0,2,0,3
ofatumumab,0,0,0,3,0,3
opaganib,0,3,0,0,0,3
pcr/serology,0,1,0,2,0,3
pfizer-biontech covid-19 vaccine,0,1,0,2,0,3
physical therapy,2,1,0,0,0,3
placebo control,0,0,1,2,0,3
prednisone,0,1,0,0,2,3
probiotics,0,2,0,1,0,3
psychological,1,1,0,1,0,3
ravulizumab,0,0,0,2,1,3
rehabilitation,0,2,0,1,0,3
resveratrol,1,0,0,1,1,3
ribavirin,0,1,0,1,1,3
sample collection,2,0,0,1,0,3
sampling,0,0,0,3,0,3
sars-cov-2,0,1,0,1,1,3
self supportive care (ssc) alone,0,3,0,0,0,3
sevoflurane,0,1,0,1,1,3
simple cognitive task intervention,0,2,0,1,0,3
sirolimus,0,0,0,3,0,3
sng001,1,0,0,2,0,3
splenic ultrasound,1,1,1,0,0,3
surgical mask,0,3,0,0,0,3
suspension of heat killed (autoclaved) mycobacterium w,0,1,0,2,0,3
taste,0,2,0,1,0,3
throat swab,0,1,0,2,0,3
thromboprophylaxis,0,1,0,2,0,3
tofacitinib,0,2,0,0,1,3
transcranial direct current stimulation,0,0,0,3,0,3
ub-612,0,2,0,1,0,3
vitamin super b-complex,2,1,0,0,0,3
viusid,0,3,0,0,0,3
vla2001,2,0,0,1,0,3
vpm1002,2,1,0,0,0,3
water,0,1,0,0,2,3
yoga,0,0,0,3,0,3
),0,0,1,1,0,2
[18f]f-arag (2'-deoxy-2'-fluoro-9-î²-d-arabinofuranosylguanine),0,0,0,2,0,2
1 âµg cov2 sam (lnp),2,0,0,0,0,2
10 to 14 days later,0,0,0,2,0,2
100 mg,1,1,0,0,0,2
18f-î±vî²6-bp,0,0,2,0,0,2
202-cov low adjuvant dose,0,0,0,2,0,2
202-cov low antigen dose,0,0,0,2,0,2
202-cov standard dose,0,0,0,2,0,2
28-day schedule,0,0,1,1,0,2
2nd dose),1,1,0,0,0,2
3 doses recombinant covid-19 vaccine (cho cellï¼œnvsi-06-08),0,0,0,2,0,2
4c mortality score,0,0,0,2,0,2
99mtc-pertechnetate aerosol,0,2,0,0,0,2
a questionnaire,0,1,0,1,0,2
aã§aã­ palm berry extract - natural product,0,0,0,2,0,2
abatacept,0,0,0,1,1,2
acebilustat,0,0,0,2,0,2
acetylsalicylic acid,0,1,0,1,0,2
acteevâ„¢ masks,0,0,0,2,0,2
acute kidney injury,0,1,0,1,0,2
adg20,0,0,0,2,0,2
adjuvant,1,0,0,1,0,2
advax-sm adjuvant,2,0,0,0,0,2
aeonose,0,2,0,0,0,2
aerobic exercises,0,0,1,1,0,2
akl-t01,0,0,0,2,0,2
amantadine,0,0,0,2,0,2
ambrisentan,0,0,0,2,0,2
"anti-covid19 mrna-based vaccine (bnt162b2, comirnatyâ®, commercialized by pfizer)",0,0,0,2,0,2
antibody test,0,1,0,1,0,2
antigen,1,0,0,1,0,2
antihypertensives,1,0,0,1,0,2
antithrombin iii,1,0,0,1,0,2
anxiety,0,1,0,1,0,2
artecomâ® (pyronaridine-artesunate),0,0,0,2,0,2
artesunate,0,1,0,1,0,2
assessment of the anti-sars-cov-2 igg antibody titer in 2-dose schedule,1,0,0,1,0,2
assessment of the anti-sars-cov-2 igg antibody titer in 3-dose schedule,1,0,0,1,0,2
assessment of work-related stress,1,1,0,0,0,2
autopsy,0,1,0,1,0,2
avdoralimab,1,1,0,0,0,2
avigan,1,0,0,1,0,2
aviptadil,0,1,0,1,0,2
aviptadil 67î¼g,0,0,0,2,0,2
bat,0,0,0,1,1,2
bbv152,1,0,0,1,0,2
bdb-001 injection,0,1,0,1,0,2
behavioral,0,0,1,0,1,2
bioargininaâ®,0,0,0,2,0,2
biosensor,0,0,0,2,0,2
blank preparation of recombinant sars-cov-2 fusion protein vaccine (v-01),0,0,0,2,0,2
blood draw,0,0,0,2,0,2
bnt162b2 mrna covid-19 vaccine,0,0,0,2,0,2
bnt162b2 vaccine,0,0,0,2,0,2
bovine lactoferrin,0,0,0,1,1,2
breath biopsy face masks with removable filters/fitted pva strip,0,2,0,0,0,2
breathing,0,0,1,1,0,2
brequinar,0,2,0,0,0,2
brescä°a-covä°d respiratory severity scale,0,2,0,0,0,2
broncho-vaxomâ®,2,0,0,0,0,2
c21,0,1,0,1,0,2
canine odor detection of volatile organic compounds,0,1,0,1,0,2
capillary blood sampling,0,1,0,1,0,2
cardiac,1,1,0,0,0,2
cardiac/electrodermal recordings,1,1,0,0,0,2
caring contacts,1,0,1,0,0,2
casirivimab / imdevimab,0,0,0,2,0,2
celecoxib,1,0,0,1,0,2
cellectraâ„¢ 2000,0,0,0,2,0,2
cellular immunity,0,1,1,0,0,2
chadox1-s not less than 2.5 ã— 10^8 infectious units,0,0,0,2,0,2
chest computed tomography,0,2,0,0,0,2
chlorine dioxide,0,0,0,2,0,2
clevudine,0,0,0,2,0,2
clinical examination,0,1,0,1,0,2
clorhexidine dental phbâ©,0,2,0,0,0,2
cobicistat,0,0,0,2,0,2
colgate periogardâ® mouthwash,0,0,2,0,0,2
colgate peroxylâ® -1.5% hydrogen peroxide,0,2,0,0,0,2
colgate peroxylâ® mouthwash,0,0,2,0,0,2
colgate totalâ® mouthwash,0,0,2,0,0,2
cominarty (pfizer-biontech),0,0,0,2,0,2
conjunctival swab,0,1,0,1,0,2
control treatment schedule,1,1,0,0,0,2
controls,0,0,0,2,0,2
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",0,0,0,2,0,2
conventional oxygen therapy,0,2,0,0,0,2
coronavirus vaccine,0,0,0,2,0,2
corsodylâ® alcohol free -0.2 % chlorhexidine digluconate,0,2,0,0,0,2
covax,1,1,0,0,0,2
covax only (1st,1,1,0,0,0,2
covax only (1st/2nd dose),1,1,0,0,0,2
covi-amg,0,0,0,2,0,2
covi-msc,0,0,0,2,0,2
covid-19 antibody test,0,1,1,0,0,2
covid-19 infection,0,1,0,0,1,2
covid-19 patients,1,0,0,1,0,2
covid-19 testing,0,0,1,1,0,2
covid-19 vaccine hipra,0,0,0,2,0,2
covid-19/ observational,0,0,0,1,1,2
covid-viroâ® test,0,2,0,0,0,2
covidity administered via needle-free injection (pharmajet stratisâ®; intramuscular injection).,0,0,0,2,0,2
covidity administered via needle-free injection (pharmajet tropisâ®; intradermal injection).,0,0,0,2,0,2
ct-p59,1,1,0,0,0,2
culturally adapted cognitive behavioral intervention (ca-cbi),0,0,0,2,0,2
curosurfâ® (poractant alfa),0,0,0,2,0,2
current clinical practices of participating physicians,0,2,0,0,0,2
cvncov,1,0,0,1,0,2
cvncov 12 î¼g,2,0,0,0,0,2
cvncov 12î¼g,2,0,0,0,0,2
cvncov 6 î¼g,2,0,0,0,0,2
cyt107,0,0,0,2,0,2
cytokine adsorption,0,1,0,1,0,2
cytotoxic t lymphocytes,0,0,0,2,0,2
d,0,1,0,1,0,2
dapagliflozin,0,1,0,1,0,2
darunavir,0,0,0,2,0,2
darunavir/cobicistat,0,0,0,2,0,2
data collection/clinical testing of subjects,0,1,0,1,0,2
"ddropsâ® products, 50,000 iu, oral",0,0,0,2,0,2
diagnostic test,0,1,0,1,0,2
dialysis,1,0,0,1,0,2
diffusing capacity of carbon monoxide,0,0,1,1,0,2
dipyridamole,0,1,0,1,0,2
disulfiram,0,1,0,1,0,2
dornase alfa,0,2,0,0,0,2
dose),1,0,0,1,0,2
dose)- stage 2,2,0,0,0,0,2
dose) - stage 1,2,0,0,0,0,2
dose) - stage 2,2,0,0,0,0,2
drã¤ger antigen test sars-cov-2,0,0,0,0,2,2
duvelisib,0,0,0,2,0,2
dzif-10c,0,2,0,0,0,2
ðžxygen therapy,0,0,0,2,0,2
ebselen,0,0,2,0,0,2
ec-18,0,0,0,2,0,2
edp1815,0,0,0,1,1,2
electrical impedance tomography,0,1,0,1,0,2
electrodermal recordings,1,1,0,0,0,2
elispot,0,0,0,2,0,2
emotional stimulation,1,1,0,0,0,2
endotracheal intubation,0,0,0,2,0,2
entrã©e: behavioral skills,0,2,0,0,0,2
entrã©e: cognitive skills,0,2,0,0,0,2
entrã©e: interpersonal skills,0,2,0,0,0,2
escola l'horitzã³,0,2,0,0,0,2
essential oils,1,1,0,0,0,2
evaluation,0,2,0,0,0,2
exo 1,0,1,1,0,0,2
exo 2,0,1,1,0,0,2
extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,0,0,0,2,0,2
face mask,0,2,0,0,0,2
favipiravir / standard care,0,1,0,1,0,2
favipiravir/hydroxychloroquine,1,1,0,0,0,2
fear of covid-19 scale,0,1,0,1,0,2
fenofibrate,0,0,1,1,0,2
file scanning,0,1,0,1,0,2
filmarrayâ® analysis,0,2,0,0,0,2
fit test,0,2,0,0,0,2
fitted pva strip,0,2,0,0,0,2
fmd,0,0,0,2,0,2
folic acid,1,0,0,1,0,2
fondaparinux,0,2,0,0,0,2
fotv,0,0,0,2,0,2
fultiumâ® -d3 800,0,2,0,0,0,2
fuzheng huayu,0,1,0,1,0,2
gam-covid-vac / gam-covid-vac,0,1,0,1,0,2
gammacoreâ® (vagus nerve stimulation),2,0,0,0,0,2
gammacoreâ® sapphire (non-invasive vagus nerve stimulator),2,0,0,0,0,2
gargle,0,0,0,2,0,2
glycine,0,0,0,2,0,2
grad-cov2,1,1,0,0,0,2
guduchi ghan vati,0,2,0,0,0,2
gx-19n,2,0,0,0,0,2
gx-i7,0,0,0,2,0,2
had5-s-fusion/n-etsd vaccine,1,0,0,1,0,2
health supplements,0,0,0,2,0,2
home based exercises,0,1,0,1,0,2
hormones,1,0,0,1,0,2
human amniotic fluid,0,0,0,2,0,2
hyperimmune immunoglobulin to sars-cov-2 (hivig),0,1,0,1,0,2
î²-hydroxy î²-methyl butyrate (hmb) enriched amino acid,0,0,0,2,0,2
"ib10 sphingotestâ® bio-admâ® apparatus (sphingotec gmbh, hennigsdorf, germany)",0,0,0,2,0,2
ibrutinib,0,1,0,1,0,2
ibuprofen,0,0,0,2,0,2
icu treatment,0,0,0,2,0,2
id nowâ„¢ covid-19 screening test,2,0,0,0,0,2
igg test,0,1,0,1,0,2
iiv4,1,0,0,1,0,2
iloprost,0,1,0,1,0,2
imatinib,1,0,0,1,0,2
impulseâ„¢ una e-stethoscope,0,2,0,0,0,2
impulseâ„¢ una infrasound-to-ultrasound e-stethoscope,0,0,0,2,0,2
imu-838,0,1,0,1,0,2
inactivated sars-cov-2 vaccine (vero cellï¼‰,2,0,0,0,0,2
indicators of central sensitisation,0,0,0,2,0,2
inspiratory muscle training,0,0,0,2,0,2
interferon-ãÿ-1a,0,0,0,0,2,2
interferon-î² 1a,0,0,2,0,0,2
interferon î²-1b,0,0,0,2,0,2
intramuscular vaccine,2,0,0,0,0,2
ion mobility spectrometry (ims),0,2,0,0,0,2
iota-carrageenan,0,1,0,1,0,2
js016,0,0,0,2,0,2
kb109 / self supportive care (ssc),0,2,0,0,0,2
kg),0,0,0,2,0,2
l-citrulline,0,1,0,1,0,2
laboratory test,0,0,0,2,0,2
lanadelumab,0,2,0,0,0,2
laryngoscope,0,1,0,1,0,2
ledipasvir,0,2,0,0,0,2
leronlimab,0,0,0,2,0,2
life2000â® ventilator,0,0,0,2,0,2
longitudinally,0,0,0,2,0,2
lucira covid-19 all-in-one test kit,0,2,0,0,0,2
lung ultrasound (lus),0,0,0,2,0,2
machine learning,0,0,0,2,0,2
mad0004j08,1,0,0,1,0,2
"magpro x100 stimulator, b70 fluid-cooled coil",2,0,0,0,0,2
marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),0,0,0,2,0,2
mechanical ventilation,1,0,0,1,0,2
meditation (1 x 20-minute guided audio training),0,0,0,2,0,2
medium dosage inactivated sars-cov-2 vaccine,2,0,0,0,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-,0,0,1,1,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,0,0,1,1,0,2
mefloquine,0,2,0,0,0,2
menacwy,2,0,0,0,0,2
meplazumab,0,1,0,1,0,2
metanebâ® system,0,0,0,2,0,2
microbiome immunity formula,0,0,0,2,0,2
mindfulness-based stress reduction,0,0,1,1,0,2
"moderna covid-19 vaccine, mrna-1273 (100 î¼g)",2,0,0,0,0,2
moderna mrna-1273,0,0,0,2,0,2
moderna mrna-1273 covid-19 vaccine,0,0,0,2,0,2
monoclonal antibody,0,0,0,2,0,2
mrna-1273.211,0,0,0,2,0,2
mrna-1273.351,1,1,0,0,0,2
musä±c therapy,0,0,0,2,0,2
mvc-cov1901,1,0,0,1,0,2
mvc-cov1901(saline),2,0,0,0,0,2
n-etsd vaccine,1,0,0,1,0,2
nä°cas,0,0,0,2,0,2
nanomix elabâ® covid-19 rapid antigen panel (non-interventional),0,2,0,0,0,2
nasafytolâ®,0,2,0,0,0,2
nasal rinse,0,0,0,2,0,2
nasopharyngeal,1,1,0,0,0,2
nasopharyngeal swabs,1,0,0,1,0,2
ndv-hxp-s 10î¼g (stage a),0,0,0,2,0,2
ndv-hxp-s 1î¼g (stage a),0,0,0,2,0,2
ndv-hxp-s 3î¼g (stage a),0,0,0,2,0,2
neurocognitive assessment,0,0,0,2,0,2
neuromuscular electrical stimulation,0,0,0,2,0,2
neuropsychological assessment,0,0,0,2,0,2
news,0,1,0,0,1,2
nicotinamide,0,1,0,1,0,2
nicotinamide riboside,0,0,0,2,0,2
nigella sativa oil,0,1,0,1,0,2
nintedanib,0,0,0,2,0,2
nioâ® (intraosseous access),0,2,0,0,0,2
nitric oxide delivered via lungfitâ„¢ system,0,0,0,2,0,2
non,0,1,1,0,0,2
non interventional study,0,0,0,2,0,2
normal saline (0.9% sodium chloride solution)- stage 2,2,0,0,0,0,2
normal saline (0.9% sodium chloride solution) - stage 1,2,0,0,0,0,2
not applicable (observational study),0,1,0,1,0,2
novaferon,0,0,0,2,0,2
nowdx covid-19 test,0,1,0,0,1,2
nusepinâ® 0.1 mg,0,0,0,2,0,2
nusepinâ® 0.2 mg,0,0,0,2,0,2
octagam,1,1,0,0,0,2
omega-3,1,0,0,1,0,2
omega3-fatty acid,0,0,1,1,0,2
omegavenâ®,0,0,0,2,0,2
online questionnaires,0,2,0,0,0,2
online support group,1,1,0,0,0,2
ophthalmologic exam,0,2,0,0,0,2
oral,0,1,0,1,0,2
oral polio vaccine,1,0,1,0,0,2
oximenâ® 3%,0,2,0,0,0,2
patient-reported online questionnaire on olfactory,0,1,0,1,0,2
patient-reported online questionnaire on olfactory/taste disturbances,0,1,0,1,0,2
patient navigation (pn),2,0,0,0,0,2
pegylated interferon-î±2b,2,0,0,0,0,2
pentarlandirâ„¢ uppta,0,0,0,2,0,2
pf-06650833,0,0,0,1,1,2
pf-07304814,0,1,0,1,0,2
pfizer,1,0,1,0,0,2
pfizer-biontech covid-19 vaccine bnt162b2 (30 âµg)( comirnatyâ®),2,0,0,0,0,2
phone call interview,0,1,0,1,0,2
photobiomodulation,1,0,0,1,0,2
photodynamic therapy,1,1,0,0,0,2
physical activity level,0,0,1,1,0,2
physical examination,0,0,0,2,0,2
placebo injection,0,0,0,2,0,2
plitidepsin,0,1,0,1,0,2
plx-pad,2,0,0,0,0,2
poc covidxâ„¢ rapid antigen test,0,2,0,0,0,2
povidone-iodine,0,0,0,2,0,2
practice details,0,2,0,0,0,2
prayer,0,0,0,2,0,2
preventive information,2,0,0,0,0,2
prothioneâ„¢ (6g),2,0,0,0,0,2
protransâ®,0,0,0,2,0,2
psychoeducational intervention,0,0,0,2,0,2
pul-042,0,2,0,0,0,2
pulmonary function test,0,0,0,2,0,2
pyronaridine-artesunate,0,2,0,0,0,2
qazcovid-inâ®-vaccine against covid-19,0,2,0,0,0,2
qazcovid-inâ® - covid-19 inactivated vaccine,0,2,0,0,0,2
quantitative analysis of sars-cov-2 antibodies,0,1,1,0,0,2
questionaire,0,1,1,0,0,2
questionnaire survey,0,2,0,0,0,2
rad26-s,0,0,0,2,0,2
radiological,0,0,0,2,0,2
rd-x19,0,1,0,1,0,2
recombinant covid-19 vaccine (cho cellï¼œnvsi-06-08),0,0,0,2,0,2
recombinant human interferon î±2b spray,2,0,0,0,0,2
recombinant new coronavirus vaccine (cho cell),0,0,0,2,0,2
recombinant new coronavirus vaccine (cho cell) low-dose group,2,0,0,0,0,2
recombinant new coronavirus vaccine (cho cells) high-dose group,2,0,0,0,0,2
recombinant sars-cov-2 ad5 vectored vaccine,1,0,0,1,0,2
recombinant sars-cov-2 fusion protein vaccine,2,0,0,0,0,2
recombinant sars-cov-2 fusion protein vaccine (v-01),0,0,0,2,0,2
recommended treatment schedule,1,1,0,0,0,2
recop unit patient,0,2,0,0,0,2
recordings of cough sounds from adults,0,0,0,2,0,2
regn10933 / regn10987,1,1,0,0,0,2
regn10933/regn10987 combination therapy,0,2,0,0,0,2
reparixin,0,0,0,1,1,2
"resp301, a nitric oxide generating solution",0,0,0,2,0,2
retrospective data collection,0,0,0,2,0,2
rhea health toneâ®,2,0,0,0,0,2
rosmalipâ®,0,0,2,0,0,2
rosuvastatin,0,1,0,1,0,2
rothâ´s test,0,2,0,0,0,2
rtb101,1,0,0,0,1,2
ruconest,0,0,0,2,0,2
rutiâ® vaccine,0,0,0,2,0,2
saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,0,2,0,0,0,2
saliva sampling,0,1,0,1,0,2
sars-cov-2 mrna vaccine,1,0,0,1,0,2
sars-cov-2 recombinant spike protein,2,0,0,0,0,2
sars-cov-2 recombinant spike protein / advax-sm adjuvant,2,0,0,0,0,2
sars-cov-2 rs/matrix-m1 adjuvant,1,0,0,1,0,2
sars-cov-2 virus,1,0,0,1,0,2
sars-cov2 infection,1,0,0,1,0,2
sars-cov2 testing,0,1,0,1,0,2
scb-2019,1,0,0,1,0,2
scta01,0,1,0,1,0,2
self-benefit,0,1,1,0,0,2
self supportive care (ssc),0,2,0,0,0,2
self test,0,0,0,2,0,2
selinexor,0,1,0,1,0,2
semen analysis,0,1,0,1,0,2
semi-directive interview,0,1,0,1,0,2
seraph,0,0,0,2,0,2
seraphâ®-100 microbindâ® affinity blood filter,0,0,2,0,0,2
silmitasertib,1,0,0,1,0,2
siltuximab,0,1,0,1,0,2
silymarin,0,0,0,2,0,2
sivomixx,1,0,0,1,0,2
smell training,1,0,0,1,0,2
soap,1,1,0,0,0,2
sodium bicarbonate,2,0,0,0,0,2
sofosbuvir/daclatasvir,0,1,0,1,0,2
sofosbuvir/ledipasvir,0,2,0,0,0,2
spironolactone,0,1,0,1,0,2
standard covid-19 care,0,2,0,0,0,2
standard of care/placebo,0,1,0,1,0,2
standard treatment of covid-19,0,1,0,1,0,2
stool collection,0,1,0,1,0,2
stress,0,0,0,2,0,2
surgery,0,1,0,1,0,2
swab,0,0,0,2,0,2
t-detectâ„¢ sars-cov-2 assay,0,2,0,0,0,2
tacrolimus,0,0,0,2,0,2
take home saliva kits,2,0,0,0,0,2
targeted wellness formula câ„¢ sublingual drops - 1200mg - 30 ml (formula c),2,0,0,0,0,2
taste disturbances,0,1,0,1,0,2
td-0903,0,2,0,0,0,2
tele-yoga,0,2,0,0,0,2
teleconsultation,1,0,0,1,0,2
teleconsultation either by phone,0,1,0,1,0,2
teleorientation,0,0,0,2,0,2
"telerehabilitation ä°ntervention, motor learning",0,0,0,2,0,2
tenofovir disoproxil,0,2,0,0,0,2
text-messaging (tm),2,0,0,0,0,2
the binaxnowâ„¢ antibody tests measure igg antibodies against sars-cov-2.,0,0,0,2,0,2
therapeutic exercise,0,0,1,1,0,2
"three doses of placebo at the schedule of day 0, 14, 28ï¼ˆhigh-dose groupï¼‰",2,0,0,0,0,2
throat,1,1,0,0,0,2
thymalfasin,0,0,0,2,0,2
tinzaparin/dalteparin,0,2,0,0,0,2
traditional chinese medicine,0,0,0,2,0,2
tricorâ® 145mg tablets,0,0,0,2,0,2
trv027,0,1,0,1,0,2
turkovac,1,0,0,1,0,2
two doses of coronavac,0,0,0,2,0,2
"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,1,0,0,2
"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,1,0,0,2
"two doses of placebo at the schedule of day 0, 28ï¼ˆhigh-dose groupï¼‰",2,0,0,0,0,2
"two doses of placebo at the schedule of day 0, 28ï¼ˆmiddle-dose groupï¼‰",2,0,0,0,0,2
txa127,0,1,0,1,0,2
ty027,0,1,0,1,0,2
ultrasonography,0,1,0,1,0,2
uvc irradiation,0,2,0,0,0,2
vã§ac,0,2,0,0,0,2
vaccination,0,0,0,2,0,2
vaccine comirnatyâ® (bnt162b2),0,0,0,2,0,2
veru-111,0,1,0,1,0,2
vibrolung,0,0,0,2,0,2
vital signs,0,0,0,2,0,2
vitamin d (cholecalciferol),0,0,0,2,0,2
vitamin e,0,1,0,1,0,2
vitis xtra forteâ©,0,2,0,0,0,2
viusid/asbrip,0,2,0,0,0,2
volatile organic compounds analysis,0,1,0,1,0,2
vv-ecmo,0,2,0,0,0,2
writing,0,2,0,0,0,2
xav-19,1,0,0,1,0,2
xc221,0,1,0,1,0,2
zilucoplanâ®,0,2,0,0,0,2
zinc acetate,1,0,0,1,0,2
zyesamiâ„¢ (aviptadil acetate),0,0,0,2,0,2
'tib' olfactory test,0,1,0,0,0,1
- tocilizumab,0,1,0,0,0,1
-cd25,0,0,0,1,0,1
-interferon nebulization,0,1,0,0,0,1
"""sham""-block with placebo (isotone nacl)",0,0,0,1,0,1
"""stay at home take a step program (shtsp)""",0,1,0,0,0,1
(2) interferon-gamma release in response to sars-cov-2 antigen stimulation,0,0,0,1,0,1
(pm,0,0,0,1,0,1
(ppa >95%) fda eua rt-pcr,0,0,0,1,0,1
": igg, ig m serologies in the amniotoc fluid, the blood cord",0,1,0,0,0,1
[11c]sl25.1188 pet scan,0,0,0,1,0,1
[18f]feppa pet scan,0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet,0,1,0,0,0,1
[68ga]ga-dota-(rgd)2 pet/ct,0,1,0,0,0,1
[timp-2]*[igfbp-7],0,1,0,0,0,1
"0, 112 day schedule",0,0,0,1,0,1
"0, 28 day schedule",0,0,0,1,0,1
0.07% cetylpyridinium chloride (cpc) in mouthwash,0,1,0,0,0,1
0.075% cetylpyridinium chloride,1,0,0,0,0,1
0.075% cetylpyridinium chloride (cpc),0,1,0,0,0,1
0.1% sodium hypochlorite,0,1,0,0,0,1
0.12% chg oral rinse,0,0,0,1,0,1
0.12% chlorhexidine gluconate mouth rinse,0,0,0,1,0,1
0.12% chlorohexidine gluconate,1,0,0,0,0,1
0.4ml inj syringe 0.4ml,0,0,0,1,0,1
0.5% povidone iodine,0,0,0,1,0,1
0.5% w,1,0,0,0,0,1
0.5% w/v povidone-iodide,1,0,0,0,0,1
0.5ml,1,0,0,0,0,1
0.6% pvp-i oral,0,0,0,1,0,1
0.6% pvp-i oral/nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,0,0,0,1,0,1
0.6% pvp-i oral/nasal spray to healthy volunteer,0,0,0,1,0,1
0.6% pvp-i oral/nasal spray to moderately ill covid-19 positive patient,0,0,0,1,0,1
0.67ml inj syringe,0,0,0,0,1,1
0.9% (w,0,1,0,0,0,1
0.9% (w/v) saline,0,1,0,0,0,1
0.9% normal saline,0,0,0,1,0,1
0.9% sodium chloride,0,0,0,1,0,1
01,0,0,0,1,0,1
1-mna,0,1,0,0,0,1
1 minute sit to stand test,0,1,0,0,0,1
1% hydrogen peroxide,0,0,0,1,0,1
1% povidone iodine (pvp-i),0,1,0,0,0,1
1% pvp- mouthwash,0,0,0,1,0,1
1.5% hydrogen peroxide (h2o2),0,1,0,0,0,1
1.5% w,1,0,0,0,0,1
1.5% w/v hydrogen peroxide,1,0,0,0,0,1
10 ml (20 mg,0,1,0,0,0,1
100 mg/ml virazole,0,1,0,0,0,1
"12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",0,1,0,0,0,1
1200 mg),1,0,0,0,0,1
129xenon gas,0,0,0,1,0,1
14-day schedule,0,0,0,1,0,1
15mg,0,0,0,1,0,1
16-hour pp,0,1,0,0,0,1
1600 mg),1,0,0,0,0,1
1test1,0,1,0,0,0,1
1x10^10 vp azd1222,0,0,0,1,0,1
1x10^9 vp azd1222,0,0,0,1,0,1
2-way sms delivery of information,0,0,0,1,0,1
2 doses of vaccine,0,0,0,1,0,1
2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,0,0,0,1,0,1
2.2x10^10vp (qpcr) boost,1,0,0,0,0,1
2010,0,0,0,1,0,1
23-valent pneumococcal polysaccharide vaccine,0,0,0,1,0,1
24 hour holter ecg,0,0,0,1,0,1
24h transdermal patch - 24 hour,0,0,0,1,0,1
25 âµg spfn_1b-06-pl,1,0,0,0,0,1
25 âµg spfn_1b-06-pl / alfq (qs21 adjuvant),1,0,0,0,0,1
25 oh vitamin d level,0,1,0,0,0,1
25 post icu-patients,0,0,0,1,0,1
25 post non-icu patients,0,0,0,1,0,1
27% ethanol,1,0,0,0,0,1
27% ethanol/essential oils,1,0,0,0,0,1
28),0,1,0,0,0,1
"3-doses schedule 1 of covid-19 vaccine (vero cell), inactivated",0,0,0,1,0,1
"3-doses schedule 2 of covid-19 vaccine (vero cell), inactivated",0,0,0,1,0,1
"3-doses schedule 3 of covid-19 vaccine (vero cell), inactivated",0,0,0,1,0,1
3 consecutive lots (group c1a),0,0,0,1,0,1
3 consecutive lots (group c2a),0,0,0,1,0,1
3 nasopharyngeal swab,0,1,0,0,0,1
3),0,0,0,0,1,1
4-free app,0,1,0,0,0,1
4-free app / phn intervention,0,1,0,0,0,1
40-steps-test,0,0,0,1,0,1
400 mg,1,0,0,0,0,1
40ml blood sample,0,0,1,0,0,1
4plants,0,0,1,0,0,1
4plants/azythromycin,0,0,1,0,0,1
5-ala-phosphate,0,0,0,1,0,1
5-ala-phosphate / sfc (5-ala / sfc),0,0,0,1,0,1
5-week prevention program,1,0,0,0,0,1
5 blood samples,0,0,0,1,0,1
5 times sit to stand test,0,1,0,0,0,1
5% glucose,1,0,0,0,0,1
50 âµg spfn_1b-06-pl,1,0,0,0,0,1
50 âµg spfn_1b-06-pl / alfq (qs21 adjuvant),1,0,0,0,0,1
50 mg,0,1,0,0,0,1
50 mg/ml virazole,0,1,0,0,0,1
5x10^9 vp azd1222,0,0,0,1,0,1
6-min-walk fpp2,0,0,0,1,0,1
6-min-walk surgical mask,0,0,0,1,0,1
6-min-walk without mask,0,0,0,1,0,1
6 minutes walk test,1,0,0,0,0,1
6 months later,0,1,0,0,0,1
6 point likert scale,0,1,0,0,0,1
6 weeks after delivery,0,1,0,0,0,1
600mg) oral suspension,0,1,0,0,0,1
a - samples collected along routine care samples only,0,0,0,1,0,1
a $10 survey incentive,1,0,0,0,0,1
a $20 survey incentive,1,0,0,0,0,1
a 940-nm diode laser,0,1,0,0,0,1
a faithful response to covid-19,0,0,0,1,0,1
"a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
a questionnaire/scales,0,0,0,1,0,1
a questionnaire/scales.,0,1,0,0,0,1
a short video intervention,0,1,0,0,0,1
"a single ""booster"" dose of the moderna mrna covid-19 vaccine",0,0,0,1,0,1
a survey form was applied to individuals included in the study face-to-face.,0,1,0,0,0,1
a survey of 60 questions was created through the internet-based 'google forms surveys' site.,0,1,0,0,0,1
a vignette intervention,0,1,0,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level",0,0,1,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level/quality of life/questioning exercise habits before/after the covid-19 outbreak in patients with behã§et/fmf.",0,0,1,0,0,1
aapc,0,0,0,1,0,1
aat( alpha 1 antitrypsin),0,1,0,0,0,1
aaz covid-19 rapid test,0,1,0,0,0,1
abbc1 immunoessential,0,0,0,1,0,1
abbv-2b04,0,1,0,0,0,1
abbv-47d11,0,1,0,0,0,1
abdominal ultrasound,0,1,0,0,0,1
abivertinib,0,1,0,0,0,1
abncov2,0,0,0,1,0,1
abncov2 vaccine,1,0,0,0,0,1
abpm,0,0,0,1,0,1
abx464,0,0,0,0,1,1
acceptance survey,0,0,0,1,0,1
accuchek inform ii platform,0,1,0,0,0,1
"ace inhibitor, angiotensin receptor blocker",0,1,0,0,0,1
ace inhibitor/arb,0,1,0,0,0,1
ace inhibitors/calcium channel blockers,0,1,0,0,0,1
ace/arb,0,0,0,1,0,1
acknowledgement racial injustice ama,0,1,0,0,0,1
"acp educator led, video assisted discussion",0,0,0,1,0,1
act,0,0,0,1,0,1
actigraphy,0,0,0,1,0,1
action (tara),0,1,0,0,0,1
activase,1,0,0,0,0,1
active comparator,0,0,0,1,0,1
active comparator: self-care group,1,0,0,0,0,1
active control:healthy living,0,1,0,0,0,1
active covid-19 disease,0,0,0,1,0,1
active vaccine control (group b1a),0,0,0,1,0,1
active vaccine control (group b1b),0,0,0,1,0,1
active vaccine control (group b1c),0,0,0,1,0,1
active vaccine control (group b1d),0,0,0,1,0,1
active vaccine control (group c2a),0,0,0,1,0,1
active vaccine control (group c2b),0,0,0,1,0,1
active vaccine control (group c2c),0,0,0,1,0,1
active vaccine control simple dose (group b1d),0,0,0,1,0,1
active vaccine control simple dose (group c2d),0,0,0,1,0,1
active vaccine control simple dose (group c2d) - 60 years old,0,0,0,1,0,1
active vaccine control simple dose (group c2d) - 60 years old/more,0,0,0,1,0,1
activity,0,1,0,0,0,1
activity list,1,0,0,0,0,1
acupuncture,0,1,0,0,0,1
acupuncture therapy,0,0,0,1,0,1
acupuncture/standard care,0,1,0,0,0,1
ad17002,0,0,0,1,0,1
ad26.cov2.s vaccine,0,0,0,1,0,1
ad5-ncov,1,0,0,0,0,1
adam sensor,0,0,0,1,0,1
adapt-232 oral solution,0,1,0,0,0,1
adaptation at work score (psas),0,1,0,0,0,1
"adaptive immune response, complement activation,",0,0,0,1,0,1
adcld-cov19,1,0,0,0,0,1
adcld-cov19-1,0,0,0,1,0,1
adcovid,1,0,0,0,0,1
additional,0,0,0,1,0,1
additional/minimal collection of products of the human body carried out during a sample for standard of care,0,0,0,1,0,1
adenovirus type-5 vectored covid-19 vaccine,1,0,0,0,0,1
adimrsc-2f,1,0,0,0,0,1
adjunctive therapies,1,0,0,0,0,1
adm03820,0,0,0,1,0,1
administration of equine immunoglobulin anti sars-cov-2,0,1,0,0,0,1
administration of systemic corticosteroid,0,1,0,0,0,1
admission to icu for covid-19,1,0,0,0,0,1
adsorbed sars-cov-2 (inactivated) vaccine,1,0,0,0,0,1
adult bubble cpap oxygen therapy device,0,0,0,1,0,1
adx-629,0,0,0,1,0,1
aerobic exercise therapy,0,0,0,1,0,1
aerobic training,0,0,0,1,0,1
aerosol box,0,1,0,0,0,1
aerosolized dnase,0,0,0,1,0,1
african american sender acknowledgement,0,1,0,0,0,1
african american sender in informational videos.,0,1,0,0,0,1
after-each-case room disinfection,0,1,0,0,0,1
after covid-19 pandemic,0,0,0,1,0,1
after covid-19 vaccination,1,0,0,0,0,1
after the covid-19 outbreak in patients with behã§et,0,0,1,0,0,1
ag0301-covid19,0,1,0,0,0,1
ag0302-covid19,0,1,0,0,0,1
ag0302-covid19 for intradermal injection,1,0,0,0,0,1
ag0302-covid19 for intramuscular injection,1,0,0,0,0,1
agent-797,0,0,0,1,0,1
ai algorithm,0,0,0,1,0,1
ai model,1,0,0,0,0,1
airflo2,0,0,0,1,0,1
airwave oscillometry,0,0,0,1,0,1
airway management during sedation,0,1,0,0,0,1
airway management during sedation/general anesthesia,0,1,0,0,0,1
airway pressure release ventilation,0,1,0,0,0,1
ak119,0,1,0,0,0,1
aks-452,1,0,0,0,0,1
alanine,0,0,0,1,0,1
albumine,0,1,0,0,0,1
albuterol sulfate (mdi),0,0,0,1,0,1
albuterol sulfate (nebulizer),0,0,0,1,0,1
alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,0,0,0,1,0,1
aldesleukin,0,0,0,1,0,1
alfq (qs21 adjuvant),1,0,0,0,0,1
algorithm,1,0,0,0,0,1
all treatment about covid-2019,0,0,0,1,0,1
allogeneic,1,0,0,0,0,1
allogeneic human menstrual blood stem cells secretome,0,1,0,0,0,1
allogeneic mesenchymal stem cell,0,1,0,0,0,1
allogeneic wharton's jelly-mscs (wj-msc),0,0,0,1,0,1
almitrine,1,0,0,0,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus",1,0,0,0,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/5% glucose",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/high-dose vitamin c treatment",1,0,0,0,0,1
alpha one antitrypsin,0,0,0,1,0,1
alpha variant,0,0,0,1,0,1
also no soap (pure control),1,0,0,0,0,1
alteplase,0,0,0,1,0,1
alternate nostril breathing,0,1,0,0,0,1
alternative medicine,0,1,0,0,0,1
altruism video,0,1,0,0,0,1
alum adjuvant,1,0,0,0,0,1
aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
alvelestat,0,1,0,0,0,1
alveolar,0,0,0,1,0,1
ama acknowledgement drug pricing,0,1,0,0,0,1
amantadine hydrochloride,0,0,0,1,0,1
ambulation,0,0,0,1,0,1
amended lls covid-19 registry,0,0,0,1,0,1
amh sampling,1,0,0,0,0,1
aminoterminal type iii peptide of procollagen,1,0,0,0,0,1
amiodarone,0,1,0,0,0,1
amlodipine,0,0,0,1,0,1
amor 18 powder,0,0,0,1,0,1
amor 18 powder/inhalation,0,0,0,1,0,1
amoxicillin,0,0,0,1,0,1
an69-oxiris,0,0,0,1,0,1
an69-standard,0,0,0,1,0,1
anakinra/osoc,0,0,0,0,1,1
anakinra/ruxolitinib,0,0,0,0,1,1
analog scale,0,0,0,1,0,1
analysis of blood samples,0,0,0,1,0,1
analysis of cell-mediated,0,0,0,1,0,1
analysis of cell-mediated/antibody-mediated immunity to sars-cov-2 virus,0,0,0,1,0,1
"analysis of cytokine response, innate",0,0,0,1,0,1
"analysis of cytokine response, innate/adaptive immune response, complement activation,/serum neurofilaments as a marker of neurological damage.",0,0,0,1,0,1
analysis of immunological response,0,1,0,0,0,1
analysis of serum antibodies,0,1,0,0,0,1
andrographis paniculata,0,0,0,1,0,1
anesthesia management,0,1,0,0,0,1
ang-3777,1,0,0,0,0,1
anger message,0,1,0,0,0,1
angiogenic biomarkers,0,1,0,0,0,1
angiography scanner,0,0,0,1,0,1
angiotensin,0,0,0,1,0,1
angiotensin-(1-7),0,1,0,0,0,1
angiotensin-converting enzyme inhibitors (ace-i)/angiotensin ii receptor blockers (arb),0,1,0,0,0,1
angiotensin ii,0,0,0,1,0,1
angiotensin ii receptor blockers,0,0,0,1,0,1
angiotensin peptide (1-7) derived plasma,0,0,0,1,0,1
anise,0,0,0,1,0,1
anluohuaxian,0,0,0,1,0,1
anne one,0,0,1,0,0,1
anti-cd14,0,0,0,1,0,1
anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,0,0,0,1,0,1
anti-covid test,1,0,0,0,0,1
anti-sars-cov-2,0,0,0,1,0,1
anti-sars-cov-2 equine immunoglobulin f(ab')2 fragments (inosars),0,0,0,1,0,1
anti-sars-cov-2 igt seropositivity,0,1,0,0,0,1
anti-sars-cov-2 igy,0,1,0,0,0,1
anti-sars-cov2 serological controls,0,1,0,0,0,1
anti-sars-cov2 serological controls/serum neutralization,0,1,0,0,0,1
anti-spike sars-cov-2 igg,0,0,0,1,0,1
anti covid-19 antibody levels (serology),1,0,0,0,0,1
anti covid 19 intravenous immunoglobulin (c-ivig),0,0,0,1,0,1
anti covid19 igg antibodies,0,0,0,1,0,1
anti sars-cov-2 equine hyperimmune serum,0,0,0,1,0,1
anti sars-cov 2 convalescent plasma in critical covid-19 patients,0,0,0,0,1,1
anti sars-cov 2 convalescent plasma in severe covid-19 patients,0,0,0,0,1,1
antibiotic,1,0,0,0,0,1
antibiotics,0,0,0,1,0,1
antibodies testing,0,1,0,0,0,1
antibody-mediated immunity to sars-cov-2 virus,0,0,0,1,0,1
antibody response to spike antigens of sars-cov-2 in both groups in peripheral blood samples,0,0,0,1,0,1
antibody testing for sars-cov-2 igg,0,0,0,1,0,1
antibody tests,0,0,0,1,0,1
"antibody tests,",1,0,0,0,0,1
anticoagulants according to different protocols.,0,1,0,0,0,1
anticoagulation agents (edoxaban and,0,0,0,1,0,1
anticoagulation agents (edoxaban and/or high dose lmwh),0,0,0,1,0,1
anticov-220 (1),1,0,0,0,0,1
anticov-220 (2),1,0,0,0,0,1
antidiabetic treatment,0,1,0,0,0,1
antigen test for covid 19,0,1,0,0,0,1
antimicrobial stewardship prospective audit,0,0,0,1,0,1
antimicrobial stewardship prospective audit/feedback,0,0,0,1,0,1
antioxidants,0,0,0,1,0,1
antirheumatic drugs,0,0,1,0,0,1
antithrombin,0,1,0,0,0,1
antithrombin / best available treatment,0,1,0,0,0,1
antithrombotic therapy (anticoagulant and,0,1,0,0,0,1
antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,0,1,0,0,0,1
"antiviral, surgical",0,1,0,0,0,1
antroquinonol,0,0,0,1,0,1
anxiety questionnaire,0,0,0,1,0,1
anxiety reduction training,1,0,0,0,0,1
anxiety),0,0,1,0,0,1
anxiety/depression assessment,0,0,0,1,0,1
any drug used to treat covid-19,0,0,0,1,0,1
ap-23,0,0,0,1,0,1
apabetalone,0,0,0,1,0,1
apilimod dimesylate,0,0,0,1,0,1
apixaban 5mg,0,0,0,0,1,1
apl-9,0,1,0,0,0,1
apn01,0,0,0,1,0,1
app,0,0,0,1,0,1
apple watch,0,0,0,1,0,1
application of cdss to provide nutritional care in breast cancer patients from home,0,1,0,0,0,1
application of ces via ear clips,0,0,0,1,0,1
approved vaccines against sars-cov2,0,0,0,1,0,1
apps,0,1,0,0,0,1
apremilast,0,1,0,0,0,1
apremilast placebo,0,1,0,0,0,1
aprepitant injectable emulsion,0,0,0,0,1,1
aprotinin,1,0,0,0,0,1
aptamex,0,0,0,1,0,1
apx-115,0,0,0,1,0,1
arb blocker,0,1,0,0,0,1
arbidol hydrochloride/interferon atomization,0,0,0,1,0,1
arbox,0,0,0,0,1,1
arc intellicare,0,0,1,0,0,1
arct-021,0,0,0,1,0,1
arct-021 dose 1,0,1,0,0,0,1
arct-021 dose 2,0,1,0,0,0,1
arct-021 dose 3,0,1,0,0,0,1
arct-021 dose 4,0,1,0,0,0,1
arct-021 dose regimen 1,0,1,0,0,0,1
arct-021 dose regimen 2,0,1,0,0,0,1
arct-021 single dose priming,1,0,0,0,0,1
arct-021 two higher dose priming,1,0,0,0,0,1
arct-021 two lower dose priming,1,0,0,0,0,1
arct-154,0,0,0,1,0,1
arct-154 self-amplifying rna sars-cov-2 vaccine,0,0,0,1,0,1
arct-165,0,0,0,1,0,1
ards,0,1,0,0,0,1
ards/covid19 treatments,0,1,0,0,0,1
ardsnet,0,0,0,1,0,1
ardsnet table,0,0,0,1,0,1
argatroban,0,0,0,1,0,1
aromatherapy,1,0,0,0,0,1
art,0,0,0,1,0,1
artemesia annua,0,0,0,1,0,1
artemether-lumefantrine (al),0,0,0,1,0,1
artemic,0,1,0,0,0,1
artemisia annua leaf,0,0,0,0,1,1
artemisinin,0,1,0,0,0,1
arterial blood gas,0,1,0,0,0,1
arterial blood gas (abg),1,0,0,0,0,1
arterial line,0,0,0,1,0,1
arterial stiffness,0,0,0,1,0,1
asc09,0,0,0,1,0,1
asc09f/oseltamivir,0,0,0,1,0,1
ascorbic acid/zinc gluconate,0,1,0,0,0,1
ashmolean website,0,1,0,0,0,1
asp,0,0,0,1,0,1
aspirin 25mg orally,0,0,0,1,0,1
"assay of (1) the level of anti-spike igg antibody,",0,0,0,1,0,1
"assay of (1) the level of anti-spike igg antibody,/(2) interferon-gamma release in response to sars-cov-2 antigen stimulation",0,0,0,1,0,1
assembled mask,1,0,0,0,0,1
"assessing antibody responses, neutralizing capacity",1,0,0,0,0,1
"assessing antibody responses, neutralizing capacity/memory b-cell function",1,0,0,0,0,1
assessing the impact of covid-19,0,1,0,0,0,1
assessment of cardiovascular diseases,1,0,0,0,0,1
assessment of cardiovascular diseases/cardiovascular risk factors,1,0,0,0,0,1
assessment of imt,0,0,0,1,0,1
assessment of lung mechanics,0,0,0,1,0,1
assessment of lung mechanics/heart-lung interactions,0,0,0,1,0,1
assessment of mental state,0,1,0,0,0,1
assessment of mental state/quality of life,0,1,0,0,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4,0,1,0,0,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4/6 weeks after delivery,0,1,0,0,0,1
assessment of proinflammatory cytokine production,0,0,0,1,0,1
assessment of proinflammatory cytokine production/immunophenotypic analysis after stimulation with overlapping s-peptides in peripheral blood mononuclear cells (pbmc),0,0,0,1,0,1
assessment of the sequelae after hospitalization for sars-cov-2,0,0,1,0,0,1
assessment tests,0,0,0,1,0,1
assessment),0,1,0,0,0,1
assigned strategies: active choice,0,1,0,0,0,1
assigned strategies: enhanced active choice,0,1,0,0,0,1
assigned strategies: opt-in,0,1,0,0,0,1
asthma control test,0,0,0,1,0,1
astrazeneca,0,0,0,1,0,1
astrazeneca chadox1 azd1222 vaccine (az) full dose,0,0,1,0,0,1
astrazeneca chadox1 azd1222 vaccine (az) half dose,0,0,1,0,0,1
astrazeneca/oxford vaccine,0,0,0,1,0,1
astrazenica vaccine,0,0,0,1,0,1
asunercept,0,0,0,1,0,1
asunercept 100mg,0,0,0,1,0,1
asunercept 25mg,0,0,0,1,0,1
asunercept 400mg,0,0,0,1,0,1
asynchronies detection,0,1,0,0,0,1
asynchronous telerehabilitation programme,0,0,0,1,0,1
at-001,0,1,0,0,0,1
at-100,0,0,0,1,0,1
at-home covid-19 testing,0,0,0,1,0,1
at risk for covid-19 infection,1,0,0,0,0,1
atazanavir/dexamethasone,0,0,0,1,0,1
ati-450,0,1,0,0,0,1
atorvastatin-ezetimibe,0,0,0,1,0,1
atorvastatin / l-arginine / folic acid / nicorandil / nebivolol,0,0,0,1,0,1
atorvastatin 20 mg oral tablet,0,0,0,1,0,1
atorvastatin 40 mg oral tablet,1,0,0,0,0,1
atorvastatin 80mg,0,0,0,1,0,1
atovaquone,0,0,0,1,0,1
atovaquone/azithromycin,0,0,0,1,0,1
atr-002,0,0,0,1,0,1
attendance by ambulance crew,0,0,0,1,0,1
attention bias modification (abm),0,1,0,0,0,1
atyr1923,0,1,0,0,0,1
audio-visual triage system (avt),0,1,0,0,0,1
audio for relaxation techniques,0,0,0,1,0,1
auditory evoked potentials (aep),0,1,0,0,0,1
augmented message,0,0,0,1,0,1
auricular neuromodulation,0,0,0,0,1,1
auricular percutaneous neurostimulation,0,0,0,1,0,1
auricular stimulation,0,0,0,1,0,1
auristim,0,0,0,1,0,1
auscul-x,0,0,0,1,0,1
autoimmunity,0,1,0,0,0,1
autologous activated platelet-rich plasma,0,0,0,1,0,1
autologous non-hematopoietic peripheral blood stem cells (nhpbsc),0,1,0,0,0,1
autologous stem cell transplantation,0,0,0,1,0,1
autophagy inhibitor (gns651),1,0,0,0,0,1
auxora,0,1,0,0,0,1
av-001 injection,0,0,0,1,0,1
av-001 placebo injection,0,0,0,1,0,1
aviptadil acetate,0,0,0,1,0,1
aviptadil placebo,0,0,0,1,0,1
aviptadil/standard care,0,1,0,0,0,1
awake prone position,0,1,0,0,0,1
award,1,0,0,0,0,1
award advice,1,0,0,0,0,1
award/covid-specific advice,1,0,0,0,0,1
axa1125,0,0,0,1,0,1
axillary sweat sample,1,0,0,0,0,1
ayurvedic kadha,0,1,0,0,0,1
azd 1222,0,0,0,1,0,1
azd1656,0,1,0,0,0,1
azd2816,1,0,0,0,0,1
azd7442 (im),0,0,0,1,0,1
azd7442 (iv),0,0,0,1,0,1
azithromycin / ivermectin / ribaroxaban / paracetamol,0,1,0,0,0,1
azithromycin / ribaroxaban / paracetamol,0,1,0,0,0,1
azithromycin pill,0,0,0,1,0,1
azoximer bromide,1,0,0,0,0,1
azvudine,0,0,0,1,0,1
azvudine placebo,0,0,0,1,0,1
"b.1.351)-as03, dosage a",0,0,0,1,0,1
"b.1.351)-as03, dosage b",0,0,0,1,0,1
b: placebo,1,0,0,0,0,1
bacillus subtilis,0,1,0,0,0,1
bacillus subtilis spore extract,0,0,0,1,0,1
background questionnaire,0,0,0,1,0,1
bactek-r,1,0,0,0,0,1
bactrl-spike,1,0,0,0,0,1
baf312,1,0,0,0,0,1
baiya sars-cov-2 vax 1,0,0,0,1,0,1
balance,0,0,1,0,0,1
balance assessments,0,0,0,1,0,1
balanced amino acid,0,0,0,1,0,1
bandebereho fathers',0,0,1,0,0,1
bardoxolone methyl,0,1,0,0,0,1
bariatric procedures,0,0,0,1,0,1
baricitinib / dexamethasone,0,0,0,1,0,1
baricitinib/anakinra,0,1,0,0,0,1
baseline,0,0,0,1,0,1
baseline blood sample,0,0,0,1,0,1
baseline disease modifying therapies (dmts),1,0,0,0,0,1
baseline message,0,1,0,0,0,1
baseline spirometry,0,0,0,1,0,1
baseline/during hospitalization blood samples,0,0,0,1,0,1
basic feedback,0,1,0,0,0,1
bat / calcifediol,0,0,0,1,0,1
bbibp-corv,0,1,0,0,0,1
bbv152a - phase i,1,0,0,0,0,1
bbv152a - phase ii,1,0,0,0,0,1
bbv152b - phase i,1,0,0,0,0,1
bbv152b - phase ii,1,0,0,0,0,1
bbv152c - phase i,1,0,0,0,0,1
bbv154 vaccine,1,0,0,0,0,1
bcg-10 vaccine,0,0,0,1,0,1
bd lyotubes,0,1,0,0,0,1
beck anxiety inventory,0,1,0,0,0,1
beck depression inventory,0,1,0,0,0,1
beck depression inventory (bdi),0,1,0,0,0,1
behavioral activation ssi,0,1,0,0,0,1
behavioral economics,0,0,0,1,0,1
behavioral intervention,0,0,0,1,0,1
behavioral/cognitive assessment,0,0,1,0,0,1
behaviour change technique intervention to improve quality of life,0,1,0,0,0,1
behavioural change campaign for covid-19 prevention in zambia,0,1,0,0,0,1
beijing,1,0,0,0,0,1
belnacasan,0,0,0,1,0,1
bemcentinib,0,1,0,0,0,1
bemiparin,0,0,0,1,0,1
bemiparin sodium,0,0,0,1,0,1
bempegaldesleukin,0,1,0,0,0,1
berberine,0,1,0,0,0,1
bereavement virtual support group,0,0,1,0,0,1
best message,0,0,0,1,0,1
best message / augmented message/implementation strategy,0,0,0,1,0,1
best message alone,0,0,0,1,0,1
best standard of care / cardio,0,1,0,0,0,1
best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
betadine (c) mouth rinse with the solution provided,0,0,0,1,0,1
betadineâ© bucal 100 mg,0,1,0,0,0,1
betadineâ© bucal 100 mg/ml,0,1,0,0,0,1
beva,0,0,0,1,0,1
beva/soc,0,0,0,1,0,1
bgb-dxp593,0,1,0,0,0,1
bgb dxp593,0,1,0,0,0,1
bge-175,0,0,0,1,0,1
bi 764198,0,0,0,0,1,1
bi 767551 inhaled,0,0,0,0,1,1
bi 767551 intravenous,0,0,0,0,1,1
bicalutamide 150 mg,0,0,0,0,1,1
bidirectional oxygenation mouthpiece,0,0,0,1,0,1
big five inventory (bfi) scale,0,0,0,1,0,1
binaxnow ag card,0,0,0,0,1,1
bio 300 oral suspension,0,0,0,1,0,1
bio101,0,0,0,1,0,1
bioarginina c,0,0,0,1,0,1
biobehavioral tele-rehabilitation sessions,1,0,0,0,0,1
biochemical analyses,0,0,0,1,0,1
biochemical analysis,0,1,0,0,0,1
biochemistry blood test,0,0,0,1,0,1
biocollection,0,0,0,1,0,1
biological assays in particular on the lipid metabolism,0,1,0,0,0,1
biological check-up data collect,0,1,0,0,0,1
biological sample/clinical data collection,0,0,0,1,0,1
biological test,0,0,0,1,0,1
biological/vaccine: bnt162b2 10mcg,0,0,0,1,0,1
biological/vaccine: bnt162b2 3mcg,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1,0,0,0,0,1
biological/vaccine: sars-cov-2 vaccine,0,0,0,1,0,1
biological: mrna-1273,0,1,0,0,0,1
"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",0,0,0,1,0,1
biomarkers determination,0,0,0,1,0,1
biomarkers expression,0,0,0,1,0,1
biomarkers of inflammation,0,0,0,1,0,1
biontech bnt162b2 vaccine (pf) full dose,0,0,1,0,0,1
biontech bnt162b2 vaccine (pf) half dose,0,0,1,0,0,1
biontech),1,0,0,0,0,1
biovitals,0,0,0,1,0,1
biozek covid-19 antigen rapid test,0,0,0,1,0,1
biozek covid-19 antigen rapid test (saliva),0,0,0,1,0,1
bipap,0,0,0,1,0,1
bis analysis,0,0,0,1,0,1
bivalirudin,0,0,0,1,0,1
bld-2660,1,0,0,0,0,1
blended gaming covid-19 training system (bgcts),0,0,0,1,0,1
blink,0,1,0,0,0,1
blink/masseter inhibitory reflex,0,1,0,0,0,1
blis k12,0,1,0,0,0,1
blood biomarkers,0,0,0,1,0,1
blood coagulation profile,0,1,0,0,0,1
"blood collection at 1st injection of vaccine against covid-19, at at second injection of vaccine, at month 1, month 2, month 6",0,0,0,1,0,1
"blood collection at 1st injection of vaccine against covid-19, at at second injection of vaccine, at month 1, month 2, month 6/month 12 after second injection of vaccine for volunteers",0,0,0,1,0,1
"blood collection at day 8, day 16, day 24, month 6",0,0,0,1,0,1
"blood collection at day 8, day 16, day 24, month 6/month 12 after first symptoms from sars-cov-2 infection.",0,0,0,1,0,1
blood count,0,1,0,0,0,1
blood d-dimer assay,0,1,0,0,0,1
blood group determination,0,0,0,1,0,1
blood oxygen saturation level.,0,0,0,1,0,1
blood sample analyses,0,0,0,1,0,1
blood sample/data record,0,0,0,1,0,1
blood sample/salivary sample,0,0,0,1,0,1
blood samples for biomarkers,0,0,0,1,0,1
blood samples for the study of the humoral response to sars-cov-2 variants,0,0,0,1,0,1
blood samples for the study of the humoral response to sars-cov-2 variants/of the cellular response after vaccination against covid-19,0,0,0,1,0,1
blood sampling (4 per year),0,0,0,1,0,1
blood sampling (venesection),0,1,0,0,0,1
blood serum samples,0,1,0,0,0,1
blood test for igg antibodies against sars-cov-2,0,1,0,0,0,1
blood test for inflammatory markers,0,0,0,1,0,1
blood test for sars-cov2 serology,0,0,0,1,0,1
blood test to describe the humoral,0,0,0,1,0,1
blood test to describe the humoral/cellular response to vaccination bnt162b2 in the elderly,0,0,0,1,0,1
"blood tests sputum, nasal lavage",0,0,0,1,0,1
"blood tests sputum, nasal lavage/brushing",0,0,0,1,0,1
blood/derivatives,0,1,0,0,0,1
blood/nasal fluid sampling before/after covid-19 vaccination,1,0,0,0,0,1
blood/saliva samples will be taken,0,0,0,1,0,1
bloodwork,1,0,0,0,0,1
"bloodwork, echocardiogram, mri",0,0,0,1,0,1
"bloodwork, echocardiogram, pet",0,0,0,1,0,1
"bloodwork, echocardiogram, pet/mri",0,0,0,1,0,1
bloot testing,0,0,0,1,0,1
bms-986253,0,0,0,0,1,1
bms-986413,0,0,0,1,0,1
bms-986414,0,0,0,1,0,1
bms-986414 / bms-986413,0,0,0,1,0,1
bno 1030,0,1,0,0,0,1
bnt162a1,0,0,0,1,0,1
bnt162b2 (tozinameran),1,0,0,0,0,1
bnt162b2 20mcg,0,0,0,1,0,1
bnt162b2 30mcg,0,0,0,1,0,1
bnt162b2.b.1.351,0,1,0,0,0,1
bnt162b2sa,0,0,0,1,0,1
bnt162b3,1,0,0,0,0,1
bnt162c2,0,0,0,1,0,1
body odor samples,0,0,0,1,0,1
body position change,0,0,0,1,0,1
boesenbergia,0,0,0,1,0,1
boost,1,0,0,0,0,1
booster vaccine,0,0,0,1,0,1
botulinum neurotoxin,0,1,0,0,0,1
bovhyaluronidase azoxymer,0,0,0,1,0,1
bovine lipid extract surfactant,0,1,0,0,0,1
bovine plasma-derived immunoglobulin concentrate,0,0,0,1,0,1
brain mri,0,0,0,1,0,1
brain mri assessment,0,0,0,1,0,1
brain parenchyma biopsies,0,0,0,1,0,1
brainstem responses assessment sedation score (brass),0,1,0,0,0,1
brazilian green propolis extract (epp-af),0,1,0,0,0,1
breast feeding adherence,0,0,0,1,0,1
breath biopsy analysis,0,0,0,1,0,1
breath sample analysis,0,0,0,1,0,1
breath test/cheek swab,0,1,0,0,0,1
"breathing exercise, aerobic exercises",0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",0,0,0,1,0,1
breathing exercises,0,1,0,0,0,1
breathing/chest mobilization exercises,0,0,0,1,0,1
breathing/wellness webinar,0,0,1,0,0,1
brensocatib,0,1,0,0,0,1
brexanolone,0,0,0,0,1,1
bridge therapy,0,0,0,1,0,1
brief cope scale,0,0,0,1,0,1
brief counseling,0,0,0,1,0,1
brief digital imagery-competing task intervention,0,0,0,1,0,1
brief informational infographic,0,1,0,0,0,1
brief interpersonal telepsychotherapy,0,0,1,0,0,1
brief mindfulness based intervention,0,1,0,0,0,1
brief psychiatric rating scale,0,0,0,0,1,1
brief skills for safer living,0,0,0,1,0,1
brilacidin,0,1,0,0,0,1
broad-spectrum cbd oil,0,0,0,1,0,1
bromelain,0,0,0,1,0,1
bromhexine oral tablet and/or hydroxychloroquine tablet,0,0,0,1,0,1
bronchial fibroscopy,0,0,0,1,0,1
bronchoalveolar lavage fluid diagnostics,0,0,0,1,0,1
brushing,0,0,0,1,0,1
btl-tml-covid,0,1,0,0,0,1
buccal swab- copan flocked swab,0,0,0,1,0,1
bucillamine,0,0,1,0,0,1
buddy,1,0,0,0,0,1
buddy assigned in community,1,0,0,0,0,1
building of the classification model,0,0,0,1,0,1
burnout,0,0,0,1,0,1
butterfly,0,0,0,1,0,1
butterfly iq,0,1,0,0,0,1
bva-100,0,0,0,1,0,1
by computer consultation,0,1,0,0,0,1
by computer consultation. quantitative,0,0,0,1,0,1
c-135-ls,1,0,0,0,0,1
c-reactive protein,0,1,0,0,0,1
c1 inhibitor human,0,1,0,0,0,1
c144-ls,1,0,0,0,0,1
c144-ls/c-135-ls,1,0,0,0,0,1
c19-ig 20%,0,0,0,1,0,1
c3,0,1,0,0,0,1
c3/ holter monitor,0,1,0,0,0,1
cag,0,0,0,1,0,1
calcifediol,0,0,0,1,0,1
calcium channel blockers,0,1,0,0,0,1
calisthenic exercises,0,1,0,0,0,1
cam-icu 7 score,0,0,0,1,0,1
cambridge validated viral detection,0,0,0,1,0,1
camostat mesylate,0,0,0,1,0,1
candesartan,0,0,0,1,0,1
"cannabidiol, pharmaceutically produced with < 5 ppm thc",0,0,0,1,0,1
canrenoate potassium,0,0,0,1,0,1
canswab,0,1,0,0,0,1
cap-1002,0,0,0,1,0,1
capillary collection,0,0,0,1,0,1
capillary collection/testing,0,0,0,1,0,1
capnodynamic monitoring,0,0,0,1,0,1
capnography,0,1,0,0,0,1
cardiac ct,1,0,0,0,0,1
cardiac echocardiography,0,1,0,0,0,1
cardiac magnetic resonance imaging (cmr),0,0,0,1,0,1
cardiac pet,0,0,0,1,0,1
cardiac pet/mri,0,0,0,1,0,1
cardiac rhythm monitoring,0,1,0,0,0,1
cardiac surgery,1,0,0,0,0,1
cardio,0,1,0,0,0,1
cardiology clinical consultations,0,0,0,1,0,1
cardiopulmonary exercise (centre-based),0,0,0,1,0,1
cardiopulmonary exercise (online-based),0,0,0,1,0,1
cardiopulmonary exercise test,0,1,0,0,0,1
cardiopulmonary exercise training,0,0,0,1,0,1
cardiopulmonary fitness level,0,0,0,1,0,1
cardiopulmonary resuscitation,0,1,0,0,0,1
cardiopulmonary stress test (cpet),0,1,0,0,0,1
cardiorespiratory exercise,0,0,0,1,0,1
cardiovascular,0,0,0,1,0,1
cardiovascular magnetic resonance (cmr) imaging,0,0,0,1,0,1
cardiovascular magnetic resonance imaging,1,0,0,0,0,1
cardiovascular risk factors,1,0,0,0,0,1
cardiovascular/respiratory systems monitoring,0,0,0,1,0,1
care as usual,0,1,0,0,0,1
care modalities,0,1,0,0,0,1
care modalities. quantitative,0,0,0,1,0,1
care modalities. quantitative/qualitative approaches to analysis,0,0,0,1,0,1
caregiver,0,0,0,1,0,1
caring contacts without an introductory phone call (cc),0,0,1,0,0,1
caring contacts/introductory phone call (cc/),0,0,1,0,0,1
carotid-femoral pulse-wave velocity,0,0,0,1,0,1
carotid artery reactivity testing,1,0,0,0,0,1
carrageenan nasal,0,0,0,1,0,1
carrageenan nasal spray,0,0,0,1,0,1
carrageenan nasal spray/1% pvp- mouthwash/gargle,0,0,0,1,0,1
carrageenan nasal/throat spray,0,0,0,1,0,1
carragelose,0,0,0,1,0,1
carrimycin,0,0,0,1,0,1
case fatality rate,0,1,0,0,0,1
cases,0,0,0,1,0,1
cash transfer,1,0,0,0,0,1
casirivimab/imdevimab combination therapy,0,0,0,1,0,1
castem,0,0,0,1,0,1
cbc-diff monocyte volume width distribution,0,1,0,0,0,1
cbd,0,0,0,1,0,1
cbd isolate,0,0,0,1,0,1
ccp,0,0,0,1,0,1
cd127lo,0,0,0,1,0,1
cd24fc,0,1,0,0,0,1
cefditoren pivoxil 400mg,0,1,0,0,0,1
celecoxib famotidine,0,0,0,1,0,1
cell therapy protocol 1,0,0,0,1,0,1
cell therapy protocol 2,0,0,0,1,0,1
cellular,0,0,0,1,0,1
cellular immune response after anti-sars-cov-2 vaccine administration,0,0,0,1,0,1
cellular response,0,1,0,0,0,1
cellular response to vaccination bnt162b2 in the elderly,0,0,0,1,0,1
cellular/antibody response to spike antigens of sars-cov-2 in both groups in peripheral blood samples,0,0,0,1,0,1
cenicriviroc,0,0,0,1,0,1
cenicriviroc (closed to enrollment as of 3-sep-2021),0,0,0,1,0,1
centricyte 1000,0,0,0,1,0,1
cerc-002,0,1,0,0,0,1
cerebral compliance,0,1,0,0,0,1
cerebral compliance/hemodynamics monitoring,0,1,0,0,0,1
cerebrolysin,0,1,0,0,0,1
"cerebrospinal fluid sampling, meningeal",0,0,0,1,0,1
"cerebrospinal fluid sampling, meningeal/brain parenchyma biopsies",0,0,0,1,0,1
cereset research,0,0,0,1,0,1
certified cloth face mask,1,0,0,0,0,1
certified cloth face mask/preventive information,1,0,0,0,0,1
chadox1-ncov-19 (astra-zeneca),1,0,0,0,0,1
chadox1-s [recombinant],0,0,0,1,0,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine (lv),1,0,0,0,0,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine two (lvt),1,0,0,0,0,1
chadox1 ncov-19 single dose,0,0,0,1,0,1
chadox1 ncov-19 single dose / paracetamol,0,0,0,1,0,1
chadox1 ncov-19 two dose,0,0,0,1,0,1
chadox1 ncov-19 two dose / paracetamol,0,0,0,1,0,1
chadox1 ncov-19 vaccine (azd1222),0,0,0,1,0,1
chadv68-s,0,0,0,1,0,1
chadv68-s-tce,0,0,0,1,0,1
chain-referral,0,0,0,1,0,1
chair-yoga program,0,0,0,1,0,1
chamindwell,0,0,0,1,0,1
change in kidney function,0,1,0,0,0,1
change in kidney function/proteinuria,0,1,0,0,0,1
"change in knowledge, motivation, skills, resources",0,0,0,1,0,1
change in preference to surgery under covid-19 pandemic.,0,1,0,0,0,1
change in sars-cov-2 antibody levels,0,0,0,1,0,1
chart review,0,0,0,1,0,1
chat-based instant messaging support,0,1,0,0,0,1
chat-based support,1,0,0,0,0,1
chatbot,0,0,0,1,0,1
chatbot on covid-19 vaccine hesitancy,0,0,0,1,0,1
check-list including lung ultrasound,0,0,0,1,0,1
cheek swab,0,1,0,0,0,1
chelsea critical care physical assessment tool,0,1,0,0,0,1
chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
chemotherapy,1,0,0,0,0,1
chest ct scan / baseline spirometry,0,0,0,1,0,1
chest cta,1,0,0,0,0,1
chest mobilization exercises,0,0,0,1,0,1
chest mri,0,0,0,1,0,1
chest physiotherapy post-covid19,0,0,0,1,0,1
chest radiography,0,0,1,0,0,1
chest x-ray,0,0,0,1,0,1
childbirth preparation education,0,1,0,0,0,1
chiropractic care,0,1,0,0,0,1
chiropractic care (more than one visit),0,1,0,0,0,1
chiropractic care (one visit),0,1,0,0,0,1
chitotriosidase activity,1,0,0,0,0,1
chlorhexidine gluconate (a) mouth rinse with the solution provided,0,0,0,1,0,1
choice of assignment: active choice,0,1,0,0,0,1
choice of assignment: enhanced active choice,0,1,0,0,0,1
choice of assignment: opt-in,0,1,0,0,0,1
cholecalciferol 6 lakh iu,0,1,0,0,0,1
christmas holiday,0,1,0,0,0,1
chx0.12,0,1,0,0,0,1
chx0.12/cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
ciclã©sonide,0,0,0,1,0,1
ciclesonide nasal,0,0,0,0,1,1
cig axial,0,1,0,0,0,1
cig tilted,0,1,0,0,0,1
cimetra-1,0,0,0,1,0,1
cimetra-2,0,0,0,1,0,1
citrox,0,1,0,0,0,1
citrus essential oil blend,0,0,0,1,0,1
ck0802,1,0,0,0,0,1
ckd-314,0,0,0,1,0,1
ckd-314 placebo,0,0,0,1,0,1
ckd-314 placebo/soc,0,0,0,1,0,1
ckd-314/soc,0,0,0,1,0,1
clarithromycin,0,1,0,0,0,1
clarithromycin 500mg,0,1,0,0,0,1
clinical,0,0,0,1,0,1
clinical data collection,0,0,0,1,0,1
clinical decision support system based on non-invasive multimodal monitoring,1,0,0,0,0,1
clinical diagnosis of covid-19 by a health care professional,0,1,0,0,0,1
clinical features,0,1,0,0,0,1
clinical features/laboratory values,0,1,0,0,0,1
clinical interview,1,0,0,0,0,1
clinical observation,0,0,0,1,0,1
clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
clinical skills,0,0,0,1,0,1
"clinical, functional",0,0,0,1,0,1
"clinical, functional/radiological lung involvement evolution",0,0,0,1,0,1
"clinical, laboratory",0,0,0,1,0,1
"clinical, laboratory/imaging characteristics of pneumonia",0,0,0,1,0,1
clinical/functional analysis,0,0,0,1,0,1
clinician endorsement,0,1,0,0,0,1
clinico-biological parameters in routine care,0,0,0,1,0,1
cliniporator,1,0,0,0,0,1
cliniporatorâ®,1,0,0,0,0,1
cliniporatorâ®/epsgun,1,0,0,0,0,1
clofazimine,0,0,0,1,0,1
closed-loop control of oxygen supplementation by o2matic,0,1,0,0,0,1
closed face shield with surgical face mask use,0,1,0,0,0,1
closys ultra sensitive rinse mouthwash,0,0,0,1,0,1
clungene rapid test cassette,0,0,0,1,0,1
cm4620-ie (injectable emulsion),0,0,0,1,0,1
cns magnetic resonance imaging (mri) imaging,1,0,0,0,0,1
co-mestring (co-coping),0,1,0,0,0,1
co-ultrapealut,0,1,0,0,0,1
coca is an observational study based on retrospective data issued from patient medial file.,0,1,0,0,0,1
cod liver oil,0,0,0,1,0,1
coenzyme q10,0,0,0,1,0,1
cognitive,0,0,0,1,0,1
cognitive activity,0,1,0,0,0,1
cognitive assessment,0,0,1,0,0,1
"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",0,0,0,1,0,1
cognitive behavioral brief-telepsychotherapy,0,0,1,0,0,1
cognitive behavioural group therapy for perinatal anxiety,0,0,0,1,0,1
cognitive testing,1,0,0,0,0,1
cognitive tests,0,1,0,0,0,1
cognitive training,1,0,0,0,0,1
cognivue,0,0,0,1,0,1
cohort study,0,0,0,1,0,1
colchcine,1,0,0,0,0,1
colchicine 0.6 mg,0,0,1,0,0,1
colchicine pill,0,1,0,0,0,1
colchicine/herbal phenolic monoterpene fractions,0,1,0,0,0,1
colchicine/symptomatic treatment (paracetamol),0,0,0,1,0,1
colgate total zero,0,0,0,0,1,1
collagen-polyvinylpyrrolidone,0,0,0,1,0,1
"collection of blood, salivary",0,1,0,0,0,1
"collection of blood, salivary/nasopharyngeal samples.",0,1,0,0,0,1
collection of breath sample,0,0,0,1,0,1
collection of clinical events of interest,0,1,0,0,0,1
collection of mucosal lining fluid,0,1,0,0,0,1
collection of odour samples,0,0,0,1,0,1
collection of swabs,0,0,0,1,0,1
collective intelligence intervention,0,0,0,1,0,1
colloidal silver,0,0,0,1,0,1
colorectal resections,1,0,0,0,0,1
combination,0,1,0,0,0,1
"combination of curcumin, quercetin",0,0,0,1,0,1
"combination of curcumin, quercetin/vitamin d",0,0,0,1,0,1
combined art,0,0,0,1,0,1
combined art/hydroxychloroquine,0,0,0,1,0,1
comet assay,0,0,0,1,0,1
comirnaty - biontech manufacturing gmbh,0,0,0,1,0,1
"comirnaty (covid-19, mrna vaccine)",1,0,0,0,0,1
comirnaty(btn162b2),0,0,0,1,0,1
commercial covid-19 vaccine,1,0,0,0,0,1
communication,0,1,0,0,0,1
communication during the covid-19 pandemic,0,0,0,1,0,1
communication type,0,1,0,0,0,1
"community-based, mobile van testing",0,0,1,0,0,1
community-driven messages to promote covid-19 testing,0,1,0,0,0,1
community-provided moderna mrna-1273 covid-19 vaccine,0,0,0,1,0,1
community-provided mrna-based covid-19 vaccine,0,0,0,1,0,1
community health worker engagement,0,0,0,1,0,1
community health worker support,0,1,0,0,0,1
community health workers.,1,0,0,0,0,1
community interest message,0,1,0,0,0,1
community mask,0,1,0,0,0,1
community popular opinion leader (pol) based intervention,0,0,0,1,0,1
comorbidities,0,0,0,1,0,1
comparative observational cohort study,0,0,0,1,0,1
comparator,0,1,0,0,0,1
compare the difference in respiratory rate between h0,0,0,0,1,0,1
comparison group,0,1,0,0,0,1
comparison masks,0,0,0,1,0,1
comparison of antigen tests with rt-pcr as reference method,0,0,0,1,0,1
comparison of cohorts,0,1,0,0,0,1
compass,1,0,0,0,0,1
compassion exercises,0,0,0,1,0,1
compassion focused intervention,0,1,0,0,0,1
complement dosage,0,1,0,0,0,1
complementary,0,1,0,0,0,1
complementary integrative medicine,0,0,0,1,0,1
complementary/alternative medicine,0,1,0,0,0,1
complete thrombophilic profile testing by multiplex pcr,0,0,0,1,0,1
completion of covid19 vaccine at least 4 weeks ago,0,0,0,1,0,1
completion of post telemedicine encounter survey,0,1,0,0,0,1
completion of pre-pandemic survey,0,1,0,0,0,1
completion of survey after peak of pandemic,0,1,0,0,0,1
complex diagnostic panel,0,0,1,0,0,1
comprehensive assessment of respiratory muscle function.,0,0,0,1,0,1
comprehensive treatment,0,0,0,1,0,1
computed tomography,0,1,0,0,0,1
computerized cognitive training,1,0,0,0,0,1
concentrate beetroot juice,0,0,0,1,0,1
concentrated air,0,0,0,1,0,1
concentrated oxygen,0,0,0,1,0,1
concentrated rehabilitation for patients with persistent symptoms post covid-19,0,0,0,1,0,1
concert,0,1,0,0,0,1
concurrent treatment of ptsd,0,0,0,1,0,1
concurrent treatment of ptsd/substance use disorders using prolonged exposure (cope),0,0,0,1,0,1
conestat alfa,0,0,0,0,1,1
confinement,0,0,0,1,0,1
confinement/communication during the covid-19 pandemic,0,0,0,1,0,1
confirm sars-cov-2 infection,0,0,0,1,0,1
conjunctival swab/nasopharyngeal swab,0,0,0,1,0,1
connected devices measurements,0,1,0,0,0,1
connor-davidson resilience scale 10 items (cd-risc 10),0,0,0,0,1,1
contain covid anxiety ssi,0,1,0,0,0,1
continuation of acei,0,0,0,1,0,1
continuation of acei/arb,0,0,0,1,0,1
continuation of arb,0,1,0,0,0,1
continuation of ras blocker,0,0,0,0,1,1
continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
continuous blind glucose measurement device (free style pro),0,0,0,1,0,1
continuous glucose monitor (cgm),0,0,0,1,0,1
"continuous glucose monitoring (cgm, dexcom g6)",0,0,1,0,0,1
continuous positive airway pressure,0,0,0,0,1,1
continuous positive airway pressure (cpap) therapy using oxyjet,1,0,0,0,0,1
continuous positive airway pressure (cpap) treatment,0,1,0,0,0,1
continuous renal replacement therapy,0,0,0,1,0,1
continuous vital sign monitoring - isansys patient status engine,0,0,0,1,0,1
contrast-enhanced cmr,0,0,0,1,0,1
contrast-enhanced mri,0,0,0,1,0,1
control blend,0,0,0,1,0,1
control condition,1,0,0,0,0,1
control group - waiting list,0,0,0,1,0,1
control group (standard hospital treatment),0,1,0,0,0,1
control group quality of life assessment,0,1,0,0,0,1
control intervention,0,0,0,1,0,1
control message,0,1,0,0,0,1
control patients,0,0,0,1,0,1
control swab,0,0,0,1,0,1
control test,0,0,0,1,0,1
control training group,0,1,0,0,0,1
controlled vaccine,0,0,0,1,0,1
convalescent plasma infusion,0,0,0,1,0,1
convalescent plasma therapy,0,1,0,0,0,1
convalescent plasma treatment,0,0,0,1,0,1
convalescent plasma with antibody against sars-cov-2.,0,0,0,1,0,1
convalescent plasma/standard care,0,0,0,1,0,1
convalscent plasma,0,0,0,1,0,1
convenient scheduling link,1,0,0,0,0,1
conventional,0,1,0,0,0,1
conventional exercises,0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",0,0,0,1,0,1
conventional n95 respirator,0,0,0,1,0,1
conventional nutritional support designed by hospital nutritionists,0,1,0,0,0,1
conventional therapy first,1,0,0,0,0,1
convp,0,0,0,1,0,1
copan swabbing,0,0,0,1,0,1
copan swabbing/blood sample collection,0,0,0,1,0,1
"copper, vitamin a, d, e plasma concentrations during patient hospitalization",0,1,0,0,0,1
cor-101,0,0,0,1,0,1
core warming,0,0,0,1,0,1
corn oil (placebo),0,0,0,1,0,1
coromec registry with ecl-19,0,0,0,1,0,1
corona-t-test,0,1,0,0,0,1
coronacheck device,0,0,0,1,0,1
coronary angiography,0,1,0,0,0,1
coronavac vaccine,0,0,0,1,0,1
"coronavac, intradermal",0,0,0,1,0,1
coronavirus-specific t cell (cst),0,0,0,1,0,1
"coronavirus anxiety scale , covid-19 phobia scale",0,1,0,0,0,1
coronavirus disease 2019,0,0,0,1,0,1
corpus cavernosum electromyography,0,1,0,0,0,1
corticosteroid alone,0,0,0,1,0,1
corticosteroid with,0,1,0,0,0,1
corticosteroid with/without colchicine,0,1,0,0,0,1
corticosteroids/derivatives,1,0,0,0,0,1
corvax,1,0,0,0,0,1
cosh self-help smoking cessation booklet,1,0,0,0,0,1
cospherunate,0,0,1,0,0,1
cospherunate/azythromycine,0,0,1,0,0,1
cospherunate/phytomedicine/azythromycien,0,0,1,0,0,1
cost-benefit frame,1,0,0,0,0,1
counselling,1,0,0,0,0,1
"couple hopes guided, internet-delivered, self-help intervention",0,0,0,1,0,1
couples' group education,0,0,1,0,0,1
cov-scan rapid covid-19 antigen test,0,0,0,0,1,1
"cov2 pres dtm adjuvanted vaccine (b.1.351), sanofi",0,0,0,1,0,1
"cov2 pres dtm adjuvanted vaccine (b.1.351), sanofi/gsk",0,0,0,1,0,1
"cov2 pres dtm adjuvanted vaccine (d614), sanofi",0,0,0,1,0,1
"cov2 pres dtm adjuvanted vaccine (d614), sanofi/gsk",0,0,0,1,0,1
covac-1,0,0,0,1,0,1
covax/iiv4; covax/ppv23,0,1,0,0,0,1
covax/ppv23;covax/iiv4,1,0,0,0,0,1
covaxin,0,0,0,1,0,1
covend24,0,0,0,1,0,1
covepit (ose13e),0,0,0,1,0,1
covi-drops,0,0,0,1,0,1
covi-vac,1,0,0,0,0,1
covi vax,0,0,0,1,0,1
covicu,0,0,0,1,0,1
covid,0,0,0,1,0,1
covid-19-impact on quality of life questionnaire,0,0,0,1,0,1
covid-19 (recombinante) vaccine,1,0,0,0,0,1
covid-19 / patients,0,1,0,0,0,1
covid-19 androgen sensitivity test (covast),0,0,1,0,0,1
covid-19 antibody testing,0,0,0,1,0,1
"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",0,0,0,1,0,1
"covid-19 antigen/antibody tests,/influenza rapid test",1,0,0,0,0,1
covid-19 barrier box,0,1,0,0,0,1
covid-19 community outreach,0,0,0,1,0,1
covid-19 community outreach/health promotion.,0,0,0,1,0,1
covid-19 convalescent plasma (cp),1,0,0,0,0,1
covid-19 diagnostic,0,0,0,1,0,1
covid-19 diagnostic test,0,1,0,0,0,1
covid-19 diagnostic/assessment tests,0,0,0,1,0,1
covid-19 e-package: psychological wellbeing for healthcare workers,0,1,0,0,0,1
covid-19 experience surveys,0,0,0,1,0,1
covid-19 facility,0,1,0,0,0,1
covid-19 group,0,1,0,0,0,1
covid-19 group (group i),0,0,0,1,0,1
covid-19 group (group ii),0,0,0,1,0,1
covid-19 health education comic books,1,0,0,0,0,1
covid-19 health education comic books/videos,1,0,0,0,0,1
"covid-19 inactive vaccine, recombinant human adenovirus serotype number 26, mrna vaccine",0,0,0,1,0,1
covid-19 individual awareness,0,0,0,1,0,1
covid-19 individual awareness/education.,0,0,0,1,0,1
covid-19 individual health education,0,0,0,1,0,1
covid-19 individual health education/linkages to medical/supportive services.,0,0,0,1,0,1
covid-19 infection status,0,0,0,1,0,1
covid-19 infection will be conducted.,0,0,0,1,0,1
covid-19 informational text,0,1,0,0,0,1
covid-19 monitoring using wearable sensors,1,0,0,0,0,1
covid-19 monitoring using wearable sensors/smartphone technology,1,0,0,0,0,1
covid-19 mrna vaccine (nucleoside modified),1,0,0,0,0,1
covid-19 mrna vaccine moderna (1 dose),0,0,0,1,0,1
covid-19 mrna vaccine moderna (2 doses),0,0,0,1,0,1
covid-19 nasal,1,0,0,0,0,1
covid-19 nasal/pharyngeal swab,1,0,0,0,0,1
covid-19 neutralizing antibody,0,0,0,1,0,1
"covid-19 pcr , igm",1,0,0,0,0,1
covid-19 pneumonia,1,0,0,0,0,1
covid-19 positive,0,0,0,1,0,1
covid-19 positive pregnant women,0,1,0,0,0,1
covid-19 presto test,0,1,0,0,0,1
covid-19 related health warning leaflet,1,0,0,0,0,1
covid-19 related muscle mass change in the intensive care unit,1,0,0,0,0,1
covid-19 rt-pcr test,0,0,0,1,0,1
covid-19 sars-cov igg,0,0,0,1,0,1
covid-19 sars-cov igg/igm antibody rapid test,0,0,0,1,0,1
covid-19 serology igg,0,0,0,1,0,1
covid-19 standard of care,0,0,0,1,0,1
covid-19 standard therapy,0,1,0,0,0,1
covid-19 survey,0,0,1,0,0,1
covid-19 swab,0,0,0,1,0,1
covid-19 symptom monitoring system,0,0,0,1,0,1
covid-19 testing home-based (aim 1),0,0,0,1,0,1
covid-19 testing mobile (aim 1),0,0,0,1,0,1
covid-19 testing mobile approach 1 (aim 2),0,0,0,1,0,1
covid-19 testing mobile approach 2 (aim 2),0,0,0,1,0,1
covid-19 treatment,0,0,0,1,0,1
covid-19 treatments,0,1,0,0,0,1
covid-19 vaccinated people,0,0,0,1,0,1
covid-19 vaccine (vero cells),0,0,0,1,0,1
covid-19 vaccine astrazeneca suspension for injection,0,0,0,1,0,1
covid-19 vaccine education campaign,0,0,0,1,0,1
covid-19 vaccine hesitancy,0,0,0,1,0,1
covid-19 vaccine hesitancy associated factors,0,0,0,1,0,1
covid-19 vaccine hesitancy scale in rheumatic diseases,0,0,0,1,0,1
covid-19 vaccine hesitancy/acceptance survey,0,0,0,1,0,1
covid-19 vaccine hipra 10,1,0,0,0,0,1
covid-19 vaccine hipra 20,1,0,0,0,0,1
covid-19 vaccine hipra 40,1,0,0,0,0,1
covid-19 vaccine ivr training,1,0,0,0,0,1
covid-19 vaccine janssen (ad26.cov2-s),0,0,0,1,0,1
covid-19 vaccine message,0,1,0,0,0,1
covid-19 vaccine moderna dispersion for injection - moderna biotech,0,0,0,1,0,1
covid-19 vaccine observation of individuals who receive the covid-19 vaccine,0,0,0,1,0,1
covid-19 vaccine pfizer (1 dose),0,0,0,1,0,1
covid-19 vaccine pfizer (2 doses),0,0,0,1,0,1
"covid-19 vaccine, booster",0,0,0,1,0,1
"covid-19 vaccine,inactivated",1,0,0,0,0,1
covid-19/ flu a&b rapid panel,0,0,0,1,0,1
covid-19/intensive care,0,1,0,0,0,1
covid-antibody test,1,0,0,0,0,1
covid-evax,1,0,0,0,0,1
covid-globulin,0,0,0,1,0,1
covid-higiv,0,1,0,0,0,1
covid-specific advice,1,0,0,0,0,1
covid-surgres questionaire,0,1,0,0,0,1
covid -19 (recombinante) vaccine,0,0,0,1,0,1
covid 19 diagnostic test,1,0,0,0,0,1
covid 19 impact,0,1,0,0,0,1
covid 19 negative,0,0,0,1,0,1
covid 19 positive,0,0,0,1,0,1
covid 19 self-questionnaire,0,0,0,1,0,1
covid 19 serology,0,0,0,1,0,1
covid 19 spinal anesthesia,0,1,0,0,0,1
covid 19 vaccine counseling,0,0,0,1,0,1
covid detect,0,1,0,0,0,1
covid icu containment measures,0,0,0,1,0,1
covid rehabilitation program for the elderly (core),0,0,1,0,0,1
covid vaccine,1,0,0,0,0,1
covid vaccines,0,0,1,0,0,1
covid watch,1,0,0,0,0,1
covid wheld,0,0,0,1,0,1
covid19 mrna vaccine,0,0,0,1,0,1
covid19 rt-pcr,0,1,0,0,0,1
covid19 treatments,0,1,0,0,0,1
covid19 vaccine,0,1,0,0,0,1
covidfree@home,0,0,0,1,0,1
covidir injections,0,1,0,0,0,1
covidseq test,0,0,1,0,0,1
covigenix vax-001,1,0,0,0,0,1
covigenix vax-001 placebo,1,0,0,0,0,1
covishield,0,0,0,1,0,1
covishield 0.25ml,1,0,0,0,0,1
covishield 0.5ml,1,0,0,0,0,1
covivac,0,0,0,1,0,1
covsurf drug delivery system,0,0,0,1,0,1
covvr,0,0,0,1,0,1
covx,0,1,0,0,0,1
cpap helmet,0,0,0,1,0,1
cpc,0,0,0,1,0,1
cpc/zn,0,0,0,1,0,1
cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cpi-006,0,1,0,0,0,1
cpi-006 1 mg,0,0,0,0,1,1
cpi-006 1 mg/kg / soc,0,0,0,0,1,1
cpi-006 2 mg,0,0,0,0,1,1
cpi-006 2 mg/kg / soc,0,0,0,0,1,1
credible messenger,0,0,0,1,0,1
crest pro-health multi-protection mouthwash,0,0,0,1,0,1
cretan iama,0,1,0,0,0,1
cri,0,0,0,0,1,1
cries 13 questionnaire,0,1,0,0,0,1
crisis intervention therapy,0,0,1,0,0,1
critical dialogue,0,0,0,1,0,1
crizanlizumab,0,1,0,0,0,1
crizanlizumab injection,0,0,0,1,0,1
cross-sectional genetics study,0,0,0,1,0,1
cross-sectional observational study,0,1,0,0,0,1
cross-sectional study investigating the association of npis with mental health,0,1,0,0,0,1
cross-sectional survey,1,0,0,0,0,1
cross sectional e-survey on surgeons exposed to any educational intervention,1,0,0,0,0,1
cross sectional study using scientifically validated psychometric scales,0,1,0,0,0,1
crp-apheresis,0,0,0,1,0,1
cryo lung biopsies,0,0,1,0,0,1
cryopreserved ex vivo expanded polyclonal cd4,0,0,0,1,0,1
cryopreserved ex vivo expanded polyclonal cd4/cd127lo/-cd25/ t regulatory cells,0,0,0,1,0,1
csl760,0,0,0,0,1,1
cst-2: eidd-2801,0,0,0,1,0,1
cst-2: placebo,0,0,0,1,0,1
cst-5: placebo,0,0,0,1,0,1
csvf,0,0,0,1,0,1
ct-p59/placebo,0,1,0,0,0,1
ctus examination,0,0,0,1,0,1
cube rapid test,1,0,0,0,0,1
cuff application with inflation,0,0,0,1,0,1
culturally tailored pcp outreach,0,1,0,0,0,1
culturally targeted sars-cov-2 communication,0,0,0,1,0,1
cumin,0,1,0,0,0,1
cupping,0,0,0,1,0,1
curently used therapy for covid-19 non-critical patients,0,0,0,1,0,1
current care per ucla treating physicians,1,0,0,0,0,1
current health,0,0,0,0,1,1
current ipac-uhn ppe,0,0,0,1,0,1
currently used therapy,0,0,0,1,0,1
cvxga1 high dose,0,0,0,1,0,1
cvxga1 low dose,0,0,0,1,0,1
cycle threshold,0,0,0,1,0,1
cyp-001,0,0,0,1,0,1
cyproheptadine,0,0,0,1,0,1
cystatin c,0,1,0,0,0,1
cytokine hemadsorption,0,0,0,1,0,1
cytokines,0,1,0,0,0,1
cytokines measurement,0,1,0,0,0,1
"d-beta-hydroxybutyrate-(r)-1,3 butanediol monoester",0,0,0,1,0,1
d-dimer test,0,0,0,1,0,1
d followed by enoxaparin,0,1,0,0,0,1
d region,0,0,0,1,0,1
d5w inj,0,0,0,1,0,1
daclastavir 60 mg,0,0,0,1,0,1
daclatasvir 200mg,0,0,0,1,0,1
daclatasvir 60 mg,0,0,0,1,0,1
daily coping toolkit,0,0,0,1,0,1
daily monitoring,0,0,1,0,0,1
daily room disinfection,0,1,0,0,0,1
daily syndromic surveillance,0,0,1,0,0,1
dalargin,0,0,0,1,0,1
dalcetrapib,0,1,0,0,0,1
dana app,0,0,0,1,0,1
danicopan,0,0,0,1,0,1
danoprevir,0,1,0,0,0,1
danoprevir/ritonavir,0,1,0,0,0,1
dapansutrile capsules,0,0,0,1,0,1
dapsone 100 mg,0,0,0,1,0,1
dapsone 85 mg po bid,0,0,0,1,0,1
das181,0,1,0,0,0,1
dass-21 instrument (depression,0,0,1,0,0,1
dass-21 instrument (depression/anxiety),0,0,1,0,0,1
dass questionnaire,0,1,0,0,0,1
data collecting,0,0,0,1,0,1
data collection (,0,0,0,1,0,1
data collection from blood draw,1,0,0,0,0,1
data collection from lumbar puncture,1,0,0,0,0,1
data collection from medical files,0,0,0,1,0,1
data collection of patients presenting to the tertiary care centre with acute coronary syndrome,0,1,0,0,0,1
data collection on cardiovascular mortality,0,1,0,0,0,1
data collection on hospitalisation,0,1,0,0,0,1
data collection on outpatient care,0,1,0,0,0,1
data collection up to 1 year,1,0,0,0,0,1
data collection/rhinopharyngeal swab,0,1,0,0,0,1
data collection: clinical care assessments,1,0,0,0,0,1
data monitoring for 48h within the first 24 hours of admission for covid-19,0,1,0,0,0,1
"data research, database analysis",0,1,0,0,0,1
day,0,1,0,0,0,1
day 28.,0,1,0,0,0,1
day for 5 days,0,1,0,0,0,1
db-001,0,1,0,0,0,1
ddpcr,1,0,0,0,0,1
death with routine,1,0,0,0,0,1
decidual stromal cells (dsc),1,0,0,0,0,1
decision science-based design,0,1,0,0,0,1
decision tool for clinicians,0,0,0,1,0,1
decisions of limitations,0,0,0,1,0,1
decisions of limitations/stop processing,0,0,0,1,0,1
decitabine,0,0,0,1,0,1
dect,0,0,1,0,0,1
deep breathing training,0,1,0,0,0,1
deferoxamine,0,0,0,1,0,1
defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
degarelix,0,1,0,0,0,1
deglycyrrhizinated licorice,0,0,0,1,0,1
delns1-ncov-rbd laiv,1,0,0,0,0,1
demographic characteristics,0,1,0,0,0,1
depression assessment,0,0,0,1,0,1
depression scale,0,0,0,1,0,1
"depression,",0,0,0,1,0,1
"depression, anxiety",0,0,0,0,1,1
"depression, anxiety/stress scale",0,0,0,0,1,1
derivatives,1,0,0,0,0,1
derivatives.,0,1,0,0,0,1
description of groups caracteristics,0,1,0,0,0,1
desidustat,0,1,0,0,0,1
desmond,1,0,0,0,0,1
detection of oral lesions,0,0,1,0,0,1
determination of covid-19 vacciantion efficacy,0,0,0,1,0,1
determination of cyp2c19 genotype,0,0,0,1,0,1
determination of sars-cov2 presence in cns,0,0,0,1,0,1
device used to record voice for screening,0,0,0,1,0,1
device),0,0,0,1,0,1
device: butterfly iq,0,0,0,1,0,1
dexamethasone 2 mg,0,1,0,0,0,1
dexamethasone 2 mg/ml,0,1,0,0,0,1
dexamethasone high dose,0,1,0,0,0,1
dexamethasone low dose,0,1,0,0,0,1
dexamethasone oral,1,0,0,0,0,1
dexamethasone/hydroxychloroquine,0,0,0,0,1,1
dexcom,0,0,0,1,0,1
dfv890,0,1,0,0,0,1
diabetes type 2,1,0,0,0,0,1
diagnosed with covid-19,1,0,0,0,0,1
"diagnosis of sars-cov2 by rt-pcr/: igg, ig m serologies in the amniotoc fluid, the blood cord/the placenta",0,1,0,0,0,1
diagnostic,0,1,0,0,0,1
diagnostic criteria for temporomandibular disorders (dc,0,1,0,0,0,1
diagnostic criteria for temporomandibular disorders (dc/tmd) scale,0,1,0,0,0,1
diagnostic examination for venous thromboembolism,0,1,0,0,0,1
diagnostic test covid-19,1,0,0,0,0,1
diagnostic test for detection of sars-cov-2,0,0,1,0,0,1
diagnostic test for sars-cov2 for patients,0,0,0,1,0,1
diagnostic test for sars-cov2 for patients/health staff,0,0,0,1,0,1
diagnostic test:blood test,0,0,0,1,0,1
diagnostic tests,0,0,0,1,0,1
diagnostic tests for covid-19 infection,0,0,0,1,0,1
dialectical behavioral therapy (dbt) skills,0,1,0,0,0,1
diclofenac sodium 1gm%,0,1,0,0,0,1
diet,0,0,0,0,1,1
diet tracking,1,0,0,0,0,1
diet/sun exposure,0,0,0,0,1,1
"dietary counselling on food groups according to iyc feeding practices, who",1,0,0,0,0,1
dietary intervention,0,1,0,0,0,1
dietary supplement,0,0,0,1,0,1
dietary supplement containing resistant starch,0,0,0,1,0,1
dietary supplementation in patients with covid disease admitted to hospital,0,0,0,1,0,1
differences in triage,0,1,0,0,0,1
differential leucocyte count (cldc) device,1,0,0,0,0,1
differential leucocyte count (cldc) device/algorithm,1,0,0,0,0,1
difficulties lived by disabled children's parents in the period of covid-19 pandemic,0,1,0,0,0,1
dig axial,0,1,0,0,0,1
dig tilted,0,1,0,0,0,1
digital brochure,0,0,0,1,0,1
digital cardiac counseling,0,0,0,1,0,1
digital dance for pd,0,1,0,0,0,1
digital health online platform,0,1,0,0,0,1
digital oximeter monitoring,0,0,0,1,0,1
digital problem solving tool,0,1,0,0,0,1
digital social activity video intervention,0,1,0,0,0,1
digital storytelling intervention,0,1,0,0,0,1
digivis visual acuity app,0,0,0,1,0,1
dimethyl fumarate,0,0,0,1,0,1
diovan,0,0,0,0,1,1
dipyridamole er 200mg,0,0,0,1,0,1
dipyridamole er 200mg/ aspirin 25mg orally/enterally/standard of care,0,0,0,1,0,1
direct antigen tests for covid-19,0,1,0,0,0,1
directive interview,0,0,0,1,0,1
discontinuation of acei,0,0,0,1,0,1
discontinuation of acei/arb,0,0,0,1,0,1
discontinuation of arb,0,1,0,0,0,1
discontinuation of ras blocker,0,0,0,0,1,1
discussion,0,0,0,1,0,1
discussion board for social support,0,1,0,0,0,1
discussion board for social support /basic feedback,0,1,0,0,0,1
discussion board for social support/personalized feedback,0,1,0,0,0,1
distance learning,0,0,1,0,0,1
distilled water with the same colorant as the experimental product,0,1,0,0,0,1
dlco,0,0,0,1,0,1
dociparstat sodium,0,0,0,0,1,1
doctella telehealth monitoring,0,0,0,0,1,1
doctor spot,0,1,0,0,0,1
doing what matters (dwm),0,0,0,1,0,1
doppler echo,1,0,0,0,0,1
dose finding phase (mtd),0,0,0,0,1,1
double-blind nt-i7,0,0,0,1,0,1
double dosage inactivated vaccine,0,0,0,1,0,1
doxazosin 2 mg oral tablet,0,0,0,1,0,1
doxycyclin,0,1,0,0,0,1
doxycycline hcl,1,0,0,0,0,1
doxycyline,0,1,0,0,0,1
dressing for external use,1,0,0,0,0,1
dried blood spot,0,1,0,0,0,1
dried blood spot/venous blood collection,0,1,0,0,0,1
driving pressure,0,0,0,1,0,1
drug covid19-0001-usr,0,0,0,1,0,1
drugs,0,1,0,0,0,1
drugs/supportive care,0,1,0,0,0,1
dry blood spot collection (euroimmun),0,0,0,1,0,1
ds-5670a,1,0,0,0,0,1
duact,0,0,0,1,0,1
dupilumab,0,0,0,1,0,1
duplex sonography,0,0,0,1,0,1
duplex ultrasound/computed tomography angiography,0,1,0,0,0,1
dur-928,0,0,0,0,1,1
"duration of hospitalization, mortality rate",0,1,0,0,0,1
during covid-19 pandemic,0,0,0,1,0,1
during hospitalization blood samples,0,0,0,1,0,1
"during the pandemic, the patient's job status, physical activity conditions, pain status",0,1,0,0,0,1
dutasteride 0.5 mg,0,1,0,0,0,1
duty frame,1,0,0,0,0,1
dvx201,0,0,0,1,0,1
dwj1248 with remdesivir,0,0,0,1,0,1
dwrx2003,0,0,0,0,1,1
"dwrx2003, 144mg",0,1,0,0,0,1
"dwrx2003, 432mg",0,1,0,0,0,1
"dwrx2003, 96mg",0,1,0,0,0,1
dysautonomia,0,0,0,1,0,1
dysphagia handicap index (dhi),0,0,0,1,0,1
e-health,0,0,0,1,0,1
early access,0,0,1,0,0,1
early occupational therapy,0,0,0,1,0,1
early physiotherapy,0,0,0,1,0,1
early rehabilitation,0,0,0,1,0,1
earsats pulse oximeter probe,0,0,0,1,0,1
easycov poc,0,0,0,1,0,1
eat-26 questionnaire,0,1,0,0,0,1
eating habits,0,0,0,1,0,1
ecco2r,0,0,0,1,0,1
ecg-holter,0,1,0,0,0,1
ecg data analysis,0,1,0,0,0,1
ecg from handheld device,0,0,0,1,0,1
echo-doppler,0,0,0,1,0,1
echocardiogram,0,0,0,1,0,1
ecmo,1,0,0,0,0,1
economic benefit message,0,1,0,0,0,1
economic freedom message,0,1,0,0,0,1
eculizumab,0,0,0,1,0,1
edinburgh postnatal depression scale,0,0,0,1,0,1
edinburgh postnatal depression scale (edps),0,0,0,1,0,1
edoxaban tablets,0,0,0,1,0,1
education.,0,0,0,1,0,1
educational meetings/visual prompts,0,1,0,0,0,1
educational moral injury video,0,1,0,0,0,1
educational program (cartoon),0,0,0,1,0,1
educational video,1,0,0,0,0,1
educational vocal health modules,0,0,0,1,0,1
"educational, culturally appropriate covid-19 messages",0,1,0,0,0,1
eeg,0,1,0,0,0,1
eeg based protocol for deep sedation,0,1,0,0,0,1
effect of covid-19 exposure,0,1,0,0,0,1
effects in oxygenation,0,1,0,0,0,1
effects in oxygenation/hypoxic pulmonary vasoconstriction,0,1,0,0,0,1
efferon ct,0,1,0,0,0,1
ehealth for covid-19 prevention,0,0,0,1,0,1
ehealth for covid-19 prevention/support,0,0,0,1,0,1
ei open ended pre-survey,0,0,1,0,0,1
ei open ended pre-survey/semi structured interview,0,0,1,0,0,1
eicosapentaenoic acid,0,0,0,1,0,1
eit-group,0,0,0,1,0,1
ejaculated semen sample,0,0,0,1,0,1
elbow flexion muscle strength,0,0,1,0,0,1
"elecsys anti-sars-cov-2 s (roche diagnostics gmbh, mannheim, germany), 2) access sars-cov-2 igg ii (beckman coulter, inc. usa)",0,0,0,1,0,1
elecsys semi-quantitative anti-sars-cov-2 antibody test,0,1,0,0,0,1
elective cancer surgery,0,0,0,1,0,1
electric pad for human external pain therapy,0,0,0,1,0,1
electrical stimulation,0,0,0,1,0,1
electrical stimulation - sham,0,0,0,1,0,1
electro impedance tomography,0,1,0,0,0,1
electrocardiogram,0,0,0,1,0,1
electrocardiogram (ecg),1,0,0,0,0,1
"electrocardiogram, telemetry, echocardiogram, laboratory values",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography/clinico-biological parameters in routine care",0,0,0,1,0,1
"electrocardiography ,tomographic imaging",0,1,0,0,0,1
electroencephalogram with ekg lead,0,1,0,0,0,1
electrolytes,0,1,0,0,0,1
electronic portable aromatic rehabilitation (epar) diffuser,0,0,0,1,0,1
electronic stethoscope,0,0,0,1,0,1
elisa poct vs rt-pcr,0,0,0,1,0,1
elisa test for the antibodies to covid-2019.,0,1,0,0,0,1
elisa/rapid test to detect antibodies against covid-19,0,1,0,0,0,1
elispot test,0,0,0,1,0,1
elispot: detection of the t cells specific to different sars-cov-2 proteins,0,0,0,1,0,1
elmo project at covid-19: proof of concept,0,1,0,0,0,1
elmo project at covid-19: proof of concept/usability,0,1,0,0,0,1
elmo project at covid-19: study in humans,0,1,0,0,0,1
eltrombopag,0,0,0,1,0,1
emapalumab,0,0,0,0,1,1
embarrassment message,0,1,0,0,0,1
emdr,0,0,0,1,0,1
emergency general surgical admissions,0,1,0,0,0,1
emergency laparotomy,0,1,0,0,0,1
emergency surgery,0,1,0,0,0,1
emergency surgical procedures,0,1,0,0,0,1
emergent cases,0,1,0,0,0,1
emotion management,0,0,0,1,0,1
emotion regulation training based on dbt,0,1,0,0,0,1
emotion regulation training via telehealth,0,0,0,1,0,1
emotional freedom technique,0,1,0,0,0,1
emotional freedom techniques (eft),1,0,0,0,0,1
emotional support plan,0,0,1,0,0,1
empagliflozin,0,0,0,1,0,1
emphasis of academic researchers involvement,1,0,0,0,0,1
emphasis of government involvement,1,0,0,0,0,1
empower,0,0,1,0,0,1
emricasan,0,0,0,1,0,1
emtricitabine 200 mg oral tablet,0,0,0,1,0,1
emtricitabine/tenofovir,0,1,0,0,0,1
emtricitabine/tenofovir disoproxil,0,1,0,0,0,1
emtricitabine/tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],0,0,0,1,0,1
enamel care -cetylpyridinium chloride,0,1,0,0,0,1
encephalography measurement,0,0,0,1,0,1
endoscopic intervention,0,1,0,0,0,1
endoscopic management according to standard of care,0,1,0,0,0,1
endoscopic procedure,0,1,0,0,0,1
endoscopy,0,1,0,0,0,1
endothelial damage,0,1,0,0,0,1
endothelial damage/angiogenic biomarkers,0,1,0,0,0,1
endothelial protocol,0,0,0,1,0,1
endurance rmt,0,0,0,1,0,1
endurance rmt/nasal breathing,0,0,0,1,0,1
enduring happiness,0,0,1,0,0,1
enduring happiness/continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
enhanced follow through message,0,0,1,0,0,1
enhanced hygiene measures,1,0,0,0,0,1
enhanced treatment as usual (eta-u),0,0,0,1,0,1
enisamium iodide,0,1,0,0,0,1
eno breathe group,0,1,0,0,0,1
enoxaparin/lovenox,0,1,0,0,0,1
enriched survey feedback,1,0,0,0,0,1
ensifentrine,1,0,0,0,0,1
ent exam,0,0,0,1,0,1
enterally,0,0,0,1,0,1
enzalutamide,0,0,0,0,1,1
ep,0,1,0,0,0,1
epa,1,0,0,0,0,1
epds (edinburgh postnatal depression scale),0,1,0,0,0,1
epi-net intervention,0,0,0,1,0,1
epic risk score display,0,0,0,1,0,1
epidemiological,0,1,0,0,0,1
epidemiological/demographic characteristics,0,1,0,0,0,1
epidemiology of admissions,0,1,0,0,0,1
epigenetic analyses,0,0,0,1,0,1
eproms assessment,0,1,0,0,0,1
epsgun,1,0,0,0,0,1
equinacea arkopharma,0,0,0,1,0,1
equine covid-19 antiserum,0,0,0,1,0,1
equipment with smartwatch throughout hospital stay on the general ward,0,1,0,0,0,1
erenumab,0,1,0,0,0,1
ergoferon,0,0,0,1,0,1
ergonomic training,0,1,0,0,0,1
erucov-vac,0,0,0,1,0,1
erucov-vac 3 âµg,0,0,0,1,0,1
erucov-vac 3 âµg/0.5 ml vaccine,0,0,0,1,0,1
erucov-vac 6 âµg,0,0,0,1,0,1
erucov-vac 6 âµg/0.5 ml vaccine,0,0,0,1,0,1
escin,0,0,0,1,0,1
escola john talabot,0,1,0,0,0,1
esophageal catheter,0,0,0,1,0,1
essence oils,0,0,1,0,0,1
essential oil blend,0,0,0,1,0,1
estetrol monohydrate 15 mg,1,0,0,0,0,1
estradiol,0,0,0,0,1,1
estradiol cypionate 5 mg,0,0,0,1,0,1
estradiol cypionate 5 mg/ml,0,0,0,1,0,1
estrogen therapy,0,0,0,1,0,1
etesevimab,0,0,0,1,0,1
ethnic frame,1,0,0,0,0,1
etoposide,1,0,0,0,0,1
eua sars-cov-2 vaccine,0,0,0,1,0,1
eucorvac-19,0,0,0,1,0,1
euroimmun assay,0,1,0,0,0,1
evaluate hacor score effectivity in this patients,0,0,0,1,0,1
evaluation of changes in the diagnostic-therapeutic pathway,0,1,0,0,0,1
"evaluation of clinical, instrumental",1,0,0,0,0,1
"evaluation of clinical, instrumental/laboratory diagnostics tests",1,0,0,0,0,1
evaluation of diaphragmatic contractility by ultrasound,1,0,0,0,0,1
evaluation of functional strength of trunk muscles,0,0,1,0,0,1
evaluation of knee extension,0,0,1,0,0,1
evaluation of knee extension/elbow flexion muscle strength,0,0,1,0,0,1
evaluation of skin microvascular flow,0,0,0,1,0,1
evaluation of skin microvascular flow/reactivity,0,0,0,1,0,1
evaluation of the degree of steatosis,0,0,0,1,0,1
evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),0,0,0,1,0,1
evaluation of the ferritin,0,0,0,1,0,1
even birth year intervention groups,0,1,0,0,0,1
evolocumab,0,0,0,1,0,1
ex vivo expanded wharton's jelly mesenchymal stem cells,0,1,0,0,0,1
examinations for the research:,0,0,0,1,0,1
examine the impact of covid-19 during pregnancy,0,0,0,1,0,1
exercise booklet,0,0,0,1,0,1
exercise program,0,0,0,1,0,1
exercise test ecg,0,0,0,1,0,1
exercise/nutrition,0,0,0,1,0,1
exercises,0,0,0,1,0,1
exg-5003,0,0,0,1,0,1
exhaled breath sampling,0,1,0,0,0,1
exo-cd24,0,0,0,1,0,1
exoflo,0,0,0,1,0,1
exosomes overexpressing cd24,1,0,0,0,0,1
expanded hemodialysis for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
"expected adverse reactions shortly following vaccination (reactogenicity), use of antipyretic",0,0,0,1,0,1
experience of pandemic,0,1,0,0,0,1
experiences in close relationship scale questionnaire (ecr-s),0,0,0,1,0,1
experiences of health care professionals working in intensive care units during the covid-19 pandemic,0,1,0,0,0,1
experimental,0,0,0,1,0,1
experimental: active care group,1,0,0,0,0,1
experimental: questionnaire without precaution information,0,1,0,0,0,1
experts consensus,0,1,0,0,0,1
expiratory muscle training group,0,1,0,0,0,1
expiratory muscle training placebo group,0,1,0,0,0,1
exposed to a sars-cov-2 infection,1,0,0,0,0,1
exposure surveys,0,1,0,0,0,1
exposure to covid-19,1,0,0,0,0,1
exposure to covid19,0,0,0,1,0,1
exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
"exposure to telemedicine, after the onset of the pandemic",0,0,0,1,0,1
exposure to the dutch measures due to the covid-19 pandemic.,0,0,0,1,0,1
exposure: covid-19 severity,0,0,0,1,0,1
extended post anaesthetic care in pacu,0,1,0,0,0,1
extension for community healthcare outcomes,0,0,0,1,0,1
extra-cvd virtual care,0,0,0,1,0,1
extracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
extracorporeal membrane oxygenation,0,1,0,0,0,1
extract psidii guava,0,1,0,0,0,1
eye movement desensitisation,0,1,0,0,0,1
eye movement desensitisation/reprocessing recent traumatic event protocol,0,1,0,0,0,1
f-652,0,0,0,1,0,1
face-mask niv,0,1,0,0,0,1
face-to-face rehabilitation,0,1,0,0,0,1
face mask / soap,0,1,0,0,0,1
face mask awareness,0,1,0,0,0,1
face mask sampling,0,0,0,1,0,1
facebook ads on the importance of staying safe during the thanksgiving,0,1,0,0,0,1
facebook ads on the importance of staying safe during the thanksgiving / christmas holiday,0,1,0,0,0,1
facial fractures reduction,0,1,0,0,0,1
facial fractures reduction/osteosynthesis,0,1,0,0,0,1
facial mask,0,0,0,1,0,1
faeces samples,0,1,0,0,0,1
family-based model,0,0,0,1,0,1
family nurture intervention (fni),0,0,0,1,0,1
family risk messaging,0,0,1,0,0,1
familychildcare (provisional name of app),0,0,1,0,0,1
famotidine tablets,0,1,0,0,0,1
far-uvc light as an additional method of disinfection,0,0,1,0,0,1
farmalarm,0,1,0,0,0,1
fast dissolving film,0,1,0,0,0,1
fatigue,0,0,1,0,0,1
fatigue severity scale,0,1,0,0,0,1
favipiravir / currently used therapy,0,0,0,1,0,1
favipiravir / hydroxychloroquine,0,1,0,0,0,1
favipiravir/azithromycin,1,0,0,0,0,1
favipiravir/chloroquine,0,0,0,1,0,1
favipiravir/nitazoxanide,0,1,0,0,0,1
favipiravir/tocilizumab,0,0,0,1,0,1
favorable outcome,0,1,0,0,0,1
fb2001,0,0,0,1,0,1
fb2001 placebo,0,0,0,1,0,1
fdg-pet,0,0,0,1,0,1
fdg-pet/ct,0,0,0,1,0,1
feasibility of using the opal app for covid,0,1,0,0,0,1
fecal,0,1,0,0,0,1
fecal sample,1,0,0,0,0,1
feedback,0,0,0,1,0,1
fenofibrate/fenofibric acid,0,0,1,0,0,1
fenofibric acid,0,0,1,0,0,1
ferinject,0,1,0,0,0,1
ffp,0,0,0,1,0,1
ffp2,0,0,0,1,0,1
ffp2 respirator,0,1,0,0,0,1
ffp3 respirator,0,1,0,0,0,1
fibreoptic endoscopic evaluation of swallowing (fees),0,0,0,1,0,1
fibrin generation markers assays,1,0,0,0,0,1
fibromyalgia impact questionnaire,0,1,0,0,0,1
file inquiry,0,1,0,0,0,1
filiform needles,0,0,0,1,0,1
filling in an online survey,0,1,0,0,0,1
filmarray pneumonia,0,1,0,0,0,1
filtering face piece,0,1,0,0,0,1
filtration test,0,1,0,0,0,1
financial incentives,1,0,0,0,0,1
fingerstick,0,0,0,1,0,1
fingertip tests for poc assays,0,0,0,1,0,1
firazyr,0,0,0,1,0,1
fixed site standard of care testing,0,0,1,0,0,1
flavor test,0,1,0,0,0,1
flexibility,0,0,1,0,0,1
flow controlled ventilation (evone-ventilator),0,0,0,1,0,1
flow cytometry: detection of the sars-cov-2 specific t-helpers,0,0,0,1,0,1
flow cytometry: detection of the sars-cov-2 specific t-helpers/cytotoxic t lymphocytes,0,0,0,1,0,1
flu a&b rapid panel,0,0,0,1,0,1
flu d-qiv,1,0,0,0,0,1
flu shot,0,1,0,0,0,1
fluids,0,0,1,0,0,1
fluorescein,0,1,0,0,0,1
fluoxetine,0,0,0,1,0,1
fluoxetine tablets,0,0,0,1,0,1
fluticasone,0,0,0,1,0,1
fluticasone propionate,0,0,0,1,0,1
fluvoxamine maleate 100 mg [luvox],0,0,0,1,0,1
fluvoxamine maleate 50 mg,0,0,0,1,0,1
"fluvoxamine, bromhexine",0,0,0,1,0,1
"fluvoxamine, cyproheptadine",0,0,0,1,0,1
fmf.,0,0,1,0,0,1
focal mask,0,0,0,1,0,1
focus interview,0,1,0,0,0,1
focused,0,0,0,1,0,1
focused/targeted message,0,0,0,1,0,1
follow-up of patients with covid-19,0,0,0,1,0,1
follow-up phone call,0,1,0,0,0,1
follow-up visit,0,0,0,1,0,1
follow up,1,0,0,0,0,1
follow up calls,0,0,0,1,0,1
fondapariniux,0,0,0,1,0,1
food diary,0,0,0,1,0,1
formoterol,0,0,0,1,0,1
foy-305,0,1,0,0,0,1
fp-025 100 mg,0,0,0,1,0,1
fp-025 300 mg,0,0,0,1,0,1
freestyle libre 14 day cgm system,0,1,0,0,0,1
fresh start,0,0,1,0,0,1
fsd201,0,0,0,1,0,1
fsfi survey,0,1,0,0,0,1
fulfilling questionaires,0,0,0,1,0,1
full spectrum cbd oil,0,0,0,1,0,1
functional analysis,0,0,0,1,0,1
fungal rhinosinusitis,0,1,0,0,0,1
furfat,0,0,0,1,0,1
further processing of health data,0,0,0,1,0,1
fx06,0,1,0,0,0,1
gad-7 (7-item generalized anxiety disorder),0,1,0,0,0,1
gad-7 (general anxiety disorder) scale,0,1,0,0,0,1
gad-7 (generalized anxiety disorder) scale (during containment),0,0,0,1,0,1
gad-7 (generalized anxiety disorder) scale (post containment),0,0,0,1,0,1
gad-7 general anxiety disorder scale,0,0,0,1,0,1
gam-covid-vac (rad26),1,0,0,0,0,1
gam-covid-vac (rad26) / gam-covid-vac (rad5),1,0,0,0,0,1
gam-covid-vac (rad5),1,0,0,0,0,1
gam-covid-vac lyo,0,1,0,0,0,1
gam-covid-vac m,0,0,0,1,0,1
gamification,0,0,0,0,1,1
gamunex-c,0,1,0,0,0,1
ganovo,0,1,0,0,0,1
ganovo/ritonavir//-interferon nebulization,0,1,0,0,0,1
"garadacimab, factor xiia antagonist monoclonal antibody",0,1,0,0,0,1
gargles (hsnig),0,0,0,1,0,1
gas exchange measurement,0,1,0,0,0,1
gas exchanges at different peep,0,1,0,0,0,1
gastric cancer surgery,0,1,0,0,0,1
gastrointestinal endoscopy,0,1,0,0,0,1
gastroscopy in transnasal techique,0,0,0,1,0,1
gbp510 (rbd 10î¼g,1,0,0,0,0,1
gbp510 (rbd 10î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 (rbd 25î¼g,1,0,0,0,0,1
gbp510 (rbd 25î¼g/dose)- stage 2,1,0,0,0,0,1
gbp510 (rbd 25î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 10î¼g,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 2,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 25î¼g,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose)- stage 2,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 2,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose)- stage 2,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with as03 (receptor-binding domain(rbd) 25ug,0,0,0,1,0,1
gbp510 adjuvanted with as03 (receptor-binding domain(rbd) 25ug/dose),0,0,0,1,0,1
gc4419,0,0,0,0,1,1
gc5131,0,1,0,0,0,1
gdm screening criteria,1,0,0,0,0,1
gender concordant,1,0,0,0,0,1
general anesthesia,0,1,0,0,0,1
general communication message,0,0,0,1,0,1
general health education,0,0,0,1,0,1
general lifestyle advice to breast cancer patients by phone,0,1,0,0,0,1
general messages,0,1,0,0,0,1
general practitioner tandem,0,1,0,0,0,1
general public cohort,0,1,0,0,0,1
general recommendation,0,0,0,1,0,1
general sars-cov-2 communication,0,0,0,1,0,1
generalized anxiety disorder-7 (gad-7),0,1,0,0,0,1
generalized anxiety disorder-7 (gad 7),0,0,0,1,0,1
generic best practices,0,0,0,1,0,1
genetic,0,0,0,1,0,1
genetic analyses.,1,0,0,0,0,1
genetic analysis:,0,0,0,1,0,1
genetic blood collection,0,1,0,0,0,1
geneva emotional competence test (geco),0,0,1,0,0,1
giga-2050,0,0,0,1,0,1
gimsilumab,0,1,0,0,0,1
glatiramer acetate,0,0,0,1,0,1
glenzocimab,0,1,0,0,0,1
global longitudinal strain,0,1,0,0,0,1
global survey,0,1,0,0,0,1
gloves,0,1,0,0,0,1
glowtest covid-19 antigen home test,0,1,0,0,0,1
gls-1027,0,0,0,1,0,1
gls-1200,0,0,0,1,0,1
gls-5310,0,0,0,1,0,1
glucose control,0,1,0,0,0,1
glucose control/sensor usage,0,1,0,0,0,1
glutamine,0,1,0,0,0,1
glycaemic levels,0,0,0,1,0,1
glycomic analysis,0,0,0,1,0,1
glycophosphopeptical am3,0,0,0,1,0,1
glycosylated ferritin by standard approved serological tests,0,0,0,1,0,1
gm-csf,0,1,0,0,0,1
gns561,0,0,0,1,0,1
go2 peep mouthpiece,0,1,0,0,0,1
gossip intervention,1,0,0,0,0,1
"gps reports of potential patient safety incidents, non-covid-19 related",0,1,0,0,0,1
grandiosity subscales,0,1,0,0,0,1
grocery store gift cards,0,0,1,0,0,1
group 1,1,0,0,0,0,1
group 1 hcq,0,0,0,0,1,1
group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,0,1,0,0,0,1
group 2 placebo,0,0,0,0,1,1
group a (ag0302-covid19),1,0,0,0,0,1
group a (placebo),1,0,0,0,0,1
group a (sample collection),0,0,0,1,0,1
group a: oropharygeal spray,0,1,0,0,0,1
group a: oropharygeal spray/immunostimulant emulsion,0,1,0,0,0,1
group apixaban,0,1,0,0,0,1
group b (ag0302-covid19),1,0,0,0,0,1
group b (placebo),1,0,0,0,0,1
group b (sample collection),0,0,0,1,0,1
group d:placebo oropharyngeal spray,0,1,0,0,0,1
group d:placebo oropharyngeal spray / placebo taken po,0,1,0,0,0,1
group hydroxychloroquine,0,1,0,0,0,1
group hydroxychloroquine/apixaban,0,1,0,0,0,1
growth mindset ssi,0,1,0,0,0,1
grt-r910 booster 113 days after prime,0,0,0,1,0,1
grt-r910 booster 28 days after prime,0,0,0,1,0,1
gs-441524,0,1,0,0,0,1
gsk,0,0,0,1,0,1
gt0918,0,0,0,1,0,1
gt0918 tablets,0,0,0,1,0,1
gt0918 tablets/placebo,0,0,0,1,0,1
guduchi ghanvati,0,1,0,0,0,1
guided online support program,0,0,0,1,0,1
guilt message,0,1,0,0,0,1
gustatory,0,0,0,1,0,1
gustatory tests,0,1,0,0,0,1
gustatory/olfactory function test,0,0,0,1,0,1
gx-03,0,1,0,0,0,1
gx-19,1,0,0,0,0,1
gx-i7 vehicle,0,0,0,1,0,1
h12 of the initiation of morphine between the control,0,0,0,1,0,1
habit,0,0,0,1,0,1
had5-s-fusion/n-etsd (suspension for injection),1,0,0,0,0,1
had5-sfusion,1,0,0,0,0,1
had5-sfusion/ n-etsd (oral capsule),1,0,0,0,0,1
hads,0,0,0,1,0,1
half dose of chadox1 ncov-19 (azd1222),0,0,0,1,0,1
hand grip strength,0,0,0,1,0,1
handwashing stations at the public places,1,0,0,0,0,1
handwashing stations at the public places/no soap,1,0,0,0,0,1
hb-admscs (allogeneic),0,0,0,1,0,1
hbcc project,1,0,0,0,0,1
hbcc project/soap,1,0,0,0,0,1
hcfwo,0,0,0,1,0,1
hd-tdcs 2ma,0,0,0,1,0,1
hd-tdcs 4ma,0,0,0,1,0,1
hd pepgnp-sarscov2,0,0,0,1,0,1
hd vehicle-gnp,0,0,0,1,0,1
health,0,1,0,0,0,1
health-related quality of life,0,0,0,1,0,1
health care worker survey,0,0,0,1,0,1
health education,0,0,1,0,0,1
health enhancement program,1,0,0,0,0,1
health literacy,0,0,0,1,0,1
health promotion.,0,0,0,1,0,1
health questionnaire,1,0,0,0,0,1
health staff,0,0,0,1,0,1
health warning leaflet,1,0,0,0,0,1
"health, daily self-assessment,",0,1,0,0,0,1
health/safety executive's (hse) management standards indicator tool (msit) to measure work-related stress,0,1,0,0,0,1
healthcare providers' communication about the covid-19 vaccine,0,1,0,0,0,1
healthcare workers with the coronavac vaccine,0,1,0,0,0,1
healthy lifestyle advise,0,0,0,1,0,1
healthy minds program foundations training,0,1,0,0,0,1
heart-lung interactions,0,0,0,1,0,1
heart rate variability biofeedback,0,0,0,1,0,1
heart rateã€arrhythmiaã€blood pressureã€central body temperature (ear temperature),0,0,0,1,0,1
heart rateã€arrhythmiaã€blood pressureã€central body temperature (ear temperature)/blood oxygen saturation level.,0,0,0,1,0,1
heat therapy,0,0,0,1,0,1
helmet niv,0,1,0,0,0,1
helmet non-invasive ventilation,0,0,0,1,0,1
hematological,0,0,0,1,0,1
hematological/immunological biomarkers,0,0,0,1,0,1
hematology blood test,0,0,0,1,0,1
hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
hemodynamics changes at different peep,0,1,0,0,0,1
hemodynamics monitoring,0,1,0,0,0,1
heparin - prophylactic dosage,0,0,0,1,0,1
heparin - therapeutic dosage,0,0,0,1,0,1
hepatitis a vaccine,1,0,0,0,0,1
herbaceous essential oil blend,0,0,0,1,0,1
herbal oil,0,0,0,1,0,1
herbal phenolic monoterpene,0,1,0,0,0,1
hesperidin,0,1,0,0,0,1
heterologous mrna booster vaccine,0,0,0,1,0,1
heterologous prime-boost schedule with azd1222,0,0,0,1,0,1
heterologous prime-boost schedule with azd1222/mvc-cov1901,0,0,0,1,0,1
hfb30132a,1,0,0,0,0,1
hfno/niv,0,0,0,1,0,1
"high-dosage of covid-19 vaccine (vero cell), inactivated",1,0,0,0,0,1
high-dose dexamethasone,0,0,0,0,1,1
high-dose placebo (18-59 years),0,0,0,1,0,1
high-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years),0,0,0,1,0,1
high-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant sars-cov-2 vaccine (cho cell),0,0,0,1,0,1
high-dose vitamin c treatment,1,0,0,0,0,1
high-flow nasal cannula treatment,0,1,0,0,0,1
high-intensity aerobic training with high protein diet,0,1,0,0,0,1
high dose aerosolized ad5-ncov,0,0,0,1,0,1
high dose bcd-250 injection,0,0,0,1,0,1
high dose corticosteroid,0,0,0,1,0,1
high dose of kbp-covid-19,1,0,0,0,0,1
high dose radiation 100 cgy,0,0,0,1,0,1
high flow nasal oxygen (hfno) treatment,1,0,0,0,0,1
high flow nasal therapy,0,1,0,0,0,1
high intensity interval training,0,1,0,0,0,1
high resolution computed tomography,0,0,0,1,0,1
high touch multi-pronged behavioral intervention,0,1,0,0,0,1
hiking challenge,1,0,0,0,0,1
hip arthropalsty,0,1,0,0,0,1
hip fracture surgery,0,1,0,0,0,1
history of exposure to anti-cd20 treatment since 01,0,0,0,1,0,1
history of exposure to anti-cd20 treatment since 01/01/2010,0,0,0,1,0,1
hiv,0,0,0,1,0,1
hmsc,0,0,0,1,0,1
hmw-ha,0,0,0,1,0,1
holter monitor,0,1,0,0,0,1
home-based exercise training,0,0,1,0,0,1
home-based sars-cov-2 test kit,0,0,0,1,0,1
home-based stretching,0,1,0,0,0,1
home-based stretching/strengthening exercise,0,1,0,0,0,1
home-cov rule implementation,0,1,0,0,0,1
home-use test,0,1,0,0,0,1
home based exercises with postural,0,1,0,0,0,1
home based exercises with postural/ergonomic training,0,1,0,0,0,1
home care monitoring,0,0,0,0,1,1
home exercise,0,0,0,1,0,1
home exercise program,0,0,0,1,0,1
home pulse oximetry monitoring,0,1,0,0,0,1
home sleep apnea testing,1,0,0,0,0,1
home sleep apnea testing/in-hospital polysomnography,1,0,0,0,0,1
home spirometry,0,0,0,1,0,1
home treatment,0,0,0,1,0,1
homeopathic medication,0,0,0,1,0,1
homologous mrna booster vaccine,0,0,0,1,0,1
homologous prime-boost schedule with two doses of azd1222,0,0,0,1,0,1
"hormone levels (testosterone, fsh, lh, prolactin)",0,0,0,1,0,1
hospital acquired infection,0,0,0,1,0,1
hospital admission,1,0,0,0,0,1
hospital anxiety,0,0,0,1,0,1
hospital anxiety depression measure,0,0,0,1,0,1
hospital anxiety depression scale,0,1,0,0,0,1
hospital anxiety/depression scale,0,0,0,1,0,1
hospital telemedicine management system,0,0,0,1,0,1
hospital treatment of covid disease,0,0,0,1,0,1
hospital: dd-ca,0,0,0,1,0,1
hospital: usual care (uc),0,0,0,1,0,1
hospitalisation for sars-cov2 infection,0,0,0,1,0,1
"hospitalisation, necessity of icu, mortality rate, lung involvement",0,0,0,1,0,1
hospitalization,0,0,0,1,0,1
hospitalization for premature birth,0,0,1,0,0,1
hospitalized,0,1,0,0,0,1
hospitalized children with covid19,0,0,0,1,0,1
hospitalized patients for covid-19 infection,0,1,0,0,0,1
host genotype,0,0,0,1,0,1
host immune factors,0,0,0,1,0,1
hr-ct-scan,0,0,0,1,0,1
hscore,1,0,0,0,0,1
"human coach first, then virtual assistant",0,0,0,1,0,1
human cord tissue mesenchymal stromal cells (hct-msc) manufactured by duke university.,0,0,0,1,0,1
human milk donors,0,0,0,1,0,1
human normal immunoglobulin (ivig),0,0,0,1,0,1
human recombinant interleukin 2,0,1,0,0,0,1
human sars-cov 2 specific t lymphocytes,0,0,0,1,0,1
humoral,0,1,0,0,0,1
humoral/cellular immunity,0,1,0,0,0,1
hydrocortisone,0,1,0,0,0,1
hydrogen oxygen generator with nebulizer,0,1,0,0,0,1
hydrogen peroxide,0,0,0,1,0,1
hydrogen peroxide (b) mouth rinse with the solution provided,0,0,0,1,0,1
hydroxychloroquine / metabolic cofactor supplementation,0,0,0,1,0,1
hydroxychloroquine / sorbitol,0,0,0,1,0,1
hydroxychloroquine pill / azithromycin pill,0,0,0,1,0,1
hydroxychloroquine tablets,1,0,0,0,0,1
hydroxychloroquine with azithromycin,0,0,0,1,0,1
"hydroxychloroquine, lopinavir",0,0,0,1,0,1
"hydroxychloroquine, lopinavir/ritonavir/azithromycin/placebo (standard therapy)",0,0,0,1,0,1
hydroxychloroquine/azithromycin/ tocilizumab,0,1,0,0,0,1
hydroxychloroquine/clindamycin,0,1,0,0,0,1
hydroxychloroquine/clindamycin/primaquine,0,1,0,0,0,1
hydroxychloroquine/doxycycline,0,1,0,0,0,1
hydroxychloroquine/lopinavir/ritonavir,0,0,0,1,0,1
hydroxychloroquine/placebo,0,0,0,0,1,1
hydroxyvitamin,0,0,0,1,0,1
hyperimmune globulin,0,0,0,1,0,1
hyperpolarized 129xenon gas,0,0,0,1,0,1
hyperpolarized xe129,0,0,0,1,0,1
hypertension,1,0,0,0,0,1
hypertonic saline nasal irrigation,0,0,0,1,0,1
hypertonic saline nasal irrigation/gargles (hsnig),0,0,0,1,0,1
hypoxia : 14.3,0,1,0,0,0,1
"hypoxia : 14.3/12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",0,1,0,0,0,1
hypoxic pulmonary vasoconstriction,0,1,0,0,0,1
hz,1,0,0,0,0,1
hz/su,1,0,0,0,0,1
iamp test,0,1,0,0,0,1
ibudilast,0,0,0,1,0,1
ic14,0,0,0,1,0,1
icatibant injection,0,1,0,0,0,1
icc vaccine,1,0,0,0,0,1
ice swimming,0,1,0,0,0,1
icosapent ethyl,0,1,0,0,0,1
icosapent ethyl (ipe),0,1,0,0,0,1
icu recovery,0,1,0,0,0,1
icu recovery / physical therapy,0,1,0,0,0,1
identification of genetic variants,1,0,0,0,0,1
idoine complex,0,0,0,1,0,1
ier-r (posttraumatic stress),0,0,1,0,0,1
ifn beta-1a,0,0,0,1,0,1
ifx-1,0,0,0,1,0,1
igg antibodies assay,0,0,0,1,0,1
igg antibodies to sars-cov-2,0,0,0,1,0,1
igg detection,0,0,0,1,0,1
igg dosage,0,1,0,0,0,1
igg neutralising antibody titers to s1,0,0,0,1,0,1
igg neutralising antibody titers to s1/s2 proteins of sars-cov-2 virus,0,0,0,1,0,1
igg sars cov 2 antibodies,0,1,0,0,0,1
igg sars cov2,0,1,0,0,0,1
"igg, aaz, boulogne-billancourt, france)",1,0,0,0,0,1
igiv,0,0,0,1,0,1
igm antibody rapid test,0,0,0,1,0,1
igm test,0,0,1,0,0,1
igm/igg antibodies assay,0,0,0,1,0,1
igm/igg dosage,0,1,0,0,0,1
iibr-100 high-dose (prime-boost),0,0,0,1,0,1
iibr-100 high-dose (prime),0,0,0,1,0,1
iibr-100 low-dose (prime-boost),0,0,0,1,0,1
iibr-100 medium-dose (prime-boost),0,0,0,1,0,1
iibr-100 medium dose (prime),0,0,0,1,0,1
iibr-100 top-dose (prime-boost),0,0,0,1,0,1
"iibr-100, low dose (prime)",0,0,0,1,0,1
iir surgical mask with filtering face piece,0,1,0,0,0,1
iiv4 for the 1st dose,0,1,0,0,0,1
iiv4 for the 1st dose/ppv23 for the 2nd dose,0,1,0,0,0,1
iiv4 for the 2nd dose,1,0,0,0,0,1
iiv4; covax,0,1,0,0,0,1
il-12 plasmid,1,0,0,0,0,1
"ilr, pmk, icd",0,0,0,1,0,1
im injection of vaccination (mrna vaccination),1,0,0,0,0,1
im injection of vaccination (vector based vaccination),1,0,0,0,0,1
imaging by thoracic scanner,1,0,0,0,0,1
imaging characteristics of pneumonia,0,0,0,1,0,1
"imaging, blood tests",0,1,0,0,0,1
imatinib mesylate,0,0,0,1,0,1
imatinib mesylate intravenous solution,0,0,0,1,0,1
imdevimab combination therapy,0,0,0,1,0,1
imm-101,1,0,0,0,0,1
immediate vs. delayed provision of antibody test results,0,1,0,0,0,1
immigrant well-being project (riwp),0,0,0,1,0,1
immune globulin,0,1,0,0,0,1
immune plasma,0,0,0,1,0,1
immune response,0,0,0,1,0,1
immune response characterization,0,0,0,1,0,1
"immune response monitoring , blood samples",0,0,0,1,0,1
immune response study,0,0,0,1,0,1
"immune response to sars-cov-2 vaccinations; including covid-19 vaccin moderna, comirnaty (pfizer)",0,0,0,1,0,1
"immune response to sars-cov-2 vaccinations; including covid-19 vaccin moderna, comirnaty (pfizer)/vaxzevria (astrazeneca)",0,0,0,1,0,1
immunfluorescence,0,0,0,1,0,1
immunoformulation,0,1,0,0,0,1
immunofree tablets,0,1,0,0,0,1
immunofree tablets/reginmune capsule,0,1,0,0,0,1
immunogenicity after first,0,0,1,0,0,1
immunogenicity after first dose of participants who received first dose of chadox-1 n cov-19 vaccine,0,1,0,0,0,1
immunogenicity after first/second dose,0,0,1,0,0,1
immunoglobulin g detection,0,0,0,1,0,1
immunoglubulins,0,0,0,1,0,1
immunological,0,0,0,1,0,1
immunological analysis:,0,0,0,1,0,1
immunological biomarkers,0,0,0,1,0,1
immunophenotypic analysis after stimulation with overlapping s-peptides in peripheral blood mononuclear cells (pbmc),0,0,0,1,0,1
immunoseq,0,0,1,0,0,1
immunostimulant emulsion,0,1,0,0,0,1
immunosuppressive,0,0,0,1,0,1
immunosuppressive agents,0,0,0,1,0,1
impact event score,0,0,0,1,0,1
impact of covid-19 on health-seeking behaviors,0,1,0,0,0,1
impact of covid-19 questionnaire,0,0,0,1,0,1
impact of event scale-revised,0,0,0,0,1,1
implementation strategy,0,0,0,1,0,1
impregnation,0,0,1,0,0,1
imunor,0,1,0,0,0,1
in-b009 (high-dose),0,0,0,1,0,1
in-b009 (low-dose),0,0,0,1,0,1
in-depth individual interviews,0,0,0,1,0,1
in-hospital mortality rate,0,1,0,0,0,1
in-person instruction,1,0,0,0,0,1
in-person postoperative visit,0,0,0,1,0,1
in vivo brain pet-tspo acquisitions,0,0,0,1,0,1
inactivated covid-19 vaccine (coronavac),0,1,0,0,0,1
inactivated covid-19 vaccine (vero cells),0,0,0,1,0,1
inactivated hepatitis a vaccine,0,0,0,1,0,1
inactivated sars-cov-2 vaccine (vero cell) lot 1 of the workshop 1,1,0,0,0,0,1
inactivated sars-cov-2 vaccine (vero cell) lot 1 of the workshop 2,1,0,0,0,0,1
inactivated sars-cov-2 vaccine (vero cell) lot 1 of the workshop 3,1,0,0,0,0,1
inactivated sars-cov-2 vaccine (vero cell) lot 2 of the workshop 2,1,0,0,0,0,1
inactivated sars-cov-2 vaccine (vero cell) lot 2 of the workshop 3,1,0,0,0,0,1
inactivated sars-cov-2 vaccine (vero cell) lot 3 of the workshop 2,1,0,0,0,0,1
inactivated sars-cov-2 vaccine (vero cell) lot 3 of the workshop 3,1,0,0,0,0,1
inactivated sars cov 2 vaccine (vero cell) wuhan,1,0,0,0,0,1
inactivated sars cov 2 vaccine (vero cell) wuhan/beijing/placebo,1,0,0,0,0,1
inactivated vaccine booster,1,0,0,0,0,1
inb03,0,0,0,1,0,1
incentive spirometer,0,0,0,1,0,1
incentive spirometer/respiratory exerciser,0,0,0,1,0,1
increasing willingness,0,0,0,1,0,1
increasing willingness/uptake of covid-19 testing/vaccination,0,0,0,1,0,1
incremental shuttle walk test,0,0,0,1,0,1
incubation,0,0,1,0,0,1
independent control,0,0,0,1,0,1
indian costus,0,0,0,1,0,1
indirect calorimetry,0,0,0,1,0,1
individual interview,0,1,0,0,0,1
individualized-chinese herbal medicine,0,0,0,1,0,1
inert oil,0,0,0,1,0,1
infectious disease,0,0,0,1,0,1
infectious disease/cardiology clinical consultations,0,0,0,1,0,1
inflamatory biomarkers,0,0,0,1,0,1
inflammation (i),0,0,0,1,0,1
inflammation (ii),0,0,0,1,0,1
inflammation (iii),0,0,0,1,0,1
inflammatory cytokines,0,0,0,1,0,1
inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
inflammatory markers sampling,0,0,0,1,0,1
inflammatory parameters,0,1,0,0,0,1
influenza rapid test,1,0,0,0,0,1
influenza vaccine,0,0,0,1,0,1
information assigned in community,1,0,0,0,0,1
information on covid-19,0,1,0,0,0,1
informational sheet,0,1,0,0,0,1
informational videos,0,0,0,1,0,1
informational videos/social media campaigns encouraging cancer screening.,0,0,0,1,0,1
informed consent,0,0,0,1,0,1
informed program,0,0,0,1,0,1
inhalation,0,0,0,1,0,1
inhalation of 5% sodium chloride,0,0,0,1,0,1
"inhalation of 8,4% sodium bicarbonate",0,0,0,1,0,1
inhalation of n-acetylcysteine,0,0,0,1,0,1
inhalation of vitamin c,1,0,0,0,0,1
inhaled aviptadil,0,0,0,1,0,1
inhaled low molecular weight heparin,0,1,0,0,0,1
inhaled type i interferon,0,0,0,1,0,1
injectable placebo,0,0,0,1,0,1
injected cardiac mri,0,1,0,0,0,1
injection,0,0,0,1,0,1
injection of secretome-mscs,0,0,0,1,0,1
injection of secretome - mesenchymal stem cell,0,1,0,0,0,1
inluenza,0,1,0,0,0,1
inm005,0,1,0,0,0,1
innova lateral flow device,0,1,0,0,0,1
ino-4700,0,0,0,1,0,1
inopulse,0,0,0,0,1,1
inspiratory,0,1,0,0,0,1
inspiratory / expiratory muscle training group,0,1,0,0,0,1
inspiratory / expiratory muscle training placebo group,0,1,0,0,0,1
inspiratory muscle traiing,0,0,0,1,0,1
inspiratory muscle trainer,0,0,0,1,0,1
inspiratory muscle training (imt),0,0,0,1,0,1
inspiratory muscle training group,0,1,0,0,0,1
inspiratory muscle training placebo group,0,1,0,0,0,1
institutional support,1,0,0,0,0,1
instrumental activities of daily living shaping,0,0,0,1,0,1
instrumental examination,0,0,0,1,0,1
insulin,0,1,0,0,0,1
insulin film,0,1,0,0,0,1
insurance navigation,0,0,0,1,0,1
integral communication strategy (eics),0,0,0,1,0,1
integrated clinical evaluation,0,1,0,0,0,1
intellivent asv,0,1,0,0,0,1
intensive care,0,1,0,0,0,1
intensive care unit admission ratio,0,0,0,1,0,1
intensive care unit stay during the covid-19 pandemic,0,0,0,1,0,1
inter icu long distance patient transfer,0,0,0,1,0,1
interactive,0,0,0,1,0,1
interactive/2-way sms delivery of information,0,0,0,1,0,1
interferon alfa,0,0,0,1,0,1
interferon gamma human recombinant (ifn-g),0,1,0,0,0,1
interferon/glatiramer acetate,0,0,0,1,0,1
interleuken 6,0,0,0,1,0,1
interlukein 6,0,1,0,0,0,1
interlukein 6/procalcitonin serum levels,0,1,0,0,0,1
intermediate dose enoxaparin/ unfractionated heparin,0,1,0,0,0,1
intermittent,0,0,0,0,1,1
internal jugular vein cannulation,0,1,0,0,0,1
internet-based cognitive behavioral therapy,1,0,0,0,0,1
internet-based guided self-help based on cbt principles,0,0,0,1,0,1
internet-based self-help,0,1,0,0,0,1
internet-based self-help after 3 weeks,0,1,0,0,0,1
internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1,0,0,0,0,1
internet cognitive behavioral therapy,0,0,0,1,0,1
internet cognitive behavioral therapy/chamindwell,0,0,0,1,0,1
interval appendectomy,0,1,0,0,0,1
intervention,0,0,0,1,0,1
intervention 1: according to dgp,0,0,0,1,0,1
"intervention 2: according to cacioppo ""e.a.s.e.""",0,0,0,1,0,1
intervention app,0,1,0,0,0,1
intervention for tecc model,0,0,0,1,0,1
intervention group coronacope,1,0,0,0,0,1
intervention group_rehabilitation program,0,0,0,1,0,1
intervention program,0,1,0,0,0,1
"intervention, tbn",0,0,0,1,0,1
intervention. early,0,0,0,1,0,1
intervention. early/integral communication strategy (eics),0,0,0,1,0,1
interventional groups,0,0,0,1,0,1
interventions,0,0,0,1,0,1
interview by psychologists,0,0,0,1,0,1
intestinal microbiota,0,0,0,1,0,1
intestinal parasite,0,0,0,1,0,1
intracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
intramuscular injection,1,0,0,0,0,1
intranasal ivermectin spray,0,0,0,1,0,1
intranasal spray 1%,0,1,0,0,0,1
intraosseous,0,1,0,0,0,1
intravenous,0,1,0,0,0,1
intravenous antibiotics with low dose steroid.,0,1,0,0,0,1
intravenous drug,0,1,0,0,0,1
intravenous normal saline,0,1,0,0,0,1
intravenous saline injection,0,1,0,0,0,1
introductory phone call (cc,0,0,1,0,0,1
invasive mechanical ventilation,0,1,0,0,0,1
invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,0,1,0,0,0,1
invasive ventilation strategy,0,0,0,1,0,1
investigation of smell,0,1,0,0,0,1
investigation of smell/taste disorders,0,1,0,0,0,1
investigation of the prevalence of test positivity,0,0,0,1,0,1
investigational product - viracide,0,1,0,0,0,1
investigational treatment,0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 1, single dose, intranasal drops",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 2, single dose, intranasal drops",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal drops",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal spray",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, two doses, intranasal drops",0,0,0,1,0,1
iodine,0,0,0,1,0,1
iota carrageenan nasal spray,0,1,0,0,0,1
iota carrageenan nasal spray/ivermectin oral drops (used as buccal drops),0,1,0,0,0,1
ip-10,0,1,0,0,0,1
irl201104,0,1,0,0,0,1
is (b cell depletion therapy),0,0,0,1,0,1
is (mmf,0,0,0,1,0,1
is (mmf/mpa),0,0,0,1,0,1
is (mtx),0,0,0,1,0,1
isavuconazonium injection [cresemba],0,0,0,1,0,1
isis 721744,1,0,0,0,0,1
isoflurane inhalant product,0,0,0,1,0,1
isoquercetin,0,0,0,1,0,1
itolizumab,0,1,0,0,0,1
itraconazole,0,1,0,0,0,1
its,0,0,0,1,0,1
iv tocillizumab (tcz),0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg,0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,0,1,0,0,0,1
ivermectin / doxycycline,0,1,0,0,0,1
ivermectin / doxycycline / placebo,0,1,0,0,0,1
ivermectin / iota-carrageenan,0,1,0,0,0,1
ivermectin / placebo,0,1,0,0,0,1
ivermectin 0.4mg,0,1,0,0,0,1
ivermectin 0.4mg/kg/day for 5 days,0,1,0,0,0,1
ivermectin 06 mg oral tablet,0,0,0,1,0,1
ivermectin 3 mg,0,0,0,1,0,1
"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
ivermectin 6 mg oral tablet,0,1,0,0,0,1
ivermectin impregnated mask,0,0,0,1,0,1
ivermectin nasal spray,0,0,0,1,0,1
ivermectin pill,0,0,0,1,0,1
ivermectin powder,0,0,0,1,0,1
"ivermectin,ribavirin ,nitazoxanide",0,0,0,1,0,1
"ivermectin,ribavirin ,nitazoxanide/zinc",0,0,0,1,0,1
ivermectin/deamethisone/aspirin,0,1,0,0,0,1
ivermectin/deamethisone/exoparin,0,1,0,0,0,1
ivermectin/doxycycline,0,1,0,0,0,1
ivermectin/doxycyline,0,1,0,0,0,1
ivig,0,1,0,0,0,1
ixekizumab,0,0,0,1,0,1
jing-si-herbal-tea,0,0,0,1,0,1
"jinhua qinggan (jhqg) granules, traditional chinese medicine",0,1,0,0,0,1
jnj-78436735,0,0,0,1,0,1
jnj-78436735 vaccine,0,0,0,1,0,1
js016/placebo,0,0,0,1,0,1
js026,0,0,0,1,0,1
js026/placebo,0,0,0,1,0,1
k-237 0.3-0.4mg,0,0,0,1,0,1
k-237 0.3-0.4mg/kg (once daily),0,0,0,1,0,1
kamada anti-sars-cov-2,0,1,0,0,0,1
kan jang capsules,0,0,0,1,0,1
kb109 / self supportive care,0,1,0,0,0,1
kelea water,0,0,0,1,0,1
ketamine,0,0,0,0,1,1
ketogenic diet,0,0,0,1,0,1
ketogenic diet with phytoextracts,0,0,0,1,0,1
ketotifen,0,1,0,0,0,1
kg (once daily),0,0,0,1,0,1
kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
kg eb05 iv,0,0,0,1,0,1
kg intravenously,0,0,0,1,0,1
kg once daily,0,1,0,0,0,1
kg;100mg,0,0,0,1,0,1
kg;50mg,0,0,0,1,0,1
kidney biopsy,1,0,0,0,0,1
kinesiotherapy protocol,0,0,0,1,0,1
kir phenotype evaluation,0,1,0,0,0,1
"knowledge, attitude, practice, awareness, preference",0,1,0,0,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 4 âµg,0,0,0,1,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 4 âµg/0.5 ml vaccine,0,0,0,1,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 6 âµg,0,0,0,1,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 6 âµg/0.5 ml vaccine,0,0,0,1,0,1
kovir (td0068) oral capsule,0,0,0,1,0,1
kovir oral capsule,0,1,0,0,0,1
kukaa salama: mhealth intervention,0,1,0,0,0,1
kundalini yoga,1,0,0,0,0,1
kundalini yoga/anxiety reduction training,1,0,0,0,0,1
l,0,0,0,1,0,1
l-arginine,0,0,0,1,0,1
l. reuteri dsm 17938,0,1,0,0,0,1
l. reuteri dsm 17938 / vitamin d,0,1,0,0,0,1
lab session,0,1,0,0,0,1
lab workup (on admission,0,0,0,1,0,1
lab workup (on admission/regularly during follow up).,0,0,0,1,0,1
laboratory,0,0,0,1,0,1
laboratory analyses,0,0,0,1,0,1
laboratory blood tests,0,0,0,1,0,1
laboratory diagnostics tests,1,0,0,0,0,1
laboratory investigation,0,0,0,1,0,1
laboratory parameters,0,1,0,0,0,1
laboratory results,0,1,0,0,0,1
laboratory samples,0,0,0,1,0,1
laboratory test positive for sars-cov-2 virus,1,0,0,0,0,1
laboratory tests,0,0,0,1,0,1
laboratory tests/montreal cognitive assessment,0,0,0,1,0,1
laboratory values,0,1,0,0,0,1
laboratory/instrumental examination,0,0,0,1,0,1
labs,0,0,0,1,0,1
lactating persons,0,1,0,0,0,1
lactobacillus,1,0,0,0,0,1
lactobaciltus rhamnosus gg,0,1,0,0,0,1
lactoferrin,0,0,0,1,0,1
"lactoferrin, green tea extract",0,0,0,1,0,1
lactose monohydrate,0,0,0,1,0,1
lambda 180 mcg s.c,0,0,0,1,0,1
lamp,0,1,0,0,0,1
lanadelumab placebo,0,1,0,0,0,1
laparoscopic,0,1,0,0,0,1
laparoscopic appendectomy,0,1,0,0,0,1
laparoscopic/open appendicectomy,0,1,0,0,0,1
larazotide acetate,0,0,0,1,0,1
laryngoscopy,0,1,0,0,0,1
laser acupoint stimulation(laser pen),0,0,0,1,0,1
late dexamethazone,0,0,0,1,0,1
lateral position (left,0,1,0,0,0,1
lateral position (left/right lateral decubitus),0,1,0,0,0,1
lau-7b,0,1,0,0,0,1
laughter theraphy,1,0,0,0,0,1
lay telephone coaching,0,1,0,0,0,1
ld pepgnp-sarscov2,0,0,0,1,0,1
ld vehicle-gnp,0,0,0,1,0,1
leaf-4l6715,0,1,0,0,0,1
leitragin inhalation,0,1,0,0,0,1
leitragin intramuscular injection,0,1,0,0,0,1
let it out (lio)-c,0,0,0,0,1,1
leukapheresis,0,0,0,1,0,1
leukotriene receptor antagonist,0,0,0,1,0,1
levamisole,0,0,0,1,0,1
levamisole / budesonide/formoterol,0,0,0,1,0,1
levels of sars-cov-2 antibodies,0,0,0,1,0,1
levilimab,0,1,0,0,0,1
liberase enzyme,0,0,0,1,0,1
licensed,0,0,0,1,0,1
licensed seasonal influenza vaccine,1,0,0,0,0,1
licensed/eua sars-cov-2 vaccine,0,0,0,1,0,1
licorice extract,0,0,0,1,0,1
lidocaine,0,0,0,1,0,1
lidocaine 2%,0,0,0,1,0,1
lifestyle (exercise),0,1,0,0,0,1
lifestyle (meditation),0,1,0,0,0,1
lifestyle change promotion program,0,0,0,1,0,1
lifestyle habits,0,1,0,0,0,1
lifestyle modification webinars focused on hypertension control,0,0,0,1,0,1
lift,0,0,0,1,0,1
ligilactobacillus salivarius mp101,0,0,0,1,0,1
lilly bamlanivimab,0,0,0,1,0,1
lilly bamlanivimab / etesevimab,0,0,0,1,0,1
limbix spark,1,0,0,0,0,1
linagliptin,0,1,0,0,0,1
linagliptin 5 mg,0,0,0,0,1,1
linkages to medical,0,0,0,1,0,1
liposomal,0,1,0,0,0,1
liquid alpha1-proteinase inhibitor (human),0,0,0,1,0,1
listening to music with a bluetooth headset to patients receiving cpap support,0,0,0,1,0,1
listerine,0,0,0,1,0,1
listerine zero mouthwash product,0,0,0,1,0,1
liver,0,0,1,0,0,1
liver function tests,0,1,0,0,0,1
"liver, lung, heart",1,0,0,0,0,1
"liver, lung, heart/kidney biopsy",1,0,0,0,0,1
lmwh,0,1,0,0,0,1
lock-down,0,1,0,0,0,1
lock-down/social distancing,0,1,0,0,0,1
lockdown,0,1,0,0,0,1
lockdown/other social distancing measures,0,1,0,0,0,1
loneliness,0,0,0,1,0,1
loneliness in the covid-19 environment.,0,0,0,1,0,1
longcovidkidsdk,0,0,0,1,0,1
longeveron mesenchymal stem cells (lmscs),0,0,0,1,0,1
lopinavir 200 mg,1,0,0,0,0,1
lopinavir 200 mg / ritonavir 50 mg [kaletra],1,0,0,0,0,1
lopinavir/ ritonavir/remdesivir combination,0,0,0,1,0,1
lopinavir/ritonavir / hydoxychloroquine,0,0,0,1,0,1
lopinavir/ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
losartan 50 mg,0,0,0,1,0,1
losartan 50 mg/spironolactone 25 mg pillules oral use,0,0,0,1,0,1
losmapimod,0,0,0,0,1,1
loss protection,0,0,1,0,0,1
lottery incentive,0,0,1,0,0,1
lovenox,0,1,0,0,0,1
low-dose placebo (18-59 years),0,0,0,1,0,1
low-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years),0,0,0,1,0,1
low-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant sars-cov-2 vaccine (cho cell),0,0,0,1,0,1
low-field magnetic resonance imaging,0,0,0,1,0,1
low-field thoracic magnetic stimulation (lf-thms),0,0,1,0,0,1
low-intensity aerobic training,0,1,0,0,0,1
low-molecular-weight heparin,0,0,0,1,0,1
low calorie ketogenic diet,0,0,0,1,0,1
low dose,0,0,0,1,0,1
low dose aerosolized ad5-ncov,0,0,0,1,0,1
low dose bcd-250 injection,0,0,0,1,0,1
low dose low molecular weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin/placebo,0,0,0,1,0,1
low dose of kbp-covid-19,1,0,0,0,0,1
low dose prednisolone,0,0,0,1,0,1
low dose rmt,0,0,0,1,0,1
low dose/high dose bcd-250 injection,0,0,0,1,0,1
low molecular weight heparin as standard of care treatment,0,1,0,0,0,1
low tailored message,0,1,0,0,0,1
low tailored message/covid-19 vaccine message,0,1,0,0,0,1
low/upper respiratory tract sample,0,0,0,1,0,1
lsalt peptide,1,0,0,0,0,1
"ltx-109 gel, 3%",0,0,0,1,0,1
lucinactant,0,0,0,1,0,1
lumeneye x1 digital rectoscope,0,1,0,0,0,1
lung biopsy,0,0,0,1,0,1
lung computed tomography,1,0,0,0,0,1
lung ct,0,0,0,1,0,1
lung ct scan analysis in covid-19 patients,0,0,0,1,0,1
lung function test,0,0,1,0,0,1
lung function tests,0,0,0,1,0,1
lung impedance,0,0,0,1,0,1
lung low dose radiation,0,0,0,1,0,1
lung mechanics at different peep,0,1,0,0,0,1
lung ultrasonography,0,1,0,0,0,1
lung ultrasound use in patients hospitalized with covid,0,0,0,1,0,1
lus,0,0,0,1,0,1
lus fourteen area,0,1,0,0,0,1
lus twelve area,0,1,0,0,0,1
lv-smenp-dc vaccine,0,0,0,1,0,1
lv-smenp-dc vaccine/antigen-specific ctls,0,0,0,1,0,1
ly3127804,0,0,0,0,1,1
ly3853113,0,1,0,0,0,1
lyt-100,0,0,0,1,0,1
m-m-r ii â® vaccine,1,0,0,0,0,1
m capsules 148 mg,0,1,0,0,0,1
m5049,0,1,0,0,0,1
machine based evaluation,0,0,0,1,0,1
machine learning classification of parenchymal lung change cause,0,0,0,1,0,1
machine learning classification of recurrence,0,0,0,1,0,1
machine learning classification of recurrence/non-recurrence,0,0,0,1,0,1
machine learning model,0,1,0,0,0,1
machine learning/ai algorithm,0,0,0,1,0,1
macintosh laryngoscope,0,0,0,1,0,1
maf capsules 148 mg,0,1,0,0,0,1
magnesium citrate,0,0,0,1,0,1
magnesium citrate/probiotic,0,0,0,1,0,1
magnesium stearate),0,1,0,0,0,1
magnetic resonance imaging,0,0,0,1,0,1
magnetic resonance spectroscopy (mrs).,1,0,0,0,0,1
magnetostimulation,1,0,0,0,0,1
magventure magpro system with brainsight neuronavigation device,0,0,0,1,0,1
mailer-based finger-prick,1,0,0,0,0,1
maintenance,0,0,0,1,0,1
makair,0,0,0,0,1,1
maltodextrin,0,0,0,0,1,1
management by a medical student,0,1,0,0,0,1
management of covid-19,0,0,0,1,0,1
management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,0,1,0,0,0,1
manipulation,0,0,1,0,0,1
manremyc,0,0,0,1,0,1
manual acupuncture,0,0,0,1,0,1
maraviroc / currently used therapy,0,0,0,1,0,1
maraviroc experimental group,0,1,0,0,0,1
maraviroc/favipiravir/ct,0,0,0,1,0,1
marine liquid,0,0,1,0,0,1
marine liquid/fluids,0,0,1,0,0,1
mas825,0,1,0,0,0,1
"masimo, lidco",0,0,0,1,0,1
masitinib,0,0,0,1,0,1
masitinib mesylate,0,0,0,1,0,1
masked saline placebo,0,1,0,0,0,1
maslach burnout inventory (mbi),0,1,0,0,0,1
masseter inhibitory reflex,0,1,0,0,0,1
massive parallel sequencing of host genome,0,0,0,1,0,1
"maternal attachment, edinburgh depression scoring",0,1,0,0,0,1
"maternal attachment, edinburgh depression scoring/postpartum anxiety scale scores",0,1,0,0,0,1
maternal sars-cov-2 infection,0,0,0,1,0,1
maternal stress,0,0,0,1,0,1
matrix-m adjuvant - phase 2,1,0,0,0,0,1
matrix-m1 adjuvant (crossover vaccination period),1,0,0,0,0,1
matrix-m1 adjuvant (initial vaccination period),1,0,0,0,0,1
matrix m1-adjuvant,1,0,0,0,0,1
maximal effort test,0,0,0,1,0,1
mcc ims,0,1,0,0,0,1
mcgrath videolaryngoscope,0,1,0,0,0,1
mct,0,0,0,1,0,1
mcv covid-19 vaccine,0,0,0,1,0,1
me,0,1,0,0,0,1
me/my wishes,0,1,0,0,0,1
measurement of circulating sflt1 concentration,0,1,0,0,0,1
measurement of concentration on exhaled carbon monoxide,0,0,0,1,0,1
measurement of respiratory muscle force,0,0,0,1,0,1
measurement of sublingual microcirculation,0,0,0,1,0,1
mechanical trombectomy,0,1,0,0,0,1
media intervention,0,0,0,1,0,1
medical consultation,0,0,0,1,0,1
medical evaluation,0,1,0,0,0,1
medical follow-up,0,0,0,1,0,1
medical mask,0,0,0,1,0,1
medical record review - inpatient treatment,0,1,0,0,0,1
medical records analysis,0,1,0,0,0,1
medical research council (mrc) dyspnea scale,0,1,0,0,0,1
medical research council sum score,0,0,0,1,0,1
medication review,1,0,0,0,0,1
meditation app usage,0,1,0,0,0,1
meditation therapy,0,0,0,1,0,1
meditation/anxiety reduction training,1,0,0,0,0,1
"medium-dose covid-19 vaccine(vero cell),inactivated",1,0,0,0,0,1
medium chain triglyceride oil,0,0,0,1,0,1
medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,0,0,0,1,0,1
medium dose prednisolone,0,0,0,1,0,1
mefloquine as a prophylaxis against sars-cov-2 infection in household contacts of covid 19 confirmed cases,0,0,0,1,0,1
mefloquine/azithromycin/ tocilizumab,0,1,0,0,0,1
mejoracare,0,1,0,0,0,1
melatonin intravenous,0,1,0,0,0,1
melphalan,0,0,0,1,0,1
membrane-based immunoassay kit,0,0,0,1,0,1
memory b-cell function,1,0,0,0,0,1
menacwy prime,0,0,0,1,0,1
menacwy prime/saline placebo boost / paracetamol,0,0,0,1,0,1
menacwy single dose,0,0,0,1,0,1
menacwy single dose / paracetamol,0,0,0,1,0,1
menacwy vaccine,1,0,0,0,0,1
mencare,0,0,1,0,0,1
mencare//bandebereho fathers'/couples' group education,0,0,1,0,0,1
mental health questionnaire,0,0,0,1,0,1
mental health student,0,1,0,0,0,1
mental imagery,0,0,0,1,0,1
mental well-being,0,1,0,0,0,1
mental well-being assessment,0,1,0,0,0,1
"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%,",0,1,0,0,0,1
"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%,/diclofenac sodium 1gm%",0,1,0,0,0,1
merimepodib,0,0,0,0,1,1
mesenchymal stem cells transplantation,0,1,0,0,0,1
mesenchymal stromal cell-based therapy,0,0,0,1,0,1
mesenchymalÂ stem cells/heparin,0,1,0,0,0,1
mesencure,0,0,0,1,0,1
messaging,0,1,0,0,0,1
metabolic cofactor supplementation,0,0,0,1,0,1
metabolomic,0,0,0,1,0,1
metenkefalin,0,1,0,0,0,1
metenkefalin / tridecactide,0,1,0,0,0,1
metformin,0,0,0,1,0,1
metformin glycinate,0,1,0,0,0,1
methotrexate-lde phase 1,0,0,0,1,0,1
methotrexate-lde phase 2,0,0,0,1,0,1
methylene-blue photodisinfection,0,1,0,0,0,1
methylene blue/ vitamin c/n-acetyl cysteine,0,0,0,1,0,1
methylene blue/photodynamic therapy,0,1,0,0,0,1
methylprednisolone group,1,0,0,0,0,1
methylprednisolone injectable product,0,0,0,1,0,1
methylprednisolone injection,0,1,0,0,0,1
methylprednisolone sodium succinate 10 mg,0,0,0,1,0,1
methylprednisolone sodium succinate 10 mg/kg intravenously,0,0,0,1,0,1
methylprednisolone sodium succinate 2 mg,0,0,0,1,0,1
methylprednisolone sodium succinate 2 mg/kg,0,0,0,1,0,1
methylprednisolone tablet,0,0,0,1,0,1
mf59 adjuvanted sars-cov-2 sclamp vaccine,1,0,0,0,0,1
mfs,0,0,0,1,0,1
mhealth assessments,0,0,0,1,0,1
mhealth platform,1,0,0,0,0,1
mib-626,0,0,0,1,0,1
microcirculation recording,0,1,0,0,0,1
microcrystalline cellulose capsule,0,0,0,1,0,1
micronized,0,1,0,0,0,1
"micronized/ultra-micronized palmitoylethanolamide (mpea/umpea, 300mg / 600mg) oral suspension",0,1,0,0,0,1
microscopy of defined brain regions on autopsy specimens,1,0,0,0,0,1
midazolam,0,0,0,1,0,1
mind body syndrome therapy for long covid,0,0,0,1,0,1
mindfullness training,0,1,0,0,0,1
mindfulness-based cognitive therapy,0,0,0,1,0,1
mindfulness-based health promotion,0,0,0,1,0,1
mindfulness-based stress reduction / exercise,0,0,1,0,0,1
mindfulness based cognitive therapy for resilience during covid-19,0,0,0,1,0,1
mindfulness based cognitive therapy for resilience during covid-19/chamindwell,0,0,0,1,0,1
mindfulness practice,1,0,0,0,0,1
mindfulness rounds,0,1,0,0,0,1
mindfulness session(s),0,1,0,0,0,1
mindfulness training,0,0,0,1,0,1
mindrhythm harmony,0,0,0,1,0,1
minimal attention control intervention,0,0,0,0,1,1
minimal collection of products of the human body carried out during a sample for standard of care,0,0,0,1,0,1
miniprobe alveoflex,0,0,0,1,0,1
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste",1,0,0,0,0,1
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation",1,0,0,0,0,1
mitigation measures against covid 19,0,1,0,0,0,1
mitochondrial dna,0,0,0,1,0,1
mitral valve surgery,0,0,0,1,0,1
ml intravenous solution [actemra]_#1,0,0,0,0,1,1
ml intravenous solution [actemra]_#1 (2 doses),0,0,0,0,1,1
ml oral solution [calcidol],0,1,0,0,0,1
"ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",0,1,0,0,0,1
ml prefilled syringe [kineret],0,1,0,0,0,1
ml) intraven vial (ml),0,1,0,0,0,1
mls laser,0,1,0,0,0,1
mmrc (modified medical research council) dyspnea scale,0,0,0,1,0,1
mobile internet survey on self-test,0,1,0,0,0,1
mobile intervention,0,0,0,1,0,1
mobile mental health app - 1,0,1,0,0,0,1
mobile mental health app - 2,0,1,0,0,0,1
mobile mental health app - 3,0,1,0,0,0,1
mobile mental health app - 4,0,1,0,0,0,1
modafinil,0,1,0,0,0,1
model building,0,1,0,0,0,1
model validation,0,1,0,0,0,1
moderate exercise training (age group 1; young adult 17 -30 years),0,1,0,0,0,1
moderate exercise training (age group 2; 31 to 45 years),0,1,0,0,0,1
moderate exercise training (age group 3; above 45 years),0,1,0,0,0,1
moderate intensity aerobic exercises,0,1,0,0,0,1
moderna,1,0,0,0,0,1
moderna mrna-1273 vaccine,1,0,0,0,0,1
moderna sars-cov-2 vaccine,0,0,0,1,0,1
modification,0,1,0,0,0,1
modified bai he gu jin tang,0,0,0,1,0,1
modified ipac-uhn ppe,0,0,0,1,0,1
modified rankin score,0,1,0,0,0,1
molecular assessment of saliva,0,0,0,1,0,1
molecular hydrogen,0,0,0,1,0,1
molgramostim nebuliser solution,0,0,0,1,0,1
molixan,0,0,0,1,0,1
mometasone furoate nasal spray,0,1,0,0,0,1
mon002,0,0,0,1,0,1
monalizumab,1,0,0,0,0,1
monitoring,0,0,0,1,0,1
monitoring for aggravation,0,0,0,1,0,1
monitoring of the immune response,0,0,0,1,0,1
monitoring visit,0,0,0,0,1,1
monoclonal antibodies,0,0,0,1,0,1
montelukast,0,1,0,0,0,1
month 12 after first symptoms from sars-cov-2 infection.,0,0,0,1,0,1
month 12 after second injection of vaccine for volunteers,0,0,0,1,0,1
montmorrillonite,0,1,0,0,0,1
montreal cognitive assessment,0,0,0,1,0,1
more,0,0,0,1,0,1
mortality,0,0,0,1,0,1
motivation,0,0,0,1,0,1
motivational interviewing,0,0,0,1,0,1
motivational interviewing/covid-19 symptom monitoring system,0,0,0,1,0,1
motivational messages,0,1,0,0,0,1
mout-to-mouth ventilation,0,1,0,0,0,1
mout-to-mouth ventilation with quantitative analysis,0,1,0,0,0,1
"mouthpiece b1(mouthpiece mpc-st gmdn:62534 generic name: endoscopic bite block, basic, reusable",0,1,0,0,0,1
mouthrinse with bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse with bãªta-cyclodextrin/citrox,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin/citrox,0,1,0,0,0,1
mouthwash,0,1,0,0,0,1
mouthwash/nose rinse with the agnps solution,0,1,0,0,0,1
mouthwashes,0,1,0,0,0,1
mouthwashes/nose rinse in a conventional way,0,1,0,0,0,1
moxibustion,0,0,0,1,0,1
moxibustion/cupping,0,0,0,1,0,1
mp0420,0,0,0,1,0,1
mpa),0,0,0,1,0,1
mpas questionnaire,0,0,0,1,0,1
mqfpd,0,0,0,1,0,1
mr,1,0,0,0,0,1
mr-pro-adm,0,1,0,0,0,1
mr/m-m-r ii â® vaccine,1,0,0,0,0,1
mrg-001,1,0,0,0,0,1
"mri (heart, brain, lungs, liver)",1,0,0,0,0,1
mri scans,0,0,0,1,0,1
"mrm , toilet mastectomy , bcs",0,1,0,0,0,1
mrna-1273 sars-cov-2 vaccine,0,0,0,1,0,1
mrna-1273 sars-cov-2 vaccine from moderna,1,0,0,0,0,1
mrna-1273 vaccine,1,0,0,0,0,1
mrna-1273 vaccine (moderna),1,0,0,0,0,1
mrna-1273 vaccine (pfizer,1,0,0,0,0,1
mrna-1273 vaccine (pfizer/biontech),1,0,0,0,0,1
mrna-1273.213,0,0,0,1,0,1
mrna-1273.617.2,0,0,0,1,0,1
mrna-1283,1,0,0,0,0,1
mrna covd19 vaccine,0,0,0,1,0,1
mrna covid-19,0,0,0,1,0,1
mrna covid-19 vaccine,0,0,0,1,0,1
mrna in urine test,0,1,0,0,0,1
mrna vaccine booster,1,0,0,0,0,1
msc,0,0,0,1,0,1
mstt1041a,0,1,0,0,0,1
mt-2766 high dose,0,0,0,1,0,1
mt-2766 low dose,0,0,0,1,0,1
mucodentol,0,0,0,1,0,1
multi-omics,0,0,0,1,0,1
multicapillary column coupled ion mobility spectrometry,0,0,0,1,0,1
multidisciplinary rehabilitation,0,0,0,1,0,1
multifrequency bioimpedance spectroscopy,0,0,0,1,0,1
multimodal teleprehabilitation,0,0,0,1,0,1
multipeptide cocktail,1,0,0,0,0,1
multistem,0,0,0,1,0,1
multisystem inflammatory syndrome in children (mis-c),0,0,0,1,0,1
multitest 6 color tbnk,0,1,0,0,0,1
multitest 6 color tbnk/bd lyotubes,0,1,0,0,0,1
multivitamin with 11mg of zinc,0,1,0,0,0,1
muscle,1,0,0,0,0,1
muscle-target oral nutritional supplementation,0,0,0,1,0,1
muscle biopsy,0,1,0,0,0,1
muscle endurance,0,0,1,0,0,1
muscle relaxation therapy,0,0,0,1,0,1
muscle ultrasound evaluation,0,0,0,1,0,1
musclesound ultrasound,0,0,0,1,0,1
museum virtual guided tours,0,1,0,0,0,1
music,0,1,0,0,0,1
music therapy,0,0,0,1,0,1
music therapy group,0,1,0,0,0,1
mva-sars-2-s vaccinations (days 0,0,1,0,0,0,1
mva-sars-2-s vaccinations (days 0/28),0,1,0,0,0,1
mva-sars-2-st,0,0,0,1,0,1
mvc-cov1901 (high-dose),1,0,0,0,0,1
mvc-cov1901(3 months),0,0,0,1,0,1
mvc-cov1901(6 months),0,0,0,1,0,1
mvc-cov1901(mid-dose),1,0,0,0,0,1
mw33 injection,0,0,0,1,0,1
mw33 injection placebo,0,0,0,1,0,1
my wishes,0,1,0,0,0,1
n,0,0,0,1,0,1
n-803,1,0,0,0,0,1
n-acetyl glucosamine (nag),0,1,0,0,0,1
n-binding igg immunoassays,0,0,0,1,0,1
n-etsd (oral capsule),1,0,0,0,0,1
n-etsd (suspension for injection),1,0,0,0,0,1
n/a - samples collected along routine care samples only,0,0,0,1,0,1
n95 respirator,0,0,0,1,0,1
na-831/atazanavir,0,0,0,1,0,1
na-831/dexamethasone,0,0,0,1,0,1
na (no intervention),1,0,0,0,0,1
nad,0,0,0,1,0,1
nad/,0,0,0,1,0,1
nangibotide,0,0,0,1,0,1
nanocovax,0,0,0,1,0,1
naproxen,0,0,0,0,1,1
narrow band ultraviolet b-band light,0,0,0,1,0,1
narsoplimab,0,0,0,1,0,1
nasal breathing,0,0,0,1,0,1
nasal fluid sampling before,1,0,0,0,0,1
nasal high flow,0,1,0,0,0,1
nasal lavage,0,1,0,0,0,1
nasal spray by distilled water to control group,0,0,0,1,0,1
nasal spray containing anti-sars-cov-2 antibodies derived from bovine colostrum,0,1,0,0,0,1
nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,0,0,0,1,0,1
nasal spray to healthy volunteer,0,0,0,1,0,1
nasal spray to moderately ill covid-19 positive patient,0,0,0,1,0,1
nasal swab covid-19 reverse transcription polymerase chain reaction test (rt-pcr),0,0,0,1,0,1
naser al-husban,0,1,0,0,0,1
nasopharyngeal (np) swab,0,0,0,1,0,1
nasopharyngeal samples,0,0,0,1,0,1
nasopharyngeal samples.,0,1,0,0,0,1
nasopharyngeal sampling,0,0,0,1,0,1
nasopharyngeal swab for sars-cov-2,1,0,0,0,0,1
nasopharyngeal/throat swab,0,1,0,0,0,1
nasopharyngeal/throat/oropharyngeal swabs analyses by rt-pcr/ddpcr,1,0,0,0,0,1
nasopharynx,0,0,0,0,1,1
nasovax,0,0,0,0,1,1
nature,0,0,1,0,0,1
nature only,0,0,1,0,0,1
nature/mindfulness,0,0,1,0,0,1
navigation services,0,0,0,1,0,1
nbi images and,0,0,0,1,0,1
nbi images and/or videos,0,0,0,1,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g/dose),1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g/dose),1,0,0,0,0,1
nbt-nm108,0,0,0,1,0,1
ncapp,0,0,0,1,0,1
ndv-hxp-s b.1351 vaccine (group b1e),0,0,0,1,0,1
ndv-hxp-s p.1 vaccine (group b1e),0,0,0,1,0,1
ndv-hxp-s p.1 vaccine (group b2a),0,0,0,1,0,1
ndv-hxp-s p.1.351 vaccine (group b2a),0,0,0,1,0,1
ndv-hxp-s parental vaccine (group b1b),0,0,0,1,0,1
ndv-hxp-s parental vaccine (group b1c),0,0,0,1,0,1
ndv-hxp-s parental vaccine in 3 consecutive lots (group b1a),0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group b1d),0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group b1d) - 60 years old,0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group b1d) - 60 years old/more,0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group c2d),0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group c2d) - 60 years old,0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group c2d) - 60 years old/more,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1b),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1c),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1c) - 60 years old,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1c) - 60 years old/more,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c2b),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c2c),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant / 3 consecutive lots (group c1a),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant / 3 consecutive lots (group c2a),0,0,0,1,0,1
nebivolol,0,0,0,1,0,1
nebulised heparin,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 1,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 imv,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 niv,0,0,0,1,0,1
nebulised unfractionated heparin (ufh),0,0,0,1,0,1
nebulized administration of zyesamiâ„¢,0,0,0,1,0,1
nebulized administration of zyesamiâ„¢/placebo,0,0,0,1,0,1
nebulized furosemide,0,0,0,1,0,1
nebulized platelet lysate,1,0,0,0,0,1
nebulized saline,0,0,0,1,0,1
nebulized sterile saline,1,0,0,0,0,1
negative control,0,0,0,1,0,1
neonatal resuscitation with ppe for the prevention of sars-cov-2 infection,0,1,0,0,0,1
neonatal resuscitation without ppe for the prevention of sars-cov-2 infection,0,1,0,0,0,1
netosis markers,0,0,0,1,0,1
neumifil,0,0,0,1,0,1
neural network diagnosis algorithm,0,0,0,1,0,1
neuro,0,1,0,0,0,1
neuro -,0,1,0,0,0,1
neuro /,0,1,0,0,0,1
neuro linguistic programming,0,1,0,0,0,1
neuroimaging findings in patients with covid-19,0,1,0,0,0,1
neurological analysis,0,0,0,1,0,1
neurology test,0,0,1,0,0,1
neuromuscular,0,0,0,1,0,1
neuropsychological questionnaires,0,0,0,1,0,1
neuropsychometric test,1,0,0,0,0,1
neutral writing control,0,0,0,0,1,1
new crown vaccine,0,0,0,1,0,1
new ppe,0,1,0,0,0,1
newborns,0,1,0,0,0,1
news-2 score,0,1,0,0,0,1
news score,0,0,0,1,0,1
next generation sequencing (ngs) analysis,0,0,0,1,0,1
ng test,0,1,0,0,0,1
ngm621,0,0,0,1,0,1
nhanes smell,0,0,0,1,0,1
nhanes smell/taste tests,0,0,0,1,0,1
niagen,0,0,0,1,0,1
niclosamide / camostat,0,0,0,0,1,1
niclosamide oral tablet,0,0,0,1,0,1
niclosamide pill,0,0,0,1,0,1
niclosamide suspension,0,0,0,1,0,1
"niclosamide, bromhexine",0,0,0,1,0,1
nicorandil,0,0,0,1,0,1
nicotine 7 mg,0,0,0,1,0,1
nicotine 7 mg/ 24h transdermal patch - 24 hour,0,0,0,1,0,1
nicotine patch,0,0,0,1,0,1
nigella,0,0,0,1,0,1
nigella sativa,0,1,0,0,0,1
nigella sativa / black cumin,0,1,0,0,0,1
nigella sativa capsule twice daily,0,0,0,1,0,1
nigella sativa seed,0,0,0,1,0,1
nintedanib 150 mg [ofev],0,0,0,1,0,1
nirs (near-infrared spectroscopy),0,0,0,1,0,1
nitazoxanide placebo,0,0,0,1,0,1
nitazoxanide/atazanavir/ritonavir,0,1,0,0,0,1
nitazoxanide/ciclã©sonide,0,0,0,1,0,1
nitrate-deplete beetroot juice,0,0,0,1,0,1
"nitric oxide lozenges, 30 mg",0,0,0,1,0,1
nitrogen gas,1,0,0,0,0,1
nitroglycerin,0,0,0,1,0,1
niv,0,0,0,1,0,1
nk-1r antagonist,0,0,0,1,0,1
no-immunosuppressive,0,0,0,1,0,1
no active intervention (observational only),1,0,0,0,0,1
no activities of the hbcc project,1,0,0,0,0,1
no activities of the hbcc project/also no soap (pure control),1,0,0,0,0,1
no instruction regarding positioning,0,1,0,0,0,1
no intervention-mechanistic study,0,0,0,1,0,1
no intervention (surveillance system),0,1,0,0,0,1
no intervention (survey study for medical doctors).,0,1,0,0,0,1
no intervention as it is an observational study,0,0,0,1,0,1
no intervention group,1,0,0,0,0,1
no intervention is planned,0,0,1,0,0,1
no intervention performed,0,1,0,0,0,1
no intervention planned due to the observational study design only a diagnostic testing,0,0,1,0,0,1
no intervention used,0,0,0,1,0,1
"no intervention will be administered, this is a retrospective observational study.",0,0,0,1,0,1
no intervention will be used.,0,0,0,1,0,1
"no intervention, observation only",0,0,0,1,0,1
"no intervention, questioner only",0,1,0,0,0,1
no intervention. method study. psychometric testing,0,0,0,1,0,1
no intervention; observational study,0,0,0,1,0,1
no interventional study,0,1,0,0,0,1
"no interventions performed. just collecting data, blood samples",0,0,0,1,0,1
"no interventions performed. just collecting data, blood samples/post-mortem biopsies.",0,0,0,1,0,1
no intervetion will be used,0,0,0,1,0,1
no message,0,1,0,0,0,1
no messaging,1,0,0,0,0,1
no personal protective equipment (ppe),0,1,0,0,0,1
no racial inequality highlighting,0,1,0,0,0,1
no research related technology based social interactions,0,1,0,0,0,1
no rinsing,0,1,0,0,0,1
no severe covid-19,1,0,0,0,0,1
no soap,1,0,0,0,0,1
no social norm,0,1,0,0,0,1
no special intervention,0,1,0,0,0,1
no treatment,0,0,0,1,0,1
non-acei,0,1,0,0,0,1
non-acei/arb,0,1,0,0,0,1
non-cardiac surgery,0,0,0,1,0,1
non-contact mce system,0,1,0,0,0,1
non-deceptive placebo,0,1,0,0,0,1
non-emergency care,0,1,0,0,0,1
non-hospitalization procedures,1,0,0,0,0,1
non-hospitalized,0,1,0,0,0,1
non-hospitalized with emergency care,0,1,0,0,0,1
non-hospitalized/non-emergency care,0,1,0,0,0,1
non-interventional study,1,0,0,0,0,1
non-invasive cardiac imaging,0,0,0,1,0,1
non-invasive ventilation strategies,0,0,0,1,0,1
non-invasive ventilatory support,1,0,0,0,0,1
non-mindfulness intervention,0,1,0,0,0,1
non-mrna booster vaccine a,0,0,0,1,0,1
non-mrna booster vaccine b,0,0,0,1,0,1
non-mrna booster vaccine c,0,0,0,1,0,1
non-operative management,0,0,0,0,1,1
non-recurrence,0,0,0,1,0,1
non intervention,1,0,0,0,0,1
"non invasive cardiovascular monitoring with cnap device of arterial pressure, ecg",0,0,0,1,0,1
"non invasive cardiovascular monitoring with cnap device of arterial pressure, ecg/respiratory activity",0,0,0,1,0,1
non invasive visual acuity testing,0,1,0,0,0,1
non narrow band ultraviolet b-band light,0,0,0,1,0,1
none - descriptive study,0,0,0,1,0,1
none - na,0,1,0,0,0,1
none - observational,0,1,0,0,0,1
none (not interventional),0,0,0,1,0,1
"none, this study is observational",0,1,0,0,0,1
none. as this was an observational study.,0,1,0,0,0,1
noninvasive ventilation,0,1,0,0,0,1
noninvasive ventilation treatment,0,1,0,0,0,1
normal saline intranasal,0,0,0,0,1,1
normal saline intranasal/placebo inhaler,0,0,0,0,1,1
normal saline placebo,1,0,0,0,0,1
normal saline solution,0,0,0,1,0,1
normoxic allogenic ucmsc,0,0,0,1,0,1
nose rinse in a conventional way,0,1,0,0,0,1
nose rinse with the agnps solution,0,1,0,0,0,1
nose swabs,0,1,0,0,0,1
"nose swabs, bronchoalveolar lavage ,urine)",0,0,0,1,0,1
nosocomial,0,0,0,1,0,1
not applicable (na),0,0,0,1,0,1
not applicable as observational study,1,0,0,0,0,1
"not applicable, this is an observational study",1,0,0,0,0,1
not bravery message,0,1,0,0,0,1
not interventional their treatments are their routine nhs care,0,0,0,1,0,1
not required,0,1,0,0,0,1
novel coronavirus infection,0,1,0,0,0,1
novottf-100l,0,1,0,0,0,1
nox66,0,1,0,0,0,1
np-120 (ifenprodil),0,1,0,0,0,1
nps test,0,0,0,1,0,1
nricm101,0,0,0,1,0,1
ntr-441,0,0,0,1,0,1
nudge,0,0,0,0,1,1
nurse-community-family partnership intervention,0,0,0,1,0,1
"nursing care to reduce anxiety, fear",0,0,0,1,0,1
"nursing care to reduce anxiety, fear/loneliness",0,0,0,1,0,1
nutrition consult,1,0,0,0,0,1
nutrition consult/protein supplementation,1,0,0,0,0,1
nutrition therapy according to icu protocol,1,0,0,0,0,1
nutritional assessment,0,0,0,1,0,1
nutritional intervention,0,0,0,1,0,1
nutritional support system (nss),0,1,0,0,0,1
nuvastatic,0,0,0,1,0,1
nvx-cov2373,0,0,0,1,0,1
obesity,1,0,0,0,0,1
observation for study group,1,0,0,0,0,1
observation group 1,0,1,0,0,0,1
observation no intervention,1,0,0,0,0,1
observation of breathing pattern,0,1,0,0,0,1
observation of covid 19 pneumonia,0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute),0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute)/settings,0,0,0,1,0,1
observation to monitor patients for these infections,0,0,0,1,0,1
observational cohort study on the natural history of hospitalized sars-cov-2 patients.,0,0,0,1,0,1
observational measurement of biometric data. no change to health care provided.,0,1,0,0,0,1
observational study - no intervention,0,0,0,1,0,1
observational study exploring the epidemiology,1,0,0,0,0,1
observational study exploring the epidemiology/outcomes of aki in critical covid-19 patients admitted to the icu,1,0,0,0,0,1
"observational, prospective, follow-up of the recipients of coronavac (inactivated), pfizer-biontech (mrna) vaccines",0,0,1,0,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal",0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal/saliva samples",0,0,0,1,0,1
obvio-19 app,1,0,0,0,0,1
ocat,0,0,0,1,0,1
occupational health workers,0,0,0,1,0,1
octaplas,0,0,0,1,0,1
odd,0,1,0,0,0,1
odd/even birth year intervention groups,0,1,0,0,0,1
of the cellular response after vaccination against covid-19,0,0,0,1,0,1
offsite pcr testing,0,1,0,0,0,1
ointment,1,0,0,0,0,1
ointment/dressing for external use,1,0,0,0,0,1
"ol-1, high dose",0,0,0,1,0,1
"ol-1, standard dose",0,0,0,1,0,1
old ppe,0,1,0,0,0,1
olfaction testing,1,0,0,0,0,1
olfactometry,0,0,0,1,0,1
olfactory,0,1,0,0,0,1
olfactory device,0,1,0,0,0,1
olfactory function evaluation,0,1,0,0,0,1
olfactory function test,0,0,0,1,0,1
olfactory rehab,0,1,0,0,0,1
olfactory training,0,0,0,1,0,1
olfactory/gustatory tests,0,1,0,0,0,1
olokizumab,0,1,0,0,0,1
omalizumab,0,0,0,1,0,1
omega 3 fatty acid,0,0,0,1,0,1
omega 3/nigella sativa oil,0,0,0,1,0,1
omega 3/nigella sativa oil/anise seed capsule,0,0,0,1,0,1
omega 3/nigella sativa oil/deglycyrrhizinated licorice,0,0,0,1,0,1
omega 3/nigella sativa oil/indian costus,0,0,0,1,0,1
omega 3/nigella sativa oil/quinine pills,0,0,0,1,0,1
omega dha,1,0,0,0,0,1
omega dha / epa,1,0,0,0,0,1
omeprazole,0,0,0,1,0,1
omni-biotic pro vi 5,0,0,0,1,0,1
omnibiotic aad,0,0,0,1,0,1
on-ice testing while wearing a face mask,0,1,0,0,0,1
on-ice testing while wearing a sham face mask,0,1,0,0,0,1
on-site testing (lumiradx),0,0,0,1,0,1
one covid-19 vaccine candidate (tmv-083,0,1,0,0,0,1
one covid-19 vaccine candidate (tmv-083/v-591) administration - high dose,0,1,0,0,0,1
one dose bnt162b2 (observational),0,0,0,1,0,1
one dose of bnt162b2 sars-cov-2 vaccine (observational),0,0,0,1,0,1
one dose of bnt162b2 vaccine,1,0,0,0,0,1
one dose quadrivalent influenza vaccine on day 0,0,1,0,0,0,1
one dose quadrivalent influenza vaccine on day 14.,0,1,0,0,0,1
one step test,0,1,0,0,0,1
online bibliotherapy programme,0,1,0,0,0,1
online cognitive behavioral therapy (cbt),0,1,0,0,0,1
online cognitive stimulation therapy,0,0,0,1,0,1
online instruction,1,0,0,0,0,1
online interactive courses,0,1,0,0,0,1
online intervention grief covid-19,0,1,0,0,0,1
online intervention mental health covid-19,0,1,0,0,0,1
online kkh sports singapore program with usual care,1,0,0,0,0,1
online lifestyle intervention,0,1,0,0,0,1
online psychological intervention for healthcare workers,0,0,0,1,0,1
online self-help intervention,0,1,0,0,0,1
online social network,0,0,0,1,0,1
online social network/collective intelligence intervention,0,0,0,1,0,1
online survey questionnaire,0,1,0,0,0,1
onsite covid-19 testing,0,0,0,1,0,1
onsite pcr testing,0,1,0,0,0,1
onsite point-of-care,0,0,0,1,0,1
op-101,1,0,0,0,0,1
open appendicectomy,0,1,0,0,0,1
open label bss (pepto bismol),0,0,0,1,0,1
operative management,0,0,0,0,1,1
ophtamesone,0,0,0,1,0,1
opn-019,0,0,0,1,0,1
opt-in (call-back),0,1,0,0,0,1
opt-in (in-bound),0,1,0,0,0,1
opt-in recruitment email,0,1,0,0,0,1
opt-out framing,0,1,0,0,0,1
opt-out recruitment email,0,1,0,0,0,1
optical coherence tomography (oct),0,1,0,0,0,1
optical coherence tomography angiography,0,1,0,0,0,1
optimized management of covid-19 positive kidney transplant recipients: single center experience from the middle east,0,1,0,0,0,1
optional interview,0,0,0,1,0,1
or antiplatelet) before admission for covid19,0,1,0,0,0,1
or high dose lmwh),0,0,0,1,0,1
or mis-c exposure,0,0,0,1,0,1
"or psychotherapy, n=10)",1,0,0,0,0,1
or videos,0,0,0,1,0,1
oral-b mouth sore mouthwash,0,0,0,1,0,1
oral-bâ® gum,0,1,0,0,0,1
oral-bâ® gum/enamel care -cetylpyridinium chloride,0,1,0,0,0,1
oral anti-coagulant,0,1,0,0,0,1
"oral antibiotic, antihistamine, anti-inflammatory, multivitamins",0,1,0,0,0,1
oral capsule,0,0,0,1,0,1
oral intervention with cetylpyridinium chloride,0,1,0,0,0,1
oral ivermectin,0,0,0,1,0,1
oral low dose steroid,0,1,0,0,0,1
oral polio vaccine / information,1,0,0,0,0,1
oral/nasal spray by distilled water to control group,0,0,0,1,0,1
orally suspension of cov2-ogen1,0,0,0,1,0,1
organic brown rice,0,0,0,1,0,1
oropharyngeal,0,0,0,1,0,1
oropharyngeal swabs,0,1,0,0,0,1
oropharyngeal swabs analyses by rt-pcr,1,0,0,0,0,1
oropharyngeal/intestinal microbiota,0,0,0,1,0,1
orthopaedic surgical procedures,0,1,0,0,0,1
oseltamivir 75mg,0,0,0,1,0,1
osoc,0,0,0,0,1,1
osteopathic manipulative therapy,0,1,0,0,0,1
osteopathic manipulative treatment (omt),0,0,0,1,0,1
osteopathic manipulative treatment in addition to physiotherapy,0,0,0,1,0,1
osteosynthesis,0,1,0,0,0,1
other benefit,0,1,0,0,0,1
other benefit/no social norm,0,1,0,0,0,1
other benefit/social norm,0,1,0,0,0,1
other clinical symptoms,0,1,0,0,0,1
other social distancing measures,0,1,0,0,0,1
other vaccine against sars-cov-2,0,0,0,1,0,1
otilimab,0,1,0,0,0,1
outcomes of aki in critical covid-19 patients admitted to the icu,1,0,0,0,0,1
outdoor time,0,0,0,1,0,1
outpatient clinic,0,0,0,1,0,1
overcoming anxiety in pregnancy,0,0,0,1,0,1
overcoming anxiety in pregnancy/postpartum online self-directed program,0,0,0,1,0,1
overnight intensive recovery,0,1,0,0,0,1
overnight intensive recovery / extended post anaesthetic care in pacu,0,1,0,0,0,1
oxaloacetate medical food,0,0,0,1,0,1
oxaloacetate medical food/dietary supplement,0,0,0,1,0,1
oxford vaccine,0,0,0,1,0,1
oxidative stress elisa kit,0,0,0,1,0,1
oxygen-ozone,0,0,0,1,0,1
oxygen hood,0,1,0,0,0,1
oxygen mask,0,1,0,0,0,1
oxygen therapy/physical therapy,1,0,0,0,0,1
oxyhydrogen,0,0,0,1,0,1
ozanimod,0,0,0,1,0,1
ozone,0,0,0,1,0,1
ozone plasma,0,0,1,0,0,1
p2et (caesalpinia spinosa extract),0,0,0,1,0,1
p2y12,0,0,0,1,0,1
pacritinib,0,0,0,0,1,1
pain,0,0,0,1,0,1
pain medications,0,0,0,1,0,1
pain/neuropsychological questionnaires,0,0,0,1,0,1
palmitoylethanolamide,0,0,0,1,0,1
pamrevlumab,0,0,0,0,1,1
pandemic control measures,0,0,0,1,0,1
paraclinical examination,0,0,0,1,0,1
paraclinical test,0,0,0,1,0,1
parent,0,1,0,0,0,1
parent positive,1,0,0,0,0,1
parent/peer presence,0,1,0,0,0,1
parentchat for parents of children ages 2-17,0,0,0,1,0,1
parents during induction,0,0,0,1,0,1
part 1,1,0,0,0,0,1
part 2,1,0,0,0,0,1
part a,1,0,0,0,0,1
part a/b: placebo,1,0,0,0,0,1
part a: upamostat 200 mg,1,0,0,0,0,1
part a: upamostat 400 mg,1,0,0,0,0,1
part b: upamostat 200,1,0,0,0,0,1
part b: upamostat 200/400 mg,1,0,0,0,0,1
partially hla-matched sars-covsts,0,0,0,0,1,1
participate in a massive musical event,0,1,0,0,0,1
participation,0,1,0,0,0,1
particle measurement,0,1,0,0,0,1
partners for life health behavior change program,0,0,0,1,0,1
passed infection of sars-cov-2,0,1,0,0,0,1
passive microwave radiometry,0,1,0,0,0,1
"patch, nicotine",0,1,0,0,0,1
"patch, placebo",0,1,0,0,0,1
patient-centred advice on telephone consultation in tb patients:,0,0,0,1,0,1
patient characteristics,0,1,0,0,0,1
patient educational video,0,0,1,0,0,1
patient health questionnaire (phq-9),0,0,0,1,0,1
patient mychart scheduling link,0,0,1,0,0,1
patient quality of life assessment,0,1,0,0,0,1
patient reported outcomes (pros),0,0,0,1,0,1
patient sampling,0,0,0,1,0,1
patient status engine,0,0,0,1,0,1
patient with sar-cov-2 infection,0,0,0,1,0,1
patients,0,1,0,0,0,1
patients admitted in intensive care units,0,0,0,1,0,1
patients admitted to intensive care unit with sars-cov2,0,1,0,0,0,1
patients covid 19,0,0,0,1,0,1
patients received standard of care treatment during hospitalization,0,1,0,0,0,1
patients recovering from covid19 receive usual care by allied health professionals,1,0,0,0,0,1
patients with hemopathy,0,0,0,1,0,1
patients with stable normal kidney function,0,1,0,0,0,1
patients with the treatment agains covid19,0,0,0,1,0,1
patients with unstable kidney function,0,1,0,0,0,1
pbmt,0,1,0,0,0,1
pbmt/smf,0,1,0,0,0,1
pcr value,0,0,0,1,0,1
pcr/antigen test for covid 19/inluenza,0,1,0,0,0,1
pcr/chest ct,0,1,0,0,0,1
pct/serology,1,0,0,0,0,1
pdno,0,0,0,1,0,1
peep setting,0,1,0,0,0,1
peep trial - electrical impedance tomography,0,0,0,1,0,1
peer presence,0,1,0,0,0,1
peer resilience champion,1,0,0,0,0,1
peer support,0,0,1,0,0,1
peginterferon beta-1a,0,1,0,0,0,1
peginterferon beta-1a prefilled syringe,0,0,0,1,0,1
pembrolizumab,0,0,0,1,0,1
pemziviptadil (pb1046),0,0,0,0,1,1
pentaglobin,0,0,0,1,0,1
pentoxifylline,0,1,0,0,0,1
pep flute,1,0,0,0,0,1
perceived stress scale,0,1,0,0,0,1
percutaneous coronary revascularization for stemi,1,0,0,0,0,1
percutaneous treatment,0,0,0,1,0,1
performance evaluation,0,0,0,1,0,1
performance evaluation (sensitivity,0,0,0,1,0,1
performance evaluation (sensitivity/specificity) for covid-19 diagnosis of the vocus ptr-tof process,0,0,0,1,0,1
performance evaluation study of realdetect rt-pcr kit for covid-19 detection,0,0,0,1,0,1
performance of the test antigenic,0,1,0,0,0,1
performance of the test antigenic/test rt-pcr,0,1,0,0,0,1
performing ai algorithms on images,0,0,0,1,0,1
performing of lung ultrasound,0,0,0,1,0,1
periogard,0,0,0,0,1,1
peripheral blood samples,0,0,0,1,0,1
peripheral lymphocytes subsets,0,0,0,1,0,1
peripheral sealing device for surgical mask,0,1,0,0,0,1
peripheral sealing device for surgical mask/filtering face piece,0,1,0,0,0,1
peripheral venous ultrasound,0,0,0,1,0,1
peroxyl,0,0,0,0,1,1
personal freedom message,0,1,0,0,0,1
personal protective equipment,0,0,0,1,0,1
personal protective equipment (ppe),0,1,0,0,0,1
personal protective equipment from biological hazard,0,1,0,0,0,1
personal protective measures,0,1,0,0,0,1
personal protective testing booth,0,1,0,0,0,1
personal risk messaging,0,0,1,0,0,1
personalized ambulatory training,0,0,0,1,0,1
personalized feedback,0,1,0,0,0,1
personalized health education,0,0,0,1,0,1
personalized text message delivery of information,0,0,0,1,0,1
pet-ct of 18f-fdg,0,1,0,0,0,1
petrolatum ointment,0,1,0,0,0,1
pf-07321332/ritonavir,0,1,0,0,0,1
pf-07321332/ritonavir / midazolam,0,0,0,1,0,1
pfizer-biontech covid-19 vaccine (comirnaty),0,0,0,1,0,1
pfizer bnt162b2 covid-19 vaccine,0,0,0,1,0,1
pfizer/biontech bnt162b2 vaccine (pf) full dose,0,0,1,0,0,1
pfizer/biontech bnt162b2 vaccine (pf) half dose,0,0,1,0,0,1
pharyngeal swab,1,0,0,0,0,1
phase-1: breath holding test,0,0,0,1,0,1
phase 1,0,0,0,1,0,1
phase 2,0,0,0,1,0,1
phase 2: 6-minute walk test (6mwt),0,0,0,1,0,1
phase i promotores de salud outreach,0,0,0,1,0,1
phase ii promotores de salud,0,0,0,1,0,1
philips lumify ultrasound system,0,1,0,0,0,1
philly vax sweepstakes,0,1,0,0,0,1
phn intervention,0,1,0,0,0,1
phobia questionairre,0,0,0,1,0,1
phone-call screening,0,1,0,0,0,1
phone-call screening/management by a medical student/general practitioner tandem,0,1,0,0,0,1
phone interview,0,0,0,1,0,1
phone interviews,0,0,0,1,0,1
phosphate-buffered saline,0,0,0,1,0,1
photobiomodulation/photodynamic therapy,1,0,0,0,0,1
phq,0,1,0,0,0,1
phq-9 depression scale,0,0,0,1,0,1
phr160 spray,0,0,0,1,0,1
phsyiotherapy,1,0,0,0,0,1
physical,0,1,0,0,0,1
physical activity,0,0,0,1,0,1
physical activity counseling,0,0,0,1,0,1
physical activity program,0,0,0,1,0,1
physical exam,0,0,0,1,0,1
physical exam/vital signs,0,0,0,1,0,1
physical exercise/computerized cognitive training,1,0,0,0,0,1
physical therapy that include a standardized cycling training with functional electrical stimulation,0,0,0,1,0,1
physical therapy that include a standardized cycling training with no additional functional electrical stimulation,0,0,0,1,0,1
physical/cognitive activity,0,1,0,0,0,1
physicians,0,0,0,1,0,1
physiological effects of awake prone position in covid 19 patients,0,1,0,0,0,1
physiological irrigating solution,0,1,0,0,0,1
physiological testing,0,0,0,1,0,1
phytomedicine,0,0,1,0,0,1
piclidenoson,1,0,0,0,0,1
pilot a rapid sars-cov-2 testing strategy,0,1,0,0,0,1
pioglitazone,0,1,0,0,0,1
pioglitazone 30 mg,0,0,0,1,0,1
pioglitazone 45 mg,0,0,0,1,0,1
piperacillin,0,0,0,1,0,1
piperacillin/tazobactam,0,0,0,1,0,1
pjs-539 dose 1,0,0,0,1,0,1
pjs-539 dose 2,0,0,0,1,0,1
pk test,0,0,0,1,0,1
placebo-lde phase 2,0,0,0,1,0,1
placebo-simulation of transcranial direct current stimulation,0,0,0,1,0,1
placebo - phase i,1,0,0,0,0,1
placebo (crossover vaccination period),1,0,0,0,0,1
placebo (formulation buffer),0,0,0,1,0,1
placebo (im),0,0,0,1,0,1
placebo (inhaled solution),0,0,0,1,0,1
placebo (initial vaccination period),1,0,0,0,0,1
placebo (iv),0,0,0,1,0,1
placebo (methylcellulose) capsule,0,0,0,1,0,1
placebo (normal saline),0,0,0,1,0,1
placebo (oral tablet),0,0,0,1,0,1
placebo (potato starch,0,1,0,0,0,1
placebo (potato starch/magnesium stearate),0,1,0,0,0,1
placebo (saline),0,1,0,0,0,1
placebo (sc injections),0,0,0,1,0,1
"placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",1,0,0,0,0,1
placebo (stage a),0,0,0,1,0,1
placebo (standard therapy),0,0,0,1,0,1
"placebo (two doses), priming",1,0,0,0,0,1
placebo / soc,0,0,0,0,1,1
placebo / standard of care (soc),0,0,0,1,0,1
placebo / vitamin d,0,1,0,0,0,1
placebo 0.3-0.4mg,0,0,0,1,0,1
placebo 0.3-0.4mg/kg (once daily),0,0,0,1,0,1
placebo 0.9% nacl solution,0,0,0,1,0,1
placebo 1,0,1,0,0,0,1
placebo 2,0,1,0,0,0,1
placebo 85 mg po bid,0,0,0,1,0,1
placebo atazanavir,0,0,0,1,0,1
placebo booster,1,0,0,0,0,1
placebo comparator (without active ingredient) for intramuscular injection,0,1,0,0,0,1
placebo control (non-behavioral infographic),0,1,0,0,0,1
placebo daclatasvir 60 mg,0,0,0,1,0,1
placebo empty capsule,0,0,0,1,0,1
placebo fluorescent light,0,0,1,0,0,1
placebo for abbv-2b04,0,1,0,0,0,1
placebo for abbv-47d11,0,1,0,0,0,1
placebo for camostat mesilate,0,0,0,1,0,1
placebo for inhalation,0,0,0,1,0,1
placebo for pf-07321332,0,0,0,1,0,1
placebo for ritonavir,0,0,0,1,0,1
placebo gel,0,0,0,1,0,1
placebo hydroxychloroquine,0,0,0,0,1,1
placebo inhaled,0,0,0,0,1,1
placebo inhaler,0,0,0,0,1,1
placebo injection/placebo pill,0,0,0,1,0,1
placebo intervention by photobiomodulation device,0,0,0,1,0,1
placebo iv,0,0,0,1,0,1
placebo magnesium,0,0,0,1,0,1
placebo mini drinks,0,0,0,1,0,1
placebo multiple,0,1,0,0,0,1
placebo nitazoxanide,0,0,0,0,1,1
placebo of fx06,0,1,0,0,0,1
placebo of nicotine transdermal patch,0,0,0,1,0,1
placebo oil,0,0,0,1,0,1
placebo oral solution,0,1,0,0,0,1
placebo patch,0,0,0,1,0,1
placebo pill,0,0,0,1,0,1
placebo ribavirin,0,0,0,0,1,1
placebo single,0,1,0,0,0,1
placebo sofusbuvir,0,0,0,1,0,1
placebo sofusbuvir / daclatasvir 60 mg,0,0,0,1,0,1
placebo tablets,0,0,0,1,0,1
placebo taken po,0,1,0,0,0,1
placebo videos,0,1,0,0,0,1
placebo with remdesivir,0,0,0,1,0,1
placebo without radiofrequency.,0,1,0,0,0,1
placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
placebo/control,1,0,0,0,0,1
plant stanol mini drinks,0,0,0,1,0,1
plasebo acupressure,0,0,1,0,0,1
plasma exchange/convalescent plasma,0,0,0,1,0,1
plasma igg levels,0,0,0,1,0,1
plasma sampling,0,0,0,1,0,1
"platelet count, platelet, mean platelet volume",0,1,0,0,0,1
"platelet count, platelet, mean platelet volume/platelet distribution width in covid-19",0,1,0,0,0,1
platelet distribution width in covid-19,0,1,0,0,0,1
"platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
plethysmography,0,0,0,1,0,1
plethysmography/dlco,0,0,0,1,0,1
pln-74809,0,0,0,0,1,1
pneumococcal vaccine,1,0,0,0,0,1
pneumoniacheck,0,0,0,1,0,1
poc sars-cov-2 igg antibody test,0,1,0,0,0,1
poct,1,0,0,0,0,1
point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech),0,0,0,1,0,1
point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech)/dry blood spot collection (euroimmun),0,0,0,1,0,1
point-of-care test for sars-cov-2,0,0,0,1,0,1
"point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",0,0,0,1,0,1
polio vaccine,0,0,1,0,0,1
polio vaccine/na-831,0,0,1,0,0,1
poly-iclc (hiltonolâ®),0,0,0,1,0,1
poly-iclc (hiltonolâ®)/placebo,0,0,0,1,0,1
polyester reusable mask,0,1,0,0,0,1
polyethelyene glycol,0,0,1,0,0,1
polymerase chain reaction (pcr) test,1,0,0,0,0,1
polyoxidonium,0,1,0,0,0,1
polysomnography,1,0,0,0,0,1
polyvinylalcohol strip [diagnostic],0,0,0,1,0,1
pool lamp,0,1,0,0,0,1
pool rt-pcr,0,1,0,0,0,1
pop-up community vaccination sites,0,0,0,1,0,1
poractant alfa,0,0,0,1,0,1
posaconazole,0,0,0,1,0,1
position,0,0,0,1,0,1
positive feedback,0,1,0,0,0,1
positive for sars-cov-2 infection,1,0,0,0,0,1
positive psychotherapy,0,0,0,1,0,1
post-hospitalization nutritional monitoring,0,0,0,1,0,1
post-intensive care unit syndrome,0,0,0,1,0,1
post-mortem biopsies.,0,0,0,1,0,1
post-traumatic stress screening,0,0,0,1,0,1
post traumatic stress disorder questionnaire (ptsd-8),0,0,0,1,0,1
postpartum,1,0,0,0,0,1
postpartum anxiety scale scores,0,1,0,0,0,1
postpartum online self-directed program,0,0,0,1,0,1
postpartum women under investigation for coronavirus/diagnosed with covid-19,1,0,0,0,0,1
postural positioning,0,0,0,1,0,1
power breathe,0,0,0,0,1,1
ppe level 2,0,0,0,1,0,1
ppe level 2/direct laryngoscope,0,0,0,1,0,1
ppe level 3,0,0,0,1,0,1
ppe level 3/direct laryngoscope,0,0,0,1,0,1
ppe level 3/video laryngoscope,0,0,0,1,0,1
ppg,0,0,0,1,0,1
ppg/prom,0,0,0,1,0,1
ppv23,0,1,0,0,0,1
ppv23 for the 1st dose,1,0,0,0,0,1
ppv23 for the 1st dose/iiv4 for the 2nd dose,1,0,0,0,0,1
ppv23 for the 2nd dose,0,1,0,0,0,1
ppv23;covax,1,0,0,0,0,1
prazosin,0,0,0,1,0,1
pre-operative screening,0,0,0,1,0,1
pre-pandemic stroke related metrics,0,1,0,0,0,1
predict admission of covid-19 patients to icu,1,0,0,0,0,1
"predict admission of covid-19 patients to icu/death with routine/quickly avalaible clinical, biological/radiological variables?",1,0,0,0,0,1
prediction market,0,1,0,0,0,1
predictive factors for clinical response in patients with covid-19.,0,0,0,1,0,1
predictors adverse evolution,0,0,0,1,0,1
predictors of health care provide,0,0,0,1,0,1
prednisolone,0,0,0,1,0,1
prednisone tablet,0,0,0,1,0,1
pregnant women under investigation for coronavirus,1,0,0,0,0,1
pregnant women under investigation for coronavirus/diagnosed with covid-19,1,0,0,0,0,1
presence of specific anti-sars-cov-2 antibodies,0,1,0,0,0,1
preservision areds formulation soft gels,0,1,0,0,0,1
preservision areds formulation soft gels/tablets,0,1,0,0,0,1
press needles,0,0,0,1,0,1
prevalence of covid-19,0,1,0,0,0,1
primary care,0,1,0,0,0,1
primary exposure status of pfizer-biontech covid-19 vaccine,1,0,0,0,0,1
primepro,0,1,0,0,0,1
pro-sero-cov,1,0,0,0,0,1
"pro bnp , vitamin d",0,0,0,1,0,1
probiorinse,0,1,0,0,0,1
probiotic: lactobacillus salivarius,0,0,0,1,0,1
probiotic: lactobacillus salivarius / vit d / zinc,0,0,0,1,0,1
probiotics (2 strains 10x10^9 ufc),0,1,0,0,0,1
problem-solving,0,0,0,1,0,1
problem-solving/relationship improvement intervention.,0,0,0,1,0,1
problem management,0,0,0,1,0,1
problem management/(pm/),0,0,0,1,0,1
problem solving therapy (pst).,0,0,0,1,0,1
procalcitonin,0,1,0,0,0,1
procalcitonin serum levels,0,1,0,0,0,1
produce prescription program,0,0,1,0,0,1
progesterone,0,1,0,0,0,1
progesterone 200 mg oral capsule,0,0,0,1,0,1
prognostic score,1,0,0,0,0,1
progressive cycling exercise test to exhaustion,0,1,0,0,0,1
progressive muscle relaxation,0,1,0,0,0,1
project echo,0,0,0,1,0,1
prolastin,0,1,0,0,0,1
prolectin-m; a (1-6)-alpha-d-mannopyranose class,0,1,0,0,0,1
prolonged prone position ventilation,0,0,0,1,0,1
prolonged proned positioning,0,1,0,0,0,1
prom,0,0,0,1,0,1
promotores de salud,0,0,0,1,0,1
prone lying position,0,1,0,0,0,1
prone position (pp),0,0,0,1,0,1
prone position on ecmo patient,0,1,0,0,0,1
proning,0,1,0,0,0,1
proper diet,0,0,0,1,0,1
prophylactic,0,1,0,0,0,1
prophylaxis,0,1,0,0,0,1
propofol,0,0,0,0,1,1
propolis,1,0,0,0,0,1
prosocial-benefit,0,0,1,0,0,1
prosocial acts,0,1,0,0,0,1
prospective chart review,0,1,0,0,0,1
prospective cohort in high body mass index patient with covid 19,0,1,0,0,0,1
prospective oberservational registry,0,0,0,1,0,1
prospective observation,0,0,0,1,0,1
prospekta,0,0,0,1,0,1
protect your elders campaign,0,0,0,1,0,1
protective ventilation,0,0,0,1,0,1
protein supplementation,1,0,0,0,0,1
proteinuria,0,1,0,0,0,1
prototype,0,0,0,1,0,1
proxalutamide (gt0918),0,0,0,1,0,1
"ps membrane versus pmma membrane,",1,0,0,0,0,1
psa value,0,0,0,1,0,1
psc-04,0,0,0,1,0,1
psg,0,1,0,0,0,1
psilocybin (usona institute),0,0,0,1,0,1
psqi,0,1,0,0,0,1
pss,0,1,0,0,0,1
psycho-education,0,1,0,0,0,1
psycho-education video,0,0,0,1,0,1
psychoeducation,1,0,0,0,0,1
psychoeducational videos,0,0,0,1,0,1
psychological first aid (pfa),0,0,0,1,0,1
psychological rehabilitation,0,1,0,0,0,1
psychological stress,0,1,0,0,0,1
psychological stress/adaptation at work score (psas),0,1,0,0,0,1
psychological support,0,0,0,1,0,1
psychological triaging intervention,0,1,0,0,0,1
psychological/behaviour change support,0,0,0,1,0,1
psychological/sociological interviews,0,1,0,0,0,1
psychometric scale administration,0,0,0,1,0,1
psychotherapy,0,1,0,0,0,1
ptc299,0,0,0,1,0,1
ptsd,0,0,0,1,0,1
ptsd check list (pcl) scale,0,0,0,1,0,1
ptx-covid19-b,1,0,0,0,0,1
public health england gold standard,0,0,0,1,0,1
public space exposure,0,1,0,0,0,1
pulmonary anomalies 4 months after documented covid-19 pneumonia,0,1,0,0,0,1
pulmonary function testing,1,0,0,0,0,1
pulmonary function tests,0,1,0,0,0,1
pulmonary physiotherapy techniques,0,1,0,0,0,1
pulmonary resection,0,1,0,0,0,1
pulmonary tele-rehabilitation,0,0,0,1,0,1
pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),0,0,0,1,0,1
pulse oximeter,1,0,0,0,0,1
pulse oximetry,0,1,0,0,0,1
purapo,0,0,0,1,0,1
purclo,0,0,0,1,0,1
purinf,0,0,0,1,0,1
purphl,0,0,0,1,0,1
purwet,0,0,0,1,0,1
pwv,0,0,0,1,0,1
pyramax,0,0,0,1,0,1
pyridostigmine bromide,0,0,0,1,0,1
pyronaridine-artesunate (pa),0,0,0,1,0,1
q-griffithsin,0,0,0,1,0,1
q-nrg metobolic cart device,0,0,0,1,0,1
q spect-ct,0,0,0,1,0,1
qazcovac-p -covid-19 subunit vaccine,1,0,0,0,0,1
qniv nanoparticle vaccine2 in-clinic mixed with matrix-m1 adjuvant,1,0,0,0,0,1
qrt-pcr,0,0,1,0,0,1
qrt-pcr/serology,0,0,1,0,0,1
quadramune(tm),0,0,0,1,0,1
quadrivalent inactivated influenza high dose,1,0,0,0,0,1
qualitative,0,0,0,1,0,1
qualitative analysis for professionals,0,0,0,1,0,1
qualitative approaches to analysis,0,0,0,1,0,1
qualitative assessments of mental health,0,0,0,1,0,1
qualitative interviews..,0,0,0,1,0,1
qualitative/quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quality of life assessment,0,0,0,1,0,1
quality of life diagnosis,0,1,0,0,0,1
quality of life diagnosis/therapy during the completed rct diqol,0,1,0,0,0,1
quality of life promotion,1,0,0,0,0,1
quality of life questionnaires,0,0,0,1,0,1
quality of live assessment,0,1,0,0,0,1
quantiferon,0,0,0,1,0,1
quantiferon sars-cov-2 test,0,0,0,1,0,1
quantitative,0,0,0,1,0,1
quantitative analysis for patients,0,0,0,1,0,1
quantitative analysis for professionals,0,0,0,1,0,1
quantitative analysis of anti-sars-cov-2-antibodies,0,1,0,0,0,1
quantitative antibody tests,0,0,0,1,0,1
quantitative sensory testing,0,0,0,1,0,1
quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quantitative/qualitative assessments of mental health,0,0,0,1,0,1
quantra system,0,0,1,0,0,1
quasistatic pressure-volume curve,0,1,0,0,0,1
quercetin phytosome,0,1,0,0,0,1
quercetin phytosome (qp),0,1,0,0,0,1
querying the insee database,0,0,0,1,0,1
questionnaire : preparedness for caregiving scale,0,1,0,0,0,1
questionnaire about impact of the covid-19 pandemic on orthopaedic resident training,0,1,0,0,0,1
"questionnaire administration,blood sampling",1,0,0,0,0,1
"questionnaire administration,blood sampling/genetic analyses.",1,0,0,0,0,1
questionnaire study (cross-sectional analytical clinical research),0,0,1,0,0,1
"questionnaire, phone call",0,0,0,1,0,1
questionnaire/interview,0,1,0,0,0,1
questionnaire/optional interview,0,0,0,1,0,1
questionnaires covid,0,0,0,1,0,1
questionnaires covid-,0,0,0,1,0,1
questionnaires covid/,0,0,0,1,0,1
questionnaires family,0,0,0,1,0,1
questionnaires on psychological quality of life,0,1,0,0,0,1
questionnaires patient,0,0,0,1,0,1
questionnaires/neuropsychological assessment,0,0,0,1,0,1
questionnaires/patient reported outcomes (pros),0,0,0,1,0,1
"quickly avalaible clinical, biological",1,0,0,0,0,1
quidel quickvue antigen test for covid-19,0,0,0,1,0,1
quidel sofia sars antigen fia,0,0,0,0,1,1
quinine,0,0,0,1,0,1
quinquina-stevia,0,0,1,0,0,1
quinquina-stevia/azythromycin,0,0,1,0,0,1
r tablets,1,0,0,0,0,1
race concordant,1,0,0,0,0,1
racial,1,0,0,0,0,1
racial inequality highlighted,0,1,0,0,0,1
racial/ethnic frame,1,0,0,0,0,1
radiofrequency therapy,0,1,0,0,0,1
radiological lung involvement evolution,0,0,0,1,0,1
radiological variables?,1,0,0,0,0,1
radius ppg tetherless pulse oximetry (masimo),0,0,0,1,0,1
radx chcs testing intervention strategy,0,0,0,1,0,1
rale score vs. severity score,0,0,0,1,0,1
raloxifene,0,1,0,0,0,1
"raman analysis of saliva, characterization of the raman database",0,0,0,1,0,1
"raman analysis of saliva, characterization of the raman database/building of the classification model",0,0,0,1,0,1
ramipril,0,0,0,1,0,1
randomized booster,1,0,0,0,0,1
rapa-501-allo off-the-shelf therapy of covid-19,0,0,0,0,1,1
rapid-3,0,0,1,0,0,1
rapid antibody test,0,0,0,1,0,1
rapid antigen test,0,1,0,0,0,1
rapid antigen test (panbio ag test),0,0,0,1,0,1
rapid antigen test for sars cov2,0,1,0,0,0,1
rapid antigen testing,0,1,0,0,0,1
rapid antigen testing versus rt-pcr,0,1,0,0,0,1
rapid antigen testing/offsite pcr testing,0,1,0,0,0,1
rapid antigen testing/onsite pcr testing,0,1,0,0,0,1
rapid molecular test,0,0,0,1,0,1
rapid nasopharyngeal antigen test for sars-cov-2,0,1,0,0,0,1
rapid salivary test,0,1,0,0,0,1
rarefaction,0,0,0,1,0,1
rayaldee 30mcg extended-release (er) capsule,0,1,0,0,0,1
razuprotafib subcutaneous solution,0,0,0,0,1,1
rbd-based protein subunit vaccine (zf2001) against covid-19,1,0,0,0,0,1
rbt-9 (90 mg),0,0,0,1,0,1
rdv,0,0,0,0,1,1
rdv placebo,0,0,0,1,0,1
reactivity,0,0,0,1,0,1
read leaflets containing knowledge of covid-19,0,0,0,1,0,1
read leaflets containing knowledge of covid-19/vaccination.,0,0,0,1,0,1
reading a book,0,1,0,0,0,1
reamberin,0,1,0,0,0,1
recently vaccination,0,0,0,1,0,1
recharge,0,0,0,1,0,1
recombinant ad5 vectored covid-19 vaccine,1,0,0,0,0,1
recombinant covid-19 vaccine (cho cell),0,0,0,1,0,1
recombinant covid-19 vaccine (sf9 cells),0,0,1,0,0,1
recombinant human annexin a5,0,0,0,1,0,1
recombinant human anti-sars-cov-2 monoclonal antibody(25mg,0,0,0,1,0,1
recombinant human anti-sars-cov-2 monoclonal antibody(25mg/kg;50mg/kg;100mg/kg),0,0,0,1,0,1
recombinant human plasma gelsolin (rhu-pgsn),1,0,0,0,0,1
recombinant ndv vectored vaccine for sars-cov-2,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) (ad5-ncov),0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.3ml,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.5ml,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) for inhalation,0,0,0,1,0,1
recombinant two-component covid-19 vaccine (cho cell),1,0,0,0,0,1
recombinase,0,0,0,1,0,1
recording of hemodynamic monitoring,1,0,0,0,0,1
recording of respiratory monitoring,1,0,0,0,0,1
rectal swab,0,0,0,1,0,1
reduction in antimetabolite immunosuppression,0,0,0,1,0,1
referral,0,0,0,1,0,1
referral card,1,0,0,0,0,1
referral/digital brochure,0,0,0,1,0,1
reframing,0,1,0,0,0,1
refrigeration,0,0,1,0,0,1
refugee,0,0,0,1,0,1
refugee/immigrant well-being project (riwp),0,0,0,1,0,1
regadenoson,0,0,0,1,0,1
regeneron casirivimab,0,0,0,1,0,1
regeneron casirivimab / imdevimab,0,0,0,1,0,1
reginmune,0,1,0,0,0,1
regn14256,0,0,0,1,0,1
regular care,0,1,0,0,0,1
regularly during follow up).,0,0,0,1,0,1
rehabilitation-focused program,0,0,0,1,0,1
rehabilitation by concentric exercises,0,0,0,1,0,1
rehabilitation by eccentric exercises,0,0,0,1,0,1
rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
rehabilitation programme,0,0,0,1,0,1
rehabilitation protocol through a digital platform,0,0,0,1,0,1
rehabilitative intervention,0,0,0,1,0,1
rejuveinix (rjx) active comparator,0,0,0,1,0,1
relation between frailty,0,0,0,1,0,1
relation between frailty/clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
relationship improvement intervention.,0,0,0,1,0,1
relationship scales questionnaire (rsq),0,0,0,1,0,1
relative 5:2 fasting,1,0,0,0,0,1
relaxation,0,0,0,1,0,1
relaxation technique,0,1,0,0,0,1
remain covid free ssi,0,1,0,0,0,1
remdesivir-hu,1,0,0,0,0,1
remdesivir combination,0,0,0,1,0,1
remestemcel-l,1,0,0,0,0,1
remimazolam,0,1,0,0,0,1
remote cognitive behavioral therapy for insomnia,1,0,0,0,0,1
remote controlled exercise,0,0,0,1,0,1
remote monitoring of covid-19,0,0,1,0,0,1
remote problem management plus,0,0,0,1,0,1
remote pulmonary rehabilitation,0,0,0,1,0,1
"remote sms (short message service, also known as ""text message"") delivery",0,1,0,0,0,1
removal of dead space filter,0,1,0,0,0,1
renin-angiotensin system inhibitors,0,0,0,0,1,1
repeat sars-cov-2 igg antibodies at 45-65 days,0,1,0,0,0,1
"reporting of anosmia, ageusia",0,1,0,0,0,1
"reporting of anosmia, ageusia/other clinical symptoms",0,1,0,0,0,1
reprocessing recent traumatic event protocol,0,1,0,0,0,1
research specific blood sample,1,0,0,0,0,1
residence-based testing participation pilot (sars-cov-2 testing with relaxed social distancing restrictions),0,1,0,0,0,1
residual symptoms,0,1,0,0,0,1
residual symptoms/the quality of life in individuals recovered from covid-19 infection: a survey from pakistan,0,1,0,0,0,1
resilience,1,0,0,0,0,1
resilience program,1,0,0,0,0,1
resilience/institutional support,1,0,0,0,0,1
resistance exercise,0,0,0,1,0,1
resistance training,0,0,1,0,0,1
resp-aer-meter,0,0,0,1,0,1
resp301,0,0,0,1,0,1
respiratory,0,1,0,0,0,1
respiratory activity,0,0,0,1,0,1
respiratory exerciser,0,0,0,1,0,1
respiratory function rehabilitation training,0,0,0,1,0,1
respiratory functions,0,1,0,0,0,1
respiratory infections,1,0,0,0,0,1
respiratory mechanics measurement,0,1,0,0,0,1
respiratory monitoring,0,1,0,0,0,1
respiratory muscles ultrasound,0,1,0,0,0,1
respiratory physiotherapy,0,1,0,0,0,1
respiratory rehabilitation,0,0,0,1,0,1
respiratory rehabilitation program (rr).,0,0,0,1,0,1
respiratory supports,0,1,0,0,0,1
respiratory swabs,0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety",0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety/depression,/post-traumatic stress screening",0,0,0,1,0,1
respiratory systems monitoring,0,0,0,1,0,1
respiratory tele-rehabilitation program (trr).,0,0,0,1,0,1
respiratory tract sample,0,0,0,1,0,1
respiratory training,0,0,0,1,0,1
respiratory/psychological rehabilitation,0,1,0,0,0,1
resting 12 lead ecg,0,0,0,1,0,1
resting electrocardiogram,0,1,0,0,0,1
restore: recovering from extreme stressors through online resources,0,0,0,1,0,1
restore: recovering from extreme stressors through online resources/e-health,0,0,0,1,0,1
retrospective,0,0,0,1,0,1
retrospective case-control analysis,0,1,0,0,0,1
retrospective data,0,0,0,1,0,1
retrospective data/biological samples,0,0,0,1,0,1
retrospective metagenomics on clinical samples collected during hospitalization,1,0,0,0,0,1
reverse transcription polymerase chain reaction,0,1,0,0,0,1
review of medical file,0,0,0,1,0,1
review of medical patient file,0,1,0,0,0,1
reviewed clinical records,0,1,0,0,0,1
reviewed clinical records/laboratory results,0,1,0,0,0,1
revised home-cov score,0,1,0,0,0,1
reward re-training,0,0,0,1,0,1
rh-dnase,0,0,0,1,0,1
rhace2,0,1,0,0,0,1
rhdnase i,0,0,0,1,0,1
rhinopharyngeal,0,1,0,0,0,1
rhtpo,0,0,0,1,0,1
ria-device (remote investigation,0,1,0,0,0,1
ria-device (remote investigation/assessment),0,1,0,0,0,1
ribaroxaban,0,1,0,0,0,1
right lateral decubitus),0,1,0,0,0,1
ringer's solution,0,1,0,0,0,1
rintatolimod,0,0,0,1,0,1
risankizumab,1,0,0,0,0,1
risk factors,0,1,0,0,0,1
ritonavir / midazolam,0,0,0,1,0,1
ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
ritonavir 50 mg [kaletra],1,0,0,0,0,1
ritonavir/oseltamivir,0,0,0,1,0,1
rivaroxaban 15mg tab,0,0,0,1,0,1
rnapc2,1,0,0,0,0,1
ro7496998,0,0,0,1,0,1
roactemra,0,0,0,0,1,1
robot assisted percutaneous cardiovascular intervention,0,0,0,1,0,1
robot rehabilitation,0,0,0,1,0,1
robotic assisted early mobilization,0,0,0,1,0,1
robotic assisted intervention,0,0,0,1,0,1
robotic therapy,0,0,0,1,0,1
routine care (no sars-covsts),0,0,0,0,1,1
routine daily activity,0,0,1,0,0,1
routine dental restorative procedures,0,0,0,1,0,1
routine psychological support,0,1,0,0,0,1
rp7214,0,0,0,1,0,1
rp7214 / standard of care (soc),0,0,0,1,0,1
rph-104,0,1,0,0,0,1
rrt-pcr sars-cov-2,0,0,0,1,0,1
rslv-132,0,0,0,1,0,1
rt-pcr for sars-cov-2,0,0,0,1,0,1
rt-pcr sars-cov-2,0,1,0,0,0,1
rt-pcr sars-cov2 in urine,0,0,0,1,0,1
rt-qpcr test,0,1,0,0,0,1
"s-binding igg, rbd-binding igg",0,0,0,1,0,1
"s-binding igg, rbd-binding igg/n-binding igg immunoassays/sars-cov-2 serum neutralization assay, quantitative serum immunoglobulin tests",0,0,0,1,0,1
s2 proteins of sars-cov-2 virus,0,0,0,1,0,1
sab-185,1,0,0,0,0,1
"sab-185 (10,240 units",0,0,0,1,0,1
"sab-185 (10,240 units/kg)",0,0,0,1,0,1
"sab-185 (3,840 units",0,0,0,1,0,1
"sab-185 (3,840 units/kg)",0,0,0,1,0,1
sacubitril,0,0,0,1,0,1
sacubitril / valsartan oral tablet [entresto],0,0,0,1,0,1
safety executive's (hse) management standards indicator tool (msit) to measure work-related stress,0,1,0,0,0,1
saint george respiratory questionnaire,0,0,1,0,0,1
saisei maf capsules,0,1,0,0,0,1
saline-sodium citrate (ssc) buffer,0,0,0,1,0,1
saline nasal,0,0,0,1,0,1
saline nasal spray,1,0,0,0,0,1
saline nasal/throat spray,0,0,0,1,0,1
saline placebo (double),0,0,0,1,0,1
saline placebo (single),0,0,0,1,0,1
saline placebo boost,0,0,0,1,0,1
saline with baby shampoo nasal irrigation,1,0,0,0,0,1
saline/listerine,0,0,0,1,0,1
saline/saline,0,0,0,1,0,1
saline/standard care,0,1,0,0,0,1
saliva assay,0,1,0,0,0,1
saliva based assay: crude rna extraction,0,0,0,1,0,1
saliva collected via salivette cortisol,0,1,0,0,0,1
saliva sample (self-sample),0,1,0,0,0,1
saliva sample/to an anterior nare self-swabbing (self-samples),0,1,0,0,0,1
saliva samples will be taken,0,0,0,1,0,1
saliva test kit,0,0,0,1,0,1
saliva/nps test,0,0,0,1,0,1
salivary,0,1,0,0,0,1
salivary sample,0,0,0,1,0,1
salivary test for covid19,1,0,0,0,0,1
sam-lnp-s,0,0,0,1,0,1
sam-lnp-s-tce,0,0,0,1,0,1
samba ii,0,0,0,1,0,1
sample,0,0,0,1,0,1
sample collection/performance evaluation (a),0,0,0,1,0,1
sample collection/performance evaluation (b),0,0,0,1,0,1
sampler skills,0,1,0,0,0,1
sampling by venipuncture (and eventually by nasopharyngeal swab),0,0,0,1,0,1
sampling of oropharynx,0,0,0,0,1,1
sampling of oropharynx/nasopharynx,0,0,0,0,1,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen,0,1,0,0,0,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen/saliva collected via salivette cortisol,0,1,0,0,0,1
sar443122,0,1,0,0,0,1
sarcopenia diagnosis,0,0,0,1,0,1
sarilumab prefilled syringe,0,0,0,1,0,1
sars-cov-2-test,0,0,0,1,0,1
sars-cov-2 ab,0,1,0,0,0,1
sars-cov-2 adjuvanted recombinant protein vaccine (bivalent),0,0,0,1,0,1
sars-cov-2 adjuvanted recombinant protein vaccine (monovalent),0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614/b.1.351)-as03, dosage a",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614/b.1.351)-as03, dosage b",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 1",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 2",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 3",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 4",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03, dosage a",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03, dosage b",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (d614)-as03, dosage a",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (d614)-as03, dosage b",0,0,0,1,0,1
sars-cov-2 and,0,0,0,1,0,1
sars-cov-2 and/or mis-c exposure,0,0,0,1,0,1
sars-cov-2 antibody analysis,1,0,0,0,0,1
sars-cov-2 antibody based ivig therapy,0,1,0,0,0,1
sars-cov-2 antibody immunoassays,1,0,0,0,0,1
sars-cov-2 antibody test,1,0,0,0,0,1
sars-cov-2 antibody testing,0,0,0,1,0,1
sars-cov-2 antigen-specific cytotoxic t-lymphocytes,0,0,0,1,0,1
sars-cov-2 ig g levels,0,0,0,1,0,1
sars-cov-2 igg,0,0,0,1,0,1
sars-cov-2 infection,0,0,0,1,0,1
sars-cov-2 messenger rna-1273 (moderna) vaccine,1,0,0,0,0,1
sars-cov-2 mrna vaccine formulation 1,1,0,0,0,0,1
sars-cov-2 mrna vaccine formulation 2,1,0,0,0,0,1
sars-cov-2 mrna vaccine formulation 3,1,0,0,0,0,1
sars-cov-2 negative,0,0,0,1,0,1
sars-cov-2 neutralizing antibody titer,0,0,0,1,0,1
sars-cov-2 pcr/serology tests,0,1,0,0,0,1
sars-cov-2 positive,0,0,0,1,0,1
sars-cov-2 protein subunit recombinant vaccine,0,0,0,1,0,1
sars-cov-2 rapid diagnostic test (covid-prestoâ® igm,1,0,0,0,0,1
"sars-cov-2 rapid diagnostic test (covid-prestoâ® igm/igg, aaz, boulogne-billancourt, france)",1,0,0,0,0,1
sars-cov-2 recombinant protein vaccine phase 2 formulation 1,0,0,0,1,0,1
sars-cov-2 recombinant protein vaccine phase 2 formulation 2,0,0,0,1,0,1
sars-cov-2 recombinant protein vaccine phase 2 formulation 3,0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm",0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",0,0,0,1,0,1
sars-cov-2 rs nanoparticle vaccine in-clinic mixed with matrix-m1 adjuvant,1,0,0,0,0,1
sars-cov-2 rs/matrix-m adjuvant - phase 2,1,0,0,0,0,1
sars-cov-2 rs/matrix-m1 adjuvant (crossover vaccination period),1,0,0,0,0,1
sars-cov-2 rs/matrix-m1 adjuvant (initial vaccination period),1,0,0,0,0,1
sars-cov-2 rs/matrix m1-adjuvant,1,0,0,0,0,1
sars-cov-2 rt-pcr assay for detection of covid-19 infection,0,0,0,1,0,1
sars-cov-2 s1,0,1,0,0,0,1
sars-cov-2 s1/s2 igg,0,1,0,0,0,1
sars-cov-2 screening by molecular biology,0,0,0,1,0,1
sars-cov-2 serological assessment (igg),0,0,0,1,0,1
sars-cov-2 serology,0,0,0,1,0,1
"sars-cov-2 serum neutralization assay, quantitative serum immunoglobulin tests",0,0,0,1,0,1
sars-cov-2 specific igm,0,0,0,1,0,1
sars-cov-2 specific igm/igg detection,0,0,0,1,0,1
sars-cov-2 specific t cells,0,0,0,1,0,1
sars-cov-2 testing on the eppendorf thermal cycler pcr system using self-collected saliva as the specimen,0,1,0,0,0,1
sars-cov-2 vaccination,1,0,0,0,0,1
sars-cov-2 vaccine (vero cell) inactivated,0,0,0,1,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 1,0,1,0,0,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 2,0,1,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 1,0,1,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 2,0,1,0,0,0,1
sars-cov-2 vaccine formulation 2 without adjuvant,0,1,0,0,0,1
"sars-cov-2 vaccine(vero cell), inactivated",0,0,0,1,0,1
sars-cov-2 viral composition,0,0,0,1,0,1
sars-cov-2 viral culturing,0,0,0,1,0,1
sars-cov-2 virus vaccines,1,0,0,0,0,1
sars-cov-2 vlp vaccine,0,0,0,1,0,1
sars-cov-2 vlp vaccine-alpha (british) variant,0,0,0,1,0,1
sars-cov-2 vlp vaccine-wuhan,0,0,0,1,0,1
sars-cov-2 vlp vaccine-wuhan/alpha variant,0,0,0,1,0,1
sars-cov2 antibody measurement,0,0,1,0,0,1
sars-cov2 pfizer vaccine,1,0,0,0,0,1
sars - cov 2 vaccine,0,0,0,1,0,1
sars cov-2 swabs,1,0,0,0,0,1
satisfaction,0,1,0,0,0,1
satisfaction evaluation,0,1,0,0,0,1
savr,1,0,0,0,0,1
sbi-101,0,0,0,1,0,1
sc-ad6-1,0,0,0,1,0,1
scales,0,0,0,1,0,1
scales.,0,1,0,0,0,1
scanning chest x-rays/performing ai algorithms on images,0,0,0,1,0,1
scarcity,0,1,0,0,0,1
scarcity message,0,1,0,0,0,1
scb-2019 with as03 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant/alum adjuvant,1,0,0,0,0,1
scd,0,1,0,0,0,1
sch intervention,0,0,1,0,0,1
scheduled surgery,0,1,0,0,0,1
screening blood test,0,1,0,0,0,1
screening for the components of metabolic syndrome,0,0,0,1,0,1
sd biosensor,0,0,1,0,0,1
second dose,0,0,1,0,0,1
second phase cardiac rehabilitation,0,0,0,1,0,1
sedation,0,1,0,0,0,1
"selenium, zinc",0,1,0,0,0,1
"selenium, zinc/copper, vitamin a, d, e plasma concentrations during patient hospitalization",0,1,0,0,0,1
self-acupressure,0,0,0,1,0,1
self-administered questionnaire,0,1,0,0,0,1
self-assesment questionnaire,0,1,0,0,0,1
self-benefit/no social norm,0,1,0,0,0,1
self-benefit/social norm,0,1,0,0,0,1
self-care tools,0,1,0,0,0,1
"self-collected, home-based testing",0,0,1,0,0,1
self-compassion for chronic pain virtual group treatment program,0,0,0,1,0,1
self-focused acts,0,1,0,0,0,1
self-help booklet,0,1,0,0,0,1
self-help mindfulness,0,0,0,1,0,1
self-help mindfulness/compassion exercises,0,0,0,1,0,1
self-interest message,0,1,0,0,0,1
self-management booklet (switch: stay well during covid-19),1,0,0,0,0,1
self-questionnary,0,1,0,0,0,1
self-reported symptom collection,0,1,0,0,0,1
self measurement with pulse oximeter,0,0,0,1,0,1
self study,0,0,0,1,0,1
self supportive care,0,1,0,0,0,1
semen qualitative analysis,0,1,0,0,0,1
semi-directed entretien,0,0,0,1,0,1
semi-structured qualitative interview,0,0,0,1,0,1
semi-structured telephone questionnaire,0,0,0,1,0,1
semi structured interview,0,0,1,0,0,1
sending thorax ct video images via smartphone applications,0,1,0,0,0,1
senicapoc,0,0,0,1,0,1
senior fitness test,0,1,0,0,0,1
sensor usage,0,1,0,0,0,1
sentinox--group a,0,0,0,1,0,1
sentinox--group b,0,0,0,1,0,1
separic-covid19 cohort,0,1,0,0,0,1
sequence of testing.,0,1,0,0,0,1
sequencing covid-19,0,0,0,1,0,1
serial seroconversion measurements in hospital employees during the covid-19 pandemic,0,0,0,1,0,1
serious adverse events,0,0,0,1,0,1
serodiagnosis of igg,0,0,0,1,0,1
serodiagnosis of igg/igm,0,0,0,1,0,1
serologic assays for antibodies to sars-cov-2,0,0,0,1,0,1
serologic immune response evaluation,0,1,0,0,0,1
serologic immunoassays to sars-cov-2 antibodies,0,0,0,1,0,1
serologic test,0,0,0,1,0,1
serological assay for sars-cov-2,0,0,0,1,0,1
serological covid-19 vaccine immunogenicity,0,0,0,1,0,1
serological screening,0,0,0,1,0,1
serological surveillance,0,0,0,1,0,1
serological test for covid-19.,0,1,0,0,0,1
serological testing for covid-19 infection,0,0,0,1,0,1
serological tests for sars cov-2,0,1,0,0,0,1
serology test follow-up,1,0,0,0,0,1
serology test for covid-19,0,0,0,1,0,1
serology testing profiles description,0,0,0,1,0,1
"serology testing, rt pcr",0,0,0,1,0,1
serology tests,0,1,0,0,0,1
serology to determine sars-cov-2 infection,0,0,1,0,0,1
serology/elispot test,0,0,0,1,0,1
seroprevalence of sars-cov-2 infection in patients with hiv infection,0,0,0,1,0,1
serum,0,1,0,0,0,1
"serum collection, adverse events collection",0,0,0,1,0,1
serum neurofilaments as a marker of neurological damage.,0,0,0,1,0,1
serum neutralization,0,1,0,0,0,1
serum ngal,0,1,0,0,0,1
serum ngal/cystatin c,0,1,0,0,0,1
serum pai-1 alpha analysis.,0,0,0,1,0,1
serum protein level analysis,0,1,0,0,0,1
service of questionnaire,0,1,0,0,0,1
services as usual,0,0,0,1,0,1
sessions,1,0,0,0,0,1
settings,0,0,0,1,0,1
severe acute respiratory syndrome coronavirus 2 detection,0,1,0,0,0,1
severity of lung involvement with covid-19.,0,1,0,0,0,1
sex hormones,0,1,0,0,0,1
sf-12,0,1,0,0,0,1
sfc (5-ala,0,0,0,1,0,1
sfc),0,0,0,1,0,1
sg diagnostics covid-19 antigen rapid test kit,1,0,0,0,0,1
sglt2 inhibitor,0,0,0,1,0,1
sham,0,0,0,1,0,1
sham acupressure group,0,0,0,1,0,1
sham control catheter,0,0,0,1,0,1
sham inflation,0,0,0,1,0,1
sham transcranial direct-current stimulation,0,1,0,0,0,1
sham treatment,0,0,0,1,0,1
sham: no application of ces via ear clips,0,0,0,1,0,1
shampoo,0,0,0,1,0,1
shampoo/listerine,0,0,0,1,0,1
shampoo/saline,0,0,0,1,0,1
shanshamani vati plus,0,1,0,0,0,1
shared decision making,0,1,0,0,0,1
shen cao gan jiang tang (gan cao gan jiang tang with ginseng),0,0,0,1,0,1
shg,0,1,0,0,0,1
"shingrix (zoster vaccine recombinant, adjuvanted)",1,0,0,0,0,1
sildenafil,0,1,0,0,0,1
sildenafil citrate,0,0,0,1,0,1
simha kriya,0,1,0,0,0,1
simple chest tomography,0,1,0,0,0,1
simple cognitive task,0,1,0,0,0,1
simple inflammatory biomarkers measurement,0,0,0,1,0,1
simulation intervention,0,0,0,1,0,1
simulation of repurposed drugs for covid-19,1,0,0,0,0,1
simulation training,0,1,0,0,0,1
simvastatin,0,0,0,1,0,1
single-nucleotide polymorphisms (snp) within the tcra,0,0,0,1,0,1
single-nucleotide polymorphisms (snp) within the tcra/d region,0,0,0,1,0,1
single high dose vitamin d,1,0,0,0,0,1
single passive leg movement,0,1,0,0,0,1
singstrong: strong lungs through song,0,1,0,0,0,1
sinopharm,0,0,0,1,0,1
sinopharm vaccine,0,0,0,1,0,1
sir1-365,1,0,0,0,0,1
sirukumab,0,1,0,0,0,1
sit-to-stand test,0,1,0,0,0,1
sit to stand (sts) measurement,0,0,0,1,0,1
sit to stand test,0,0,0,1,0,1
six-minute walk test (6mwt),0,0,0,1,0,1
six minutes walk test,0,1,0,0,0,1
sledd with a l-mod,0,0,0,1,0,1
sleep diagnostics,0,0,0,1,0,1
sleep education program,0,0,0,1,0,1
sleepio,0,0,0,1,0,1
sleeve gastrectomy,0,0,1,0,0,1
sm-ema,0,1,0,0,0,1
smartphone-based voice,0,1,0,0,0,1
smartphone-based voice/self-reported symptom collection,0,1,0,0,0,1
smartphone technology,1,0,0,0,0,1
smell retraining,0,0,0,1,0,1
smf,0,1,0,0,0,1
smoflipid,0,1,0,0,0,1
smoliv,0,0,0,1,0,1
sms-based support,1,0,0,0,0,1
sms delivery of information,0,0,0,1,0,1
sms message support,0,1,0,0,0,1
sno,1,0,0,0,0,1
soap distributed but no activities of the hbcc project,1,0,0,0,0,1
soc / ifx-1,0,0,0,1,0,1
soc / intravenous famotidine,0,1,0,0,0,1
soc therapy,0,1,0,0,0,1
soc/15mg/kg eb05 iv,0,0,0,1,0,1
soc/placebo iv,0,0,0,1,0,1
social,0,0,0,1,0,1
social distancing,0,1,0,0,0,1
social media,0,1,0,0,0,1
social media campaigns encouraging cancer screening.,0,0,0,1,0,1
social media/news consumption,0,1,0,0,0,1
social norm,0,1,0,0,0,1
social proof,0,1,0,0,0,1
socialization,1,0,0,0,0,1
sociodemographic,0,1,0,0,0,1
"sociodemographic/health, daily self-assessment,/feasibility of using the opal app for covid",0,1,0,0,0,1
sodium bicarbonate 150meq,0,0,0,1,0,1
sodium bicarbonate 150meq/l/d5w inj,0,0,0,1,0,1
sodium bicarbonate solution,1,0,0,0,0,1
sodium chloride,0,0,0,1,0,1
"sodium chloride, 0.9%",0,0,0,1,0,1
"sodium chloride, usp, for injection (0.9% nacl)",1,0,0,0,0,1
sodium pyruvate,0,0,0,1,0,1
sodium pyruvate nasal spray,1,0,0,0,0,1
sofosbuvir 400 mg,0,0,0,1,0,1
sofosbuvir 400 mg/daclatasvir 200mg,0,0,0,1,0,1
sofosbuvir ledipsavir,0,0,0,1,0,1
sofusbuvir,0,0,0,1,0,1
sofusbuvir / daclastavir 60 mg,0,0,0,1,0,1
solicited common,0,0,0,1,0,1
"solicited common/expected adverse reactions shortly following vaccination (reactogenicity), use of antipyretic/pain medications/unsolicited adverse events/serious adverse events",0,0,0,1,0,1
soluble urokinase plasminogen activator receptor,0,1,0,0,0,1
solution-focused support program,0,0,0,1,0,1
sonclot coagulation,0,1,0,0,0,1
"sonclot coagulation/platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
sonoclot,0,0,0,1,0,1
SOP,0,0,0,1,0,1
sorbitol,0,0,0,1,0,1
soterix tavns model 0125-lte stimulator - active-active group,1,0,0,0,0,1
soterix tavns model 0125-lte stimulator - sham-active group,1,0,0,0,0,1
soton hyperinflammation score,1,0,0,0,0,1
sotrovimab,0,0,0,1,0,1
sotrovimab (gen1),1,0,0,0,0,1
sotrovimab (gen2),1,0,0,0,0,1
sp16 (12 mg),0,0,0,1,0,1
sp16 (6mg),0,0,0,1,0,1
spartan covid-19 platform,0,0,0,1,0,1
spartan covid-19 system,0,1,0,0,0,1
spartan covid-19 test,0,1,0,0,0,1
spartan covid-19 v2 system,0,1,0,0,0,1
specific anti-sars-cov-2 antibodies,0,1,0,0,0,1
specific antibody,0,0,0,1,0,1
specific antibody/cellular immune response after anti-sars-cov-2 vaccine administration,0,0,0,1,0,1
specific exercise rehabilitation treatment,0,0,0,1,0,1
specificity) for covid-19 diagnosis of the vocus ptr-tof process,0,0,0,1,0,1
specimen collection,0,0,0,1,0,1
specimens specific for the study,0,0,0,1,0,1
speed of processing training,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia,0,1,0,0,0,1
speq (specific psychotic experiences questionnaire) - paranoia/grandiosity subscales,0,1,0,0,0,1
sperm analysis,0,0,1,0,0,1
sperm collection,0,0,0,1,0,1
sperm test,0,0,0,1,0,1
sphenopalatine ganglion block with local anesthetic,0,0,0,1,0,1
sphenopalatine ganglion block with placebo (isotone nacl),0,0,0,1,0,1
spike protein (s),0,1,0,0,0,1
spike protein (s)/the nucleocapsid (n) of sars-cov-2,0,1,0,0,0,1
spikevax (mrna-1273),0,0,0,1,0,1
spin-chat program,0,1,0,0,0,1
spinal anesthesia induced hypotension in sars-cov-2 patients.,0,1,0,0,0,1
"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",0,0,1,0,0,1
spironolactone / dexamethasone,0,0,0,1,0,1
spironolactone 25 mg pillules oral use,0,0,0,1,0,1
sputnik light,1,0,0,0,0,1
sputnik v,1,0,0,0,0,1
sras-cov-2 vaccination immunological response,0,0,0,1,0,1
sse educational intervention,0,1,0,0,0,1
st. george's respiratory questionnaire (sgrq),0,0,0,1,0,1
st266,0,0,0,1,0,1
staff wellbeing centres,0,1,0,0,0,1
staging laparoscopy,0,1,0,0,0,1
standard-of-care sars-cov-2 treatment,0,0,0,1,0,1
standard care/monitoring,0,0,0,1,0,1
standard care/placebo,0,0,0,1,0,1
standard charity resources,1,0,0,0,0,1
standard dosage inactivated vaccine,0,0,0,1,0,1
standard dose of chadox1 ncov-19 (azd1222),0,0,0,1,0,1
standard enteral nutrition,0,1,0,0,0,1
standard guidelines,0,1,0,0,0,1
standard interface,0,1,0,0,0,1
standard message,0,1,0,0,0,1
standard of care (soc)/colchicine/rosuvastatin,0,0,0,1,0,1
standard of care anticoagulation in absence of thrombotic complications,0,0,0,1,0,1
standard of care anticoagulation in combination with elastic compression,0,0,0,1,0,1
standard of care anticoagulation in presence of thrombotic complications,0,0,0,1,0,1
standard of care covid-19 swab,0,0,0,1,0,1
standard of care for covid-19 as per the hospital guidelines,0,1,0,0,0,1
standard of care non-helmet based cpap ventilation,0,0,0,1,0,1
standard of care thromboprophylaxis,0,0,0,1,0,1
standard of care_1,0,1,0,0,0,1
standard of care_2,0,1,0,0,0,1
standard of health care,0,0,0,1,0,1
standard oxygen delivery system,0,1,0,0,0,1
standard pcp outreach,0,1,0,0,0,1
standard prophylactic dose enoxaparin,0,1,0,0,0,1
standard prophylactic dose enoxaparin/ unfractionated heparin,0,1,0,0,0,1
"standard q covid-19 ag - test, produced by sd biosensor inc.",0,1,0,0,0,1
standard supportive treatment,0,0,0,1,0,1
standard therapy for covid-19 patient,0,1,0,0,0,1
standard therapy protocol (stp),1,0,0,0,0,1
standard therapy recommended by the ministry of health of the russian federation/leitragin inhalation,0,1,0,0,0,1
standard therapy recommended by the ministry of health of the russian federation/leitragin intramuscular injection,0,1,0,0,0,1
standard therapy recommended by the ministry of health of the russian federation/leitragin intramuscular injection/with leitragin inhalation,0,1,0,0,0,1
standard treatment covid-19,0,0,0,1,0,1
standard treatment covid-19 / triazavirin,0,0,0,1,0,1
standardized brazilian green propolis extract,0,0,0,1,0,1
stat-205,0,0,0,1,0,1
state-trait anxiety inventory scale,0,0,0,1,0,1
statins,1,0,0,0,0,1
stay connected,0,0,0,1,0,1
stc-19,0,1,0,0,0,1
stc3141,0,0,0,1,0,1
steam inhalations,0,0,0,1,0,1
stellate ganglion block,0,0,0,1,0,1
stepped-care model,0,0,0,1,0,1
stereotype threat manipulation,0,0,0,1,0,1
sterile normal saline (0.9%),0,0,0,1,0,1
steroid,0,1,0,0,0,1
steroid taper (prednisone),0,1,0,0,0,1
steroid/anticoagulants according to different protocols.,0,1,0,0,0,1
sti-5656,0,1,0,0,0,1
stigma awareness video intervention,0,1,0,0,0,1
stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,0,0,0,1,0,1
stool analysis,0,0,0,1,0,1
stools,0,0,0,1,0,1
stop processing,0,0,0,1,0,1
stopcov,1,0,0,0,0,1
stp,1,0,0,0,0,1
stp / covid-19 convalescent plasma (cp),1,0,0,0,0,1
stp / standard plasma (sp),1,0,0,0,0,1
strength rmt,0,0,0,1,0,1
strength rmt/nasal breathing,0,0,0,1,0,1
strengthening exercise,0,1,0,0,0,1
stress first aid,0,0,0,1,0,1
stress levels,0,1,0,0,0,1
stress levels/mental well-being assessment,0,1,0,0,0,1
stress scale,0,0,0,0,1,1
stress test,0,1,0,0,0,1
stress/anxiety questionnaire,0,0,0,1,0,1
stress/emotion management,0,0,0,1,0,1
stri formula,0,0,0,1,0,1
striveweekly,0,0,1,0,0,1
stroke related metrics during the pandemic,0,1,0,0,0,1
student-senior isolation prevention partnership (ssipp),0,0,0,1,0,1
study a,0,0,0,1,0,1
study b,0,0,0,1,0,1
study c,0,0,0,1,0,1
study d,0,0,0,1,0,1
study of immune-mediated mechanisms in patients tested positive for sars-cov-2,0,0,0,1,0,1
study of the synthesis of antibodies directed against sars,0,0,0,1,0,1
study questionnaire,0,0,0,1,0,1
su,1,0,0,0,0,1
subacute rehabilitation,0,0,0,1,0,1
sublingual methylene blue,0,0,0,1,0,1
sublingual micro-dose ketamine,1,0,0,0,0,1
substance use disorders using prolonged exposure (cope),0,0,0,1,0,1
subunit recombinant vaccine for the prevention of coronavirus infection,1,0,0,0,0,1
sudarshan kriya yoga (sky),1,0,0,0,0,1
sulfur hexafluoride lipid-type a microspheres,0,0,0,1,0,1
sulodexide,0,1,0,0,0,1
sun exposure,0,0,0,0,1,1
"supar, c-reactive protein, ferritin, d-dimer, procalcitonin, interleukin-6, lactate dehydrogenase",1,0,0,0,0,1
supervised rehabilitation program.,0,0,0,1,0,1
supervised stretching,0,1,0,0,0,1
supervised stretching/strengthening exercise,0,1,0,0,0,1
supine position,0,1,0,0,0,1
supine positioning,0,0,0,1,0,1
support,0,0,0,1,0,1
support as usual,0,0,0,1,0,1
supportive services,0,0,0,1,0,1
supportive services.,0,0,0,1,0,1
supportive therapy,0,0,0,1,0,1
supportive therapy ssi,0,1,0,0,0,1
supportive tratment,1,0,0,0,0,1
supportive/symptomatic treatment,1,0,0,0,0,1
surfactant,1,0,0,0,0,1
surge capacity,0,1,0,0,0,1
surge index,0,1,0,0,0,1
"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",0,1,0,0,0,1
surgical face mask use only,0,1,0,0,0,1
surgical facial mask,0,1,0,0,0,1
surgical procedure for cancer,0,0,0,1,0,1
surgical procedures performed under general anesthesia,0,1,0,0,0,1
surgical repair,0,0,0,1,0,1
survey of acceptability of the different self-samples.,0,1,0,0,0,1
survey of sars-cov-19 knowledge,0,1,0,0,0,1
survey/questionnaire,1,0,0,0,0,1
surveys/questionnaires,0,1,0,0,0,1
susceptibility to infection,0,1,0,0,0,1
suspension,0,0,0,1,0,1
suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,0,0,0,1,0,1
swabbing of conjunctiva,0,1,0,0,0,1
swallowing evaluation with the eat-10,0,0,0,1,0,1
swallowing evaluation with the eat-10/the volume-viscosity swallowing test (v-vst),0,0,0,1,0,1
sweat samples (covidog ancillary study),1,0,0,0,0,1
symbicort,0,0,0,0,1,1
symptom,0,1,0,0,0,1
symptom survey,1,0,0,0,0,1
symptom/exposure surveys,0,1,0,0,0,1
symptomatic drugs,0,0,0,1,0,1
symptomatic treatment,1,0,0,0,0,1
symptomatic treatment (paracetamol,0,0,0,1,0,1
symptomatic treatment (paracetamol),0,0,0,1,0,1
symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
"symptomatology, treatment. daily activities",0,0,0,1,0,1
symptoms,0,0,0,1,0,1
synthetic mva-based sars-cov-2 vaccine coh04s1,0,0,0,1,0,1
synthetic neutralising antibodies,0,0,0,1,0,1
systemic methylprednisolone,0,0,0,1,0,1
t-cell receptor,0,0,0,1,0,1
t-detect covid t-cell blood test,0,1,0,0,0,1
t-detect covid test,0,0,0,1,0,1
t cell derived exosom,1,0,0,0,0,1
t memory cells,0,0,0,1,0,1
t memory cells/nk cells,0,0,0,1,0,1
t regulatory cells,0,0,0,1,0,1
t3 solution,0,0,0,0,1,1
tab,0,0,0,1,0,1
tablets,0,1,0,0,0,1
tafenoquine oral tablet,1,0,0,0,0,1
tailored best practices,0,0,0,1,0,1
tailored information,0,0,0,1,0,1
tailored recommendations,0,0,0,1,0,1
tak-019,1,0,0,0,0,1
tak-919,1,0,0,0,0,1
take home saliva kit,1,0,0,0,0,1
taking biological samples,0,0,0,1,0,1
tape-software,0,0,0,1,0,1
targeted message,0,0,0,1,0,1
taste/olfactory function evaluation,0,1,0,0,0,1
tavr,1,0,0,0,0,1
tavr/savr,1,0,0,0,0,1
tazobactam,0,0,0,1,0,1
tcc-covid mhealth,0,0,0,1,0,1
tcm,0,1,0,0,0,1
td139,1,0,0,0,0,1
tears swab,0,1,0,0,0,1
technology based social interactions,0,1,0,0,0,1
telacebec,0,0,0,1,0,1
tele-delivered psychological intervention,0,0,0,1,0,1
tele-exergaming tablet,0,0,0,1,0,1
tele-interventions related to diabetes management,0,1,0,0,0,1
tele-interventions related to diabetes management/mental well-being,0,1,0,0,0,1
tele-pulmonary rehabilitation,0,0,0,1,0,1
tele-rheumatology,0,0,0,1,0,1
telecare group,0,0,0,1,0,1
teleconsultation either by phone/by computer consultation,0,1,0,0,0,1
teleconsultation either by phone/by computer consultation. quantitative/qualitative approaches to analysis,0,0,0,1,0,1
telegeriatric intervention,0,1,0,0,0,1
telehealth monitoring,0,1,0,0,0,1
telehealth/counselling,1,0,0,0,0,1
telemedicine in the form virtual clinic via video consultation,0,1,0,0,0,1
telemedicine visit,0,0,0,1,0,1
telemonitoring,0,0,0,1,0,1
telemonitoring/teleorientation,0,0,0,1,0,1
teleorientation/tooth brushing orientation,0,0,0,1,0,1
telephone consult,0,0,0,1,0,1
telephone follow-up,0,1,0,0,0,1
telephone interview,1,0,0,0,0,1
telepsychoeducation,0,0,1,0,0,1
telepsychoeducation with personalized videos,0,0,1,0,0,1
telepsychoeducation without personalized videos,0,0,1,0,0,1
telepsychotherapy,0,0,0,1,0,1
telerehabilitation-based relaxation exercise group (eg),0,0,0,1,0,1
telesimulation,0,1,0,0,0,1
telestroke,0,1,0,0,0,1
telmisartan 20mg oral tablet,0,0,0,1,0,1
telmisartan 40mg oral tablet,0,0,0,1,0,1
telmisartan oral product,0,0,0,1,0,1
tem-tpa,0,1,0,0,0,1
tempol,0,0,0,1,0,1
tenecteplase,0,0,1,0,0,1
tenofovir,0,1,0,0,0,1
tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],0,0,0,1,0,1
tenofovir disoproxil/emtricitabine,0,1,0,0,0,1
tenofovir disoproxyl fumarate 300 mg,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg oral tablet,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg/emtricitabine 200 mg oral tablet,0,0,0,1,0,1
tensile strength,0,1,0,0,0,1
terabio ltd.,0,0,0,1,0,1
test group: experimental - uvc therapy applied,1,0,0,0,0,1
test rt-pcr,0,1,0,0,0,1
tested for sars-cov-2 (regardless of the result),0,1,0,0,0,1
testing,0,0,0,1,0,1
testing for sars-cov-2,0,1,0,0,0,1
testing for sars-cov-2 igm,0,0,0,1,0,1
testing for sars-cov-2 igm/igg,0,0,0,1,0,1
testing for sars-cov-2 rna,0,0,0,1,0,1
testing in lab offices,0,0,0,1,0,1
testing in poc offices,0,0,0,1,0,1
testing sensitivity for sars-cov-2 virus in symptomatic individuals,0,1,0,0,0,1
testing with medical detection dogs,0,0,0,1,0,1
testis pathology samples,0,0,0,1,0,1
testnpass,0,1,0,0,0,1
tetracycline hydrochloride 3%,0,1,0,0,0,1
tetrandrine,0,0,1,0,0,1
tetravalent influenza virus lysis vaccine,0,0,0,1,0,1
text material for psychoeducation,0,0,0,1,0,1
text material for psychoeducation/audio for relaxation techniques,0,0,0,1,0,1
text message,1,0,0,0,0,1
th17 cytokine profile,0,0,0,1,0,1
"the demographic, clinical, laboratory,",0,1,0,0,0,1
"the demographic, clinical, laboratory,/instrumental data",0,1,0,0,0,1
the drugs used before,0,1,0,0,0,1
"the drugs used before/during the pandemic, the patient's job status, physical activity conditions, pain status",0,1,0,0,0,1
the effects of covid 19 pandemic on the cardiovascular heath of children with autism spectrum disorder,1,0,0,0,0,1
the icp monitoring will be performed in a non-invasive method developed by brain4care,0,0,0,1,0,1
the leisure time activity,0,1,0,0,0,1
the management of severe covid-19 cases,1,0,0,0,0,1
the nucleocapsid (n) of sars-cov-2,0,1,0,0,0,1
the pine trees health test system,0,1,0,0,0,1
the placenta,0,1,0,0,0,1
the psychosocial effects of covid-19 pandemic on dental professionals,0,1,0,0,0,1
the quality of life in individuals recovered from covid-19 infection: a survey from pakistan,0,1,0,0,0,1
the sars-cov-2 inactivated vaccine,0,0,0,1,0,1
the standard protocol only,0,1,0,0,0,1
"the study evaluates all surgical patients operated, both elective scheduled",0,1,0,0,0,1
"the study evaluates all surgical patients operated, both elective scheduled/emergent cases",0,1,0,0,0,1
the use of the mentalplusâ® digital game for assessment,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment/rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
theophylline powder,0,0,0,1,0,1
theory-based messages,0,1,0,0,0,1
therapeutic exercise/education,0,0,1,0,0,1
therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3),0,0,0,1,0,1
theraputic heparin,0,0,0,1,0,1
therapy during the completed rct diqol,0,1,0,0,0,1
therapy intervention,0,1,0,0,0,1
there is no intervention in this study,0,0,0,1,0,1
there is no intervention in this study.,0,0,0,1,0,1
there is no intervention; the study is observational,0,0,1,0,0,1
third dose vaccination with biontech vaccine,0,0,0,1,0,1
third dose vaccination with coronavac vaccine,0,0,0,1,0,1
"this is an observational cross-sectional study, there is no need for intervention",0,0,0,1,0,1
this is an observational study,0,0,0,1,0,1
this is observational study,0,0,0,1,0,1
thoracic computed tomography scan,0,0,1,0,0,1
thoracic ct,0,0,0,1,0,1
thoracic ct-scan,0,0,0,1,0,1
thoracic lung ultrasound,0,1,0,0,0,1
thorax ct,1,0,0,0,0,1
thoraxic computed tomography,0,0,0,1,0,1
three dose regimen,0,0,0,1,0,1
three doses of bnt162b2 (observational),0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1,0,0,0,0,1
three doses of high dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1,0,0,0,0,1
three doses of high dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1,0,0,0,0,1
three doses of medium dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1,0,0,0,0,1
three doses of medium dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1,0,0,0,0,1
"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
three doses of placebo at the emergency vaccination schedule,1,0,0,0,0,1
three doses of placebo at the routine vaccination schedule,1,0,0,0,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",0,0,0,1,0,1
three doses of sars-cov-2 bnt162b2 vaccine (observational),0,0,0,1,0,1
throat spray,0,0,0,1,0,1
throat swab sample for measuring current infection with sars-cov-2,0,1,0,0,0,1
throat/nose swabs,0,1,0,0,0,1
thrombin,1,0,0,0,0,1
thrombophilia screening,0,0,0,1,0,1
thromboprofylaxis protocol,0,1,0,0,0,1
thymic peptides,0,1,0,0,0,1
thymosin,0,0,0,1,0,1
thyroidectomy,0,1,0,0,0,1
tigeraseâ®,0,1,0,0,0,1
tigeraseâ®/best available care,0,1,0,0,0,1
time management,0,1,0,0,0,1
time management/participation/the leisure time activity,0,1,0,0,0,1
"tinzaparin, high dose prophylactic anticoagulation",0,0,0,1,0,1
"tinzaparin, low dose prophylactic anticoagulation",0,0,0,1,0,1
"tinzaparin,therapeutic anticoagulation",0,0,0,1,0,1
tirofiban,0,1,0,0,0,1
tj003234,0,0,0,1,0,1
tl-895,0,1,0,0,0,1
tlrs activation measurement,0,1,0,0,0,1
tm5614,0,0,0,1,0,1
tmd) scale,0,1,0,0,0,1
tmu-love,0,1,0,0,0,1
tnkase,0,0,0,0,1,1
to an anterior nare self-swabbing (self-samples),0,1,0,0,0,1
to be given as a treatment,0,0,0,1,0,1
to determine the prevalence of renal dysfunction in hospitalized children with covid19 in qatar.,0,0,0,1,0,1
to monitor the effectiveness of the single dose ad26.cov2.s covid-19 vaccine,0,0,0,1,0,1
tobacco use,1,0,0,0,0,1
tociliuzumab,0,1,0,0,0,1
tociliziumab group,1,0,0,0,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1,0,0,0,0,1,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),0,0,0,0,1,1
tocilizumab 200 mg,0,1,0,0,0,1
tocilizumab 200 mg/10 ml (20 mg/ml) intraven vial (ml),0,1,0,0,0,1
tocotrienols,0,0,0,1,0,1
tocotrienols / vitamin e,0,0,0,1,0,1
tof protocol,0,1,0,0,0,1
together for wellness digital mental health website,0,0,1,0,0,1
tomography angiography,0,1,0,0,0,1
tools development,0,0,0,1,0,1
tooth brushing orientation,0,0,0,1,0,1
toothpaste with sodium fluoride,0,0,1,0,0,1
toothpaste with sodium fluoride/zinc,0,0,1,0,0,1
toothpaste with sodium monofluorophosphate,0,0,1,0,0,1
toothpaste with tin fluoride,0,0,1,0,0,1
topotecan,0,0,0,1,0,1
tozinameran,0,0,0,1,0,1
tpa,0,1,0,0,0,1
tq formula,0,0,0,1,0,1
tq formula/tab,0,0,0,1,0,1
tr,0,1,0,0,0,1
tracheostomy,0,0,0,1,0,1
tracheostomy with aerosol box in covid-19 positive patients,0,1,0,0,0,1
tracheotomy,0,1,0,0,0,1
track u,0,0,1,0,0,1
tradipitant,0,0,1,0,0,1
traditional chinese version of the university of pennsylvania of smell identification test (upsit-tc),0,1,0,0,0,1
traditional covid -19 therapy,0,0,0,1,0,1
traditional proning arm,0,1,0,0,0,1
training,0,1,0,0,0,1
training clinicians in basic critical care,1,0,0,0,0,1
training clinicians in basic critical care/the management of severe covid-19 cases,1,0,0,0,0,1
"training for awareness, resilience,",0,1,0,0,0,1
"training for awareness, resilience,/action (tara)",0,1,0,0,0,1
training in surgery,0,1,0,0,0,1
training load,1,0,0,0,0,1
"training of youth, community health assistants",1,0,0,0,0,1
"training of youth, community health assistants/community health workers.",1,0,0,0,0,1
training session adressing information,0,0,0,1,0,1
training session adressing information/health literacy,0,0,0,1,0,1
"training video on anxiety, fear",0,0,0,1,0,1
"training video on anxiety, fear/loneliness in the covid-19 environment.",0,0,0,1,0,1
tranexamic acid,0,0,0,0,1,1
trans sodium crocetinate,0,1,0,0,0,1
transcendental meditation,0,1,0,0,0,1
transcranial direct-current stimulation,0,1,0,0,0,1
transcutaneous auricular vagus nerve stimulation,0,1,0,0,0,1
transfer package from ci therapy,0,0,0,1,0,1
transfusion of sars-cov-2 convalescent plasma.,0,0,0,1,0,1
transfusion of standard plasma.,0,0,0,1,0,1
transparent sheet,0,1,0,0,0,1
transplant patient,0,1,0,0,0,1
transpulmonary pressure measurements,0,0,0,1,0,1
transpulmonary thermodilution,0,1,0,0,0,1
transthoracic echocardiogram (tte),0,0,0,1,0,1
trauma-informed yoga video recording,0,1,0,0,0,1
trauma informed psychotherapy,0,1,0,0,0,1
trauma informed yoga,0,1,0,0,0,1
travelan otc,1,0,0,0,0,1
treadmill exercise,0,0,0,1,0,1
treamid,0,1,0,0,0,1
treated with hyperimmune plasma,0,0,0,1,0,1
treatment,0,1,0,0,0,1
treatment as usual,0,0,0,1,0,1
treatment as usual vitamin d,1,0,0,0,0,1
treatment data collect,0,1,0,0,0,1
treatment for covid-19,0,0,0,1,0,1
treatment group,0,1,0,0,0,1
treatment/prophylaxis,0,1,0,0,0,1
trial-based cognitive therapy,0,0,0,1,0,1
triazavirin,0,0,0,1,0,1
triazavirin (riamilovir),0,0,0,1,0,1
tridecactide,0,1,0,0,0,1
trier social stress test,0,0,0,1,0,1
trimetazidine,0,0,0,1,0,1
trimodulin,1,0,0,0,0,1
trimoxazole,0,0,0,1,0,1
trivalent split influenza vaccine,1,0,0,0,0,1
trust in science message,0,1,0,0,0,1
tsu,0,1,0,0,0,1
tsvf,0,0,0,1,0,1
tuberculin,0,0,0,1,0,1
turcovac,0,0,0,1,0,1
turkish physicians,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083/v-591) administrations - high dose,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083/v-591) administrations - low dose,0,1,0,0,0,1
two dose chadox1 ncov-19,1,0,0,0,0,1
two dose chadox1 ncov-19/covishield 0.25ml/0.5ml,1,0,0,0,0,1
two dose chadox1 ncov-19/covishield 0.5ml,1,0,0,0,0,1
two dose menacwy vaccine min. 4 weeks apart,1,0,0,0,0,1
two dose regimen,0,0,0,1,0,1
two doses of bnt162b2 vaccine,1,0,0,0,0,1
"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,1,0,0,0,1
two doses of coronavac/one dose bnt162b2 (observational),0,0,0,1,0,1
two doses of coronavac/one dose of bnt162b2 sars-cov-2 vaccine (observational),0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28",0,1,0,0,0,1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28/one dose quadrivalent influenza vaccine on day 0/day 28.",0,1,0,0,0,1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28/one dose quadrivalent influenza vaccine on day 14.",0,1,0,0,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,1,0,0,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",0,1,0,0,0,1
"two doses of placebo at the schedule of day 0, 14 #high-dose group#",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",0,0,0,1,0,1
type ii diabetes mellitus,0,0,0,1,0,1
type ii diabetes mellitus/covid-19 group (group ii),0,0,0,1,0,1
type of treatment,1,0,0,0,0,1
uexplorer,0,0,0,1,0,1
uexplorer/mct,0,0,0,1,0,1
ultra-micronized palmitoylethanolamide (mpea,0,1,0,0,0,1
ultra brief online mindfulness-based intervention,0,1,0,0,0,1
ultra sound,0,1,0,0,0,1
ultraprotective ventilation,0,0,0,1,0,1
umifenovir,0,0,1,0,0,1
"umpea, 300mg",0,1,0,0,0,1
unavailable covid test result - hypothetical scenario,0,1,0,0,0,1
unfractionated heparin iv,0,0,0,1,0,1
unfractionated heparin sc,0,0,0,1,0,1
uni911 inhalation 1%,0,1,0,0,0,1
uni911 inhalation 1%/intranasal spray 1%,0,1,0,0,0,1
unified protocol for covid-19 parenting stress (up-covid),0,1,0,0,0,1
unsolicited adverse events,0,0,0,1,0,1
unsupervised physical activities,0,0,0,1,0,1
upper limb training,0,0,0,1,0,1
uproleselan,0,0,0,1,0,1
uptake of covid-19 testing,0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load",0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load/metabolomic",0,0,0,1,0,1
urine collection,0,0,0,1,0,1
urine pregnancy test for women of childbearing potential,0,0,0,1,0,1
urine samples,1,0,0,0,0,1
usability,0,1,0,0,0,1
usb002,0,0,0,1,0,1
use,0,1,0,0,0,1
use of continuous positive airway pressure,0,1,0,0,0,1
use of facetime with child,0,0,0,1,0,1
use of facetime with child/parents during induction,0,0,0,1,0,1
use of high flow nasal cannula alone,0,1,0,0,0,1
use of non-invasive ventilation,0,1,0,0,0,1
use of social media during covid-19,0,1,0,0,0,1
"use of the pinpointiq solution (physiq, inc.)",0,1,0,0,0,1
use of virus (covid-19) genome sequence report to inform infection prevention control procedures,0,1,0,0,0,1
use/exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
users,0,1,0,0,0,1
using practice facilitators to support physicians,1,0,0,0,0,1
usual antibiotic treatment,0,1,0,0,0,1
usual care control,0,0,0,1,0,1
usual care only,0,0,0,1,0,1
usual care positioning with no instructions,0,0,0,0,1,1
usual care treatment,0,1,0,0,0,1
"usual care, infection control briefing",0,0,0,1,0,1
usual monitoring,0,0,0,1,0,1
usual orientations,0,0,0,1,0,1
usual practice / symbicort rapihaler,0,0,0,0,1,1
usual treatments in intensive care unit according to the current state of knowledge,0,0,0,1,0,1
utooth btc),0,0,0,1,0,1
uttr1147a,0,1,0,0,0,1
uv light treatment,0,1,0,0,0,1
uva light emitting catheter,0,0,0,1,0,1
v,0,0,0,1,0,1
v-591) administration - high dose,0,1,0,0,0,1
v-591) administrations - high dose,0,1,0,0,0,1
v-591) administrations - low dose,0,1,0,0,0,1
v-sars,1,0,0,0,0,1
v hydrogen peroxide,1,0,0,0,0,1
v povidone-iodide,1,0,0,0,0,1
v) saline,0,1,0,0,0,1
v/q spect-ct,0,0,0,1,0,1
v590,0,0,0,0,1,1
v591,0,0,0,0,1,1
vaccinated pregnant,0,1,0,0,0,1
vaccinated pregnant/lactating persons,0,1,0,0,0,1
vaccinated with polio vaccine (ipv),1,0,0,0,0,1
vaccination against covid19,0,0,0,1,0,1
vaccination with biontech vaccine,0,0,0,1,0,1
vaccination with coronavac vaccine,0,0,0,1,0,1
vaccination.,0,0,0,1,0,1
vaccine 1 dose,0,0,0,1,0,1
vaccine 1 dose / placebo,0,0,0,1,0,1
vaccine 2 dose,0,0,0,1,0,1
vaccine 2 dose / placebo,0,0,0,1,0,1
vaccine 3 dose,0,0,0,1,0,1
vaccine anti-covid19,0,0,0,1,0,1
vaccine coverage assessment,0,1,0,0,0,1
vaccine for intramuscular injection,0,1,0,0,0,1
vaccine inoculation against sars-cov-2,0,0,0,1,0,1
vaccine therapy,0,0,0,1,0,1
vaccine: bnt162b2 10mcg,0,0,0,1,0,1
vaccine: bnt162b2 3mcg,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
vaccine: sars-cov-2 vaccine,0,0,0,1,0,1
vadadustat,0,0,0,1,0,1
validation of the lamp assays,0,0,0,1,0,1
validation of the ngs method,0,0,0,1,0,1
validation of the poct antigen,0,0,0,1,0,1
validation of the poct antigen/antibody tests,0,0,0,1,0,1
valsartan oral tablet [entresto],0,0,0,1,0,1
varespladib,0,0,0,1,0,1
vas scale,0,0,0,1,0,1
vascular occlusion test,0,0,0,1,0,1
vaxzevria,0,0,0,1,0,1
vaxzevria (astrazeneca),0,0,0,1,0,1
vb-201,0,0,0,1,0,1
vb-201 / standard of care,0,0,0,1,0,1
vb10.2129,0,0,0,1,0,1
vb10.2210,0,0,0,1,0,1
vbi-2902a,0,0,0,1,0,1
vbi-2905a,0,0,0,1,0,1
vcpm,0,1,0,0,0,1
vehicle,0,1,0,0,0,1
vehicle / heparin along with best supportive care,0,1,0,0,0,1
vehicle control,0,1,0,0,0,1
venipuncture in peripheral vein,0,0,0,1,0,1
venous,0,0,0,1,0,1
venous bleeding,1,0,0,0,0,1
venous blood collection,0,1,0,0,0,1
venous blood sample,0,1,0,0,0,1
venous blood was collected for biochemistry testing,0,1,0,0,0,1
venous blood was collected for biochemistry testing.,0,1,0,0,0,1
venous draw,0,0,0,1,0,1
venous draw/testing,0,0,0,1,0,1
venous ultrasound of lower extremity,0,0,0,1,0,1
venous/capillary blood sampling,0,0,0,1,0,1
ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),0,1,0,0,0,1
verapamil,0,1,0,0,0,1
vesta respirator,0,0,0,1,0,1
vib7734,0,0,0,0,1,1
video-based intervention,0,1,0,0,0,1
video-based psychotherapy,0,1,0,0,0,1
video _ behavioral change module,1,0,0,0,0,1
video call,0,1,0,0,0,1
video calls,0,1,0,0,0,1
video chat,0,1,0,0,0,1
video chat / basic feedback,0,1,0,0,0,1
video chat /personalized feedback,0,1,0,0,0,1
video dance classes,0,0,0,1,0,1
video laryngoscope,0,0,0,1,0,1
videofluoroscopic swallowing study (vfss),0,0,1,0,0,1
videofluoroscopy,0,0,0,1,0,1
videolaryngoscope,0,0,0,1,0,1
videos,1,0,0,0,0,1
vielight rx plus,1,0,0,0,0,1
views,0,1,0,0,0,1
vir-7832,0,0,0,1,0,1
viral sequence,0,0,0,1,0,1
viral vector vaccine booster,1,0,0,0,0,1
virazole,0,1,0,0,0,1
virgin coconut oil,0,0,0,1,0,1
virgin coconut oil (vco),0,0,0,1,0,1
virtual-care cognitive behavioural therapy,0,0,0,1,0,1
"virtual assistant first, then human coach",0,0,0,1,0,1
virtual care at home,0,0,0,1,0,1
virtual elm,0,1,0,0,0,1
virtual family-based treatment,1,0,0,0,0,1
virtual group exercise,1,0,0,0,0,1
virtual group intervention,0,1,0,0,0,1
virtual individual cognitive simulation therapy,0,0,0,1,0,1
virtual meeting between patients,0,0,0,1,0,1
virtual meeting between patients/physicians/caregiver,0,0,0,1,0,1
virtual mindfulness meditation,0,0,0,1,0,1
virtual reality,0,1,0,0,0,1
virtual reality therapy first,1,0,0,0,0,1
virtual realty exercises,0,0,0,1,0,1
virtual village,0,0,1,0,0,1
viruxal oral,0,0,0,1,0,1
viruxal oral/nasal spray,0,0,0,1,0,1
visual analogue scale,0,1,0,0,0,1
visual prompts,0,1,0,0,0,1
vit-d 0.2 mg,0,1,0,0,0,1
vit-d 0.2 mg/ml oral solution [calcidol],0,1,0,0,0,1
vitamin a,0,0,0,1,0,1
vitamin b,0,0,0,1,0,1
vitamin c 500 mg oral tablet,0,0,0,1,0,1
vitamin c tablets,0,0,0,1,0,1
"vitamin c, vitamin b complex",1,0,0,0,0,1
"vitamin c, vitamin b complex/zinc acetate",1,0,0,0,0,1
vitamin c/zinc,0,0,0,1,0,1
vitamin d3 (cholecalciferol),0,0,0,1,0,1
vitamin d3 1000 iu,0,1,0,0,0,1
vitamin d3 10000 iu,0,1,0,0,0,1
"vitamin d3 50,000 iu",0,0,0,1,0,1
vitamin d3/placebo,0,0,0,0,1,1
vitamin k2,0,0,0,1,0,1
vitamin k2 in the form of menaquinone-7 (mk-7),0,0,0,1,0,1
vitamin k2/d,0,0,0,1,0,1
vitamine d3 supplementation,0,0,0,0,1,1
vitamins,0,0,0,1,0,1
vitros anti-sars-cov-2 igg test,0,0,1,0,0,1
vla2001 - adolescent part,0,0,0,1,0,1
vla2101,1,0,0,0,0,1
voclosporin,0,0,0,1,0,1
voice symptom scale (voiss),0,0,0,1,0,1
volatile organic compounds analysis (e-noses),0,0,0,1,0,1
volatile organic compounds analysis (mass spectrometry),0,0,0,1,0,1
volatile organic compounds analysis in sweat (mass spectrometry),0,0,0,1,0,1
volume rapid test,0,0,0,1,0,1
vortioxetine,0,0,0,1,0,1
vr for psychoeducation,0,0,0,1,0,1
vr for psychoeducation/relaxation,0,0,0,1,0,1
vv-ecmo / cytokine adsorption,0,1,0,0,0,1
vxa-cov2-1,1,0,0,0,0,1
vxa-cov2-1.1-s,0,0,0,1,0,1
ward css,0,0,0,1,0,1
watch your weight during the holidays program,1,0,0,0,0,1
water (e) mouth rinse with the solution provided,0,0,0,1,0,1
water without an elevated level of kelea,0,0,0,1,0,1
"wearable devices, saliva samples, survey measures",1,0,0,0,0,1
wearing a face mask at all times,0,1,0,0,0,1
web-application,0,1,0,0,0,1
web-based survey,1,0,0,0,0,1
web application users,0,1,0,0,0,1
web based questionnaire,1,0,0,0,0,1
webex physical activity program,0,0,0,1,0,1
weck-cel swab collection,1,0,0,0,0,1
weekly assessment,0,0,0,0,1,1
well-being assessment,0,1,0,0,0,1
wellness education,0,1,0,0,0,1
wellness webinar,0,0,1,0,0,1
wfi water nebulization,0,0,0,1,0,1
wharton's jelly derived mesenchymal stem cells.,0,0,0,1,0,1
white sender in acknowledgement,0,1,0,0,0,1
white sender in informational videos,0,1,0,0,0,1
who recommendations (waiting condition),0,0,0,1,0,1
who score,0,1,0,0,0,1
whole body vibration training,0,0,0,1,0,1
whole exome sequencing,0,0,0,1,0,1
whoqol-bref,0,0,1,0,0,1
wingate exercise test,0,1,0,0,0,1
wingate exercise test/on-ice testing while wearing a face mask,0,1,0,0,0,1
wingate exercise test/on-ice testing while wearing a sham face mask,0,1,0,0,0,1
with leitragin inhalation,0,1,0,0,0,1
withings scanwatch,0,0,0,1,0,1
without colchicine,0,1,0,0,0,1
woebot substance use disorder,0,1,0,0,0,1
wofb,0,1,0,0,0,1
women sexual dysfunctions were screened using female sexual functioning index (fsfi),0,1,0,0,0,1
written summary of rounds,0,1,0,0,0,1
x-ray,0,0,0,1,0,1
xagrotin,0,1,0,0,0,1
xc7 100 mg single,0,1,0,0,0,1
xc7 200 mg multiple,0,1,0,0,0,1
xc7 200 mg single,0,1,0,0,0,1
xcel-umc-beta,0,0,0,1,0,1
"xiamen wiz biotech co., ltd. sars-cov-2 antigen rapid test",0,1,0,0,0,1
xuanfei baidu granules,0,0,0,1,0,1
xvr011,0,0,0,1,0,1
yoga group,0,1,0,0,0,1
zanubrutinib,0,1,0,0,0,1
zaritt burden interview,0,1,0,0,0,1
zavegepant (bhv-3500),0,0,0,1,0,1
zidovudine,0,1,0,0,0,1
zilucoplan,0,1,0,0,0,1
zilucoplan placebo,0,1,0,0,0,1
zinc (zinc gluconate),0,0,0,1,0,1
zinc (zinc gluconate)/vitamin d (cholecalciferol),0,0,0,1,0,1
zinc citrate,0,0,0,1,0,1
zinc picolinate,1,0,0,0,0,1
zinc sulfate 220 mg,0,1,0,0,0,1
zn,0,0,0,1,0,1
zofin,0,0,0,1,0,1
zotatifin,0,0,0,1,0,1
